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ABSTRACT
Understanding the genetic and molecular basis of behavioral plasticity is an
important question in neurobiology. One such paradigm for behavioral plasticity
involves the ability of C. elegans hermaphrodites to modulate their locomotory rate in
response to the presence of a bacterial lawn, their food source, via a serotonin-
mediated signaling pathway. Mutations in the genes mod-1 and mod-5 affect both
the modulatory behavior and serotonergic neurotransmission.
To further understand how this modulation of locomotory behavior is achieved
we have cloned mod-1 and mod-5. Protein sequence comparisons revealed that
MOD-1 is a ligand-gated ion channel and MOD-5 is a protein similar to mammalian
serotonin reuptake transporters (SERTs).
We have performed electrophysiological analysis of the MOD-1 channel in
Xenopus oocytes and mammalian cells to show that this channel is specifically
gated by serotonin and that it conducts chloride ions, thereby defining a new type of
ionotropic serotonin receptor, a serotonin-gated chloride channel. We have
performed neurotransmitter uptake assays of MOD-5 in mammalian cells to show
that MOD-5-mediated uptake is specific for serotonin and that selective serotonin
reuptake inhibitors such as fluoxetine (Prozac) inhibit such uptake.
We have performed genetic epistasis analysis with mod-1, mod-5, and goa-1
(a G-protein involved in serotonin signaling) to determine the genetic pathway
involved in this modulatory behavior. We have also analyzed the various behavioral
effects of fluoxetine treatment on mod-5 and tph-1 (serotonin-minus) mutants and
determined that fluoxetine can act in C. elegans via both SERT- and serotonin-
dependent and -independent pathways.
Thesis Supervisor: H. Robert Horvitz
Title: Professor of Biology
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Chapter 1
Serotonin in Behavior
11
Introduction
Behavior is the output that ultimately characterizes an individual, be it a worm or a
human. From a reductionist viewpoint, this output is the end product of two inputs,
genes and the environment. The intimate interplay between these two inputs is the
basis for a worm's backing movement and a person's mood. In humans, the impact of
the environment is most relevant to the process of learning and memory. Elucidating the
mechanisms of learning and memory at the level of molecules, cells, organisms, and
particular circumstances is central to our understanding of both normal behavior as well
as disorders of the mind.
The manifestations of learning and memory vary enormously from non-
associative forms of learning such as habituation and sensitization of simple reflexes to
extremely complex processes such as explicit or declarative long-term memory that
allows for the recall of facts and events from decades past. Nevertheless, there appears
to be remarkable conservation in the fundamental mechanisms that mediate this vast
range of outputs from neural circuits. It is this conservation that validates the study of
such higher-order processes in model organisms, where we may manipulate the input
parameters of both genes and environment and record the output.
This dissertation focuses on the analysis of behavior in the nematode
Caenorhabditis elegans. Specifically, we describe that C. elegans hermaphrodites are
capable of a behavior with features similar to processes of learning in other organisms.
This behavior involves one aspect of the response of the animal to the presence of
food, a lawn of the bacterium Escherichia coli. If a well-fed animal is transferred to an
environment where it encounters food, it slightly slows its locomotory rate, a response
that we have termed "the basal slowing response." Additionally, if the animal is deprived
of food for 30 minutes prior to the transfer, the animal slows down dramatically when it
encounters food. We have termed this response of food-deprived animals "the
enhanced slowing response." Although this behavioral paradigm was established
primarily by prior work (Sawin, 1996), I helped complete the initial characterization, and
hence a detailed description of this behavior will be presented in Chapter 2. For the
purposes of this introductory chapter, the reader need only know that the enhanced
slowing response is mediated by the neurotransmitter serotonin and is distinct from the
basal slowing response that is mediated by the neurotransmitter dopamine.
The central finding of this dissertation is that the enhanced slowing response, an
experience-dependent modulatory behavior in C. elegans, requires a novel type of
serotonin receptor - a serotonin-gated chloride channel - and a serotonin reuptake
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transporter. In this chapter, I will begin by discussing the role of serotonin in learning
and memory in the sea slug Aplysia califomica and then discuss what is already known
about serotonin function in C. elegans. I will then dedicate a substantial portion of this
chapter to a discussion of three classes of molecules relevant to the central findings of
this dissertation: serotonin receptors, chloride channels, and serotonin reuptake
transporters.
Serotonin Synthesis, Metabolism, and Expression
Serotonin was first discovered in the circulation system of vertebrates as a potent
regulator of smooth muscle organs and was thought to act primarily as a hormone.
Subsequently, serotonin was found in the central nervous systems of many vertebrates
and invertebrates, where it acts as a neurotransmitter (see special supplement issue of
Neuropsychopharmacology 21 (2S), 1999 for a historical overview on serotonin
biology). This chapter will concern itself primarily with the neuronal functions of
serotonin.
Serotonin is synthesized in a two-step process: The amino acid tryptophan is first
hydroxylated by a specific tryptophan hydroxylase to the intermediate
5-hydroxytryptophan and then decarboxylated by a less-specific aromatic amino acid
decarboxylase to generate 5-hydroxytryptamine (5-HT; serotonin) (Cooper et al., 1996).
Degradation of serotonin occurs via the action of the enzyme monoamine oxidase found
within either the cells that release serotonin or nearby cells (Cooper et al., 1996). For
this metabolism to take place, the serotonin must be cleared from the synaptic cleft by
Na*/C--dependent reuptake transporters (Cooper et al., 1996).
Serotonergic cell bodies in the mammalian brain are restricted to clusters of cells
mainly in the raphe (or midline) regions of the brainstem (Jacobs and Fornal, 1999). The
cells can be divided into two major groups. The rostral group contains the nucleus
centralis superior and the dorsal raphe nucleus and provides serotonin to the forebrain
while the caudal group supplies serotonin to the spinal cord (Jacobs and Fornal, 1999).
Despite this very small localized cluster of cell bodies, the serotonergic neurons appear
to innervate extensive and far-reaching areas of the brain including the hippocampus,
amygdala, medulla, cerebellum, and the cerebral cortex (Martin, 1996).
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Serotonin in Memory and Learning
The best studied experimental model for the role of serotonin in learning is the gill-
withdrawal paradigm in Aplysia. In response to a tactile stimulus, sensory neurons that
innervate the siphon of the animal generate excitatory post-synaptic potentials in
interneurons and motor cells that then lead to the withdrawal of the gill (Castellucci et
al., 1970). If numerous such stimuli are applied repeatedly, the withdrawal response will
lessen, or habituate (Castellucci et al., 1970). This process of habituation is mediated
primarily by a decrease in the production of excitatory output by the sensory neurons
(Castellucci and Kandel, 1974). Massed training, in which such repeated stimuli are
presented without rest between training sessions, will result in short-term habituation,
lasting for only a few minutes. Spaced training, in which the repetitive stimuli are
appropriately spaced over time, can produce long-term habituation lasting several days
to few weeks. Long-term habituation is characterized by a "pruning" of synaptic
connections such that sensory and interneurons come to have fewer than normal
presynaptic terminals (Bailey and Chen, 1983). Serotonin does not play a role in either
short- or long-term habituation.
If the animal is challenged with a noxious stimulus, the reflexive defensive
response to the tactile stimulus is heightened, or sensitized. A shock to the tail
sensitizes the gill-withdrawal reflex (Castellucci and Kandel, 1974). Just as with
habituation, sensitization can be either short- or long-term (Pinsker et al., 1973). While a
single shock results in heightened responses for only five minutes, repeated shocks can
result in sensitization that lasts days to weeks. The interneurons that perceive the tail
shock make axo-axonal (axon-to-axon) connections with the sensory neurons that
mediate the gill-withdrawal reflex (Hawkins and Schacher, 1989). These interneurons
release serotonin that enhances neurotransmitter release from the sensory neurons.
External application of serotonin to the axonal terminal of the sensory neuron mimics
the shock to the tail in its ability to sensitize the gill-withdrawal reflex (Bernier et al.,
1982). In short-term sensitization, serotonin that is released acts via two different G
protein-coupled serotonin receptors, one coupled to adenylyl cyclase (Bernier et al.,
1982) and the other to phospholipase C (PLC) (Byrne et al., 1991). The adenylyl
cyclase generates cAMP, thereby activating protein kinase A (PKA). PKA enhances
neurotransmitter release in two ways: direct activation of presynaptic vesicles (Byrne et
al., 1991) and amplification of neurotransmitter release via an increase in Ca2+ influx
(Eliot et al., 1993). The Ca 2* influx is the indirect result of prolonged action potentials
caused by the phosphorylation and subsequent closure of a K+ channel by PKA (Klein
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et al., 1982) and to a lesser extent by activation of L-type Ca 2 channels by PKA
phosphorylation (Braha et al., 1993). The activation of the second receptor coupled to
PLC stimulates diacylglycerol to activate protein kinase C (Byrne et al., 1991), which
then directly activates vesicles and also phosphorylates L-type Ca 2 channels (Braha et
al., 1993). There are indications that the PKC-mediated phosphorylation of L-type Ca 2
channels might have slower kinetics than the PKA-mediated pathway (Braha et al.,
1993). However, the physiological relevance of these differential kinetics has not been
determined.
Long-term sensitization also uses the same serotonin-signaling pathway but
requires protein synthesis (Schacher et al., 1988). In this case, the repeated activation
of adenylyl cyclase leads to persistence in the activity of PKA. PKA recruits the mitogen-
activated protein kinase (MAPK) and they both translocate to the nucleus of the neuron.
Activity of both kinases is required for long-term sensitization to occur. PKA activates
cAMP response element binding (CREB-1) protein (Kaang et al., 1993)and MAPK
inactivates CREB-2, an inhibitor of CREB-1. CREB-1 binds to cAMP response element
(CRE) sites and activates gene expression, but inactivation of CREB-2 is a requisite
step for CREB-1 to function as a transcriptional activator (Bartsch et al., 1995). One of
the early genes thus activated is an ubiquitin hydrolase that targets the regulatory
inhibitory subunit of PKA for degradation (Hegde et al., 1997; Chain et al., 1999). Loss
of this inhibitory subunit renders PKA autonomous, i. e., it no longer requires activation
by cAMP. Another early gene activated by CREB-1 is the transcriptional activator
C/EBP, which binds to CCAAT elements and activates genes required for the structural
changes accompanying long-term sensitization (Alberini et al., 1994). Specifically, in
contrast to long-term habituation, neurons display an increase in the number of synaptic
connections in long-term sensitization, often via an increase in the area of the axonal
terminal and the production of additional axonal branches (Bailey and Chen, 1988).
There is also a concomitant increase in the arborization of the dendrites of postsynaptic
neurons to accommodate the additional inputs (Kandel et al., 2000).
The gill-withdrawal reflex can also undergo classical conditioning (Carew et al.,
1981). Classical conditioning requires the association of two types of stimuli. After a
training period, that involves providing the unconditioned stimulus (the shock to the tail)
immediately after the conditioned stimulus (the stimulation of the siphon), a large
increase in the postsynaptic response is observed (Carew et al., 1981). There are two
components to the increase, one presynaptic (Hawkins et al., 1983) and the other
postsynaptic (Murphy and Glanzman, 1997). The presynaptic component involves the
influx of Ca2 , into the presynaptic sensory neuron in response to activation of the
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conditioned stimulus pathway, thereby activating the Ca 2+-binding protein calmodulin.
Calmodulin binds to adenylyl cyclase and potentiates its ability to respond to serotonin
from the unconditioned stimulus pathway, thus producing more cAMP than normal (Eliot
et al., 1989). Increase in cAMP levels then results in enhanced activation of PKA
leading to increased neurotransmitter release by the process described above. The
postsynaptic component involves a retrograde signal from the motor neuron to the
sensory neuron, enhancing transmitter release even further (Bao et al., 1998). The
motor neuron has two types of receptors that respond to the neurotransmitter glutamate
released by the sensory neurons: N-methyl-D-aspartate (NMDA) receptors and non-
NMDA receptors (Kandel et al., 2000). The NMDA receptor is usually blocked by Mg 2.
at resting membrane potentials while the non-NMDA receptors are not (Mayer et al.,
1984). However, the appropriate pairing of the conditioned and unconditioned stimuli
results in a train of action potentials in the motor neuron, expelling the Mg2+ from the
mouth of the NMDA receptor and allowing Ca2+ to flow into the cell. This influx of Ca 2 ,
has been implicated in the generation of the retrograde signal (Bao et al., 1998).
This dissertation describes a behavior in C. elegans where the same stimulus
leads to two different responses, depending on whether or not the animal experienced a
brief "training" regimen - 30 minutes of food-deprivation. There are two major
differences between the enhanced slowing response paradigm in C. elegans and the
sensitization and classical conditioning of the gill-withdrawal reflex in Aplysia. First, no
explicit noxious stimulus is provided to elicit the enhanced slowing response. Rather, an
attractive stimulus, namely food, is removed. Second, the basal and enhanced slowing
responses use two different neural circuits in the animal (Chapter 2), while the classical
conditioning of the monosynaptic pathway of the gill-withdrawal reflex in Aplysia is in
part built upon the mechanisms utilized for sensitization. The enhanced slowing
response does not involve two types of stimuli explicitly provided in close temporal
juxtaposition. Therefore, we do not consider it a paradigm of classical conditioning. And
to avoid confusion with the established definition of sensitization, we have chosen to not
refer to the enhanced slowing response as a phenomenon of sensitization.
Nevertheless, the enhanced slowing response involves the modulation of a response to
the same stimulus after a specific experience and hence we refer to it as an experience-
dependent modulatory behavior.
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Serotonin in C. elegans
Serotonin was first detected in C. elegans (Horvitz et al., 1982), using the technique of
formaldehyde-induced fluorescence (Sulston et al., 1975), in a single pair of neurons,
the neurosecretory motor neurons (NSMs). Subsequently, by using anti-serotonin
antisera, twelve additional serotonergic neurons were identified (Desai et al., 1988; Loer
and Kenyon, 1993; and Chapter 2). The presence of serotonin in neurons in C. elegans
suggested that serotonin is likely to function as a neurotransmitter in C. elegans.
However, the NSMs by ultrastructure appear to be neurosecretory (Albertson and
Thomson, 1975). Therefore, it is possible that serotonin released by the NSMs diffuses
throughout the animal and acts as a hormone.
Application of exogenous serotonin elicits specific behavioral responses in
C. elegans: stimulation of egg laying, inhibition of locomotion, and stimulation of
pharyngeal pumping (Horvitz et al., 1982). The G protein GOA-1 is involved in
mediating the effects of exogenous serotonin on egg laying and locomotion (Mendel et
al., 1995; Segalat et al., 1995). Long-term exposure to serotonin leads to adaptation of
the egg laying response; animals exposed to serotonin overnight no longer lay eggs in
response to a fresh dose of serotonin (Schafer and Kenyon, 1995). A voltage-gated
calcium channel, UNC-2, is required for this adaptation response (Schafer and Kenyon,
1995). It has been proposed that serotonin controls a switch between the on and off
states of egg-laying behavior, in effect priming the egg-laying apparatus for the
reception of stimulatory input (Waggoner et al., 1998).
Three genetic mutations exist that affect the levels of serotonin by perturbing its
biosynthesis: bas-1 (biogenic amine synthesis defective) (Loer and Kenyon, 1993),
cat-4 (catecholamine defective) (Desai and Horvitz, 1989; Weinshenker et al., 1995),
and tph-1 (tryptophan hydroxylase) (Sze et al., 2000). cat-1 mutants also have reduced
levels of serotonin expression, but this is likely not the result of defective serotonin
biosynthesis but rather is caused by a defect in the loading of presynaptic vesicles with
serotonin, since cat-1 encodes a vesicle monoamine transporter (Duerr et al., 1999).
The cat-1 phenotype also suggests that extravesicular serotonin is rapidly degraded by
monoamine oxidase.
Serotonin function in C. elegans has also been explored using drugs thought to
interface with serotonin signaling, such as serotonin receptor antagonists and serotonin
reuptake inhibitors. Treating animals with the serotonin antagonist gramine inhibits
pharyngeal pumping, while the serotonin reuptake inhibitor imipramine stimulates
pharyngeal pumping (Avery and Horvitz, 1990). Animals treated with the serotonin
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receptor antagonist methiothepin and mutants defective in serotonin signaling are
hypersensitive to the acetylcholinesterase inhibitor aldicarb (Nurrish et al., 1999).
Increased sensitivity to aldicarb is indicative of higher than normal levels of
acetylcholine release, suggesting that the normal function of serotonin is to inhibit
acetylcholine release.
Inhibitors of serotonin reuptake also have various effects on C. elegans behavior.
These effects are examined in greater detail in the context of the enhanced slowing
response in Chapters 2 and 4 and in the context of egg-laying behavior in Chapter 4.
Serotonin Is Involved in the Responses of C. elegans to Food
Presence of food modulates several C. elegans behaviors: pharyngeal pumping (Avery
and Horvitz, 1990), egg laying (Horvitz et al., 1982), and defecation (Liu and Thomas,
1994) are stimulated, but locomotion is inhibited (See Chapter 2). As mentioned above,
exogenous serotonin has the same effect on these behaviors as does the sensation of
food.
The effect of withdrawal from food on the olfactory ability of C. elegans and the
ability of serotonin to mimic the presence of food has been described (Colbert and
Bargmann, 1997). They assayed the ability of animals to chemotax toward
benzaldehyde, as measured by the chemotaxis index (Bargmann and Horvitz, 1991).
Chemotaxis towards benzaldehyde exhibits adaptation, i. e., after at least 60 minutes of
prior exposure to a field of uniform benzaldehyde concentration, animals showed
reduced chemotaxis towards a spot source of benzaldehyde indicating that the animals
find the odorant less attractive (Colbert and Bargmann, 1995). If the animals have been
starved for 60 minutes or longer prior to the adaptation regimen, the chemotaxis index is
reduced even further (Colbert and Bargmann, 1997). In other words, starvation
enhances adaptation. Normal levels of adaptation are observed if the animals are
starved on plates containing serotonin, i. e., there is no longer any enhancement of
adaptation (Colbert and Bargmann, 1997). Put simply, serotonin can mimic the
presence of food; serotonin-treated starved animals behave as if they are well fed. By
contrast, in the experiments presented in chapter 2, we did not observe a block of the
enhanced slowing response when wild-type animals were deprived of food in the
presence of serotonin. I believe that this apparent contradiction is rooted in the
differences between the food-deprivation protocols used in this dissertation and the
starvation protocol used by Colbert and Bargmann (1997). In Appendix 2, 1 describe
these differences, propose a model that might account for these differences, and
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suggest further experiments to explore the role of serotonin in the response of
C. elegans to food.
tph-1 mutants, which completely lack serotonin (Sze et al., 2000; and Chapter 4)
have several defects in metabolic signaling: they accumulate abnormal stores of fat,
have extended life spans, and exhibit the tendency to inappropriately enter the
metabolically-inactive dauer stage (Sze et al., 2000). In addition, tph-1 mutants also
have reduced pharyngeal and egg laying rates (Sze et al., 2000) and have sluggish
locomotion (Chapter 4). These observations suggest that C. elegans might use
serotonin as a hormonal signal to generate a body-wide coordinated response to food
availability. In other words, when food is abundant, serotonin levels in the animal are
normal, the animal moves and forages actively, lays many eggs, and does not
accumulate fat or enter the dauer state. In times of dearth, serotonin levels decrease
and this allows the animal to generate an appropriate response on several fronts:
feeding, locomotion, reproduction, and energy storage and use.
By contrast, acute food-deprivation, lasting only 30 minutes, is enough to elicit
the enhanced slowing response but is not sufficient to generate the various changes
seen in tph-1 mutants (Chapter 2). Chapters 2-4 present evidence that serotonin
signaling is required for the enhanced slowing response and that this signaling is likely
to be neuronal. In Appendix 2, I discuss neuronal versus hormonal functions of
serotonin in C. elegans with respect to food sensation. However, it has not been shown
that the response to chronic food-deprivation does not require neuronal serotonin
signaling, nor have we demonstrated in this dissertation that the enhanced slowing
response does not involve hormonal effects of serotonin.
In this dissertation, I do not discuss the behavior of food-deprived C. elegans as
a model for hunger and satiety as I feel that these concepts describe an internal state
not easily accessible to evaluation by an external observer.
Mammalian Serotonin Receptors
Since this dissertation describes the cloning of a new type of serotonin receptor
(Chapter 2), I review here the various subtypes of serotonin receptors that have been
previously characterized. There are seven major classes of vertebrate serotonin
receptors, termed 5-HT, through 5-HT7 (Hoyer and Martin, 1997). These seven classes
can be grouped by their mechanisms of signaling: all of these classes except 5-HT3 are
metabotropic receptors, belonging to the superfamily of receptors with seven
transmembrane regions coupled to G proteins; the 5-HT3 receptor is a non-selective
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cation channel belonging to the Cys-loop superfamily of ligand-gated ion channels. The
second messenger cascades triggered by the metabotropic receptors include inhibition
of adenylyl cyclase (5-HT1), activation of phospholipase C and subsequent
phosphatidylinositide turnover (5-HT 2), and activation of adenylyl cyclase (5-HT4 ,6 ,7)
(Hoyer and Martin, 1997). The coupling mechanisms for 5-HT5 receptors are unknown.
The 5-HT1 and 5-HT2 classes have five (A, B, D, E, and F) and three (A, B, and
C) subfamilies, respectively, while the 5-HT3 and 5-HT5 classes each have two (A and
B) subfamilies (Hoyer and Martin, 1997). The 5-HT 4, 5-HT6, and 5-HT7 classes each
have only one subtype (Baez et al., 1995), although 5-HT4 may be present in two
alternatively spliced forms, short (5-HT4s) and long (5-HTL) (Gerald et al., 1995).
Table 1 summarizes the expression profiles of these serotonin receptor
subtypes, the predicted function of the brain regions that the subtypes are found in, and
the phenotype of available knockouts. In addition, I indicate below several additional
properties of some of these receptor subtypes (refer to Table 1 for this section).
5-HTA receptors in the raphe nuclei are on the soma and dendrites of
serotonergic neurons, where they are likely to function as autoreceptors that inhibit the
firing of these serotonergic neurons. Desensitization of these 5-HTA autoreceptors may
mediate the ability of chronic exposure to selective serotonin reuptake inhibitors (SSRIs)
to raise levels of serotonin in the synaptic cleft (also see section below on serotonin
reuptake transporters).
5-HTA knockout mice are less reactive, more anxious, and less aggressive than
the wild type while 5-HTlB knockout mice are more reactive, less anxious, and more
aggressive (Zhuang et al., 1999; also see Table 1). Contradictory studies of the 5-HT1B
knockout mice argue for and against the 5-HT1B receptor mediating the rate of alcohol
consumption (Crabbe et al., 1996; Risinger et al., 1999). 5-HT1B receptors may also act
as inhibitory autoreceptors, but in a manner distinct from 5-HT1A, since 5-HT1B receptors
are found at the nerve terminals of serotonergic neurons where they inhibit the
synthesis and release of serotonin (Ghavami et al., 1999).
Stimulation of 5-HT 2A may mediate the effects of hallucinogens such as lysergic
acid diethylamide (LSD) (Krebs-Thomson et al., 1998).
The 5-HT 3B subunit is a non-conducting subunit that modulates the properties of
the 5-HT3A channel (Davies et al., 1999). Stimulation of the 5-HT3A channel can cause
nausea and vomiting, induce vasodilation, and cause sensitization of nociceptive
receptors. The 5-HT3A-Specific antagonists granisetron and ondansetron are potent
antiemetics (Perez et al., 1998) that have been extremely helpful in the clinic in
preventing the nauseous side-effects of chemotherapy.
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5-HT 5A receptors appear to be present mainly in glial cells in one study that uses
a 5-HT5A-Specific antibody (Carson et al., 1996), while agonist binding studies label
several neuronal areas of the brain not labeled in 5-HT5A-knockout mice (Waeber et al.,
1998). While immunoreactivity data are usually considered more reliable than data
obtained by agonist binding, the knockout control for the agonist studies suggests that
the antibody may not be sufficiently sensitive. Alternatively, the loss of 5-HT 5A perturbs
other targets that also bind the agonist.
Much of the expression data in Table 1 are derived from either in situ
hybridization experiments and/or radiolabelled agonist binding data. Studies using
specific antibodies are rare. It is important to note that nearly all of the inferences about
the specificity of serotonin receptor function are based on the actions of various
agonists and antagonists. The agonist and antagonist profiles of these receptors are
usually derived from expression of the cloned receptors in heterologous systems or
recordings from tissue-slice preparations and they may not reflect the in vivo situation.
Therefore, while these functional generalizations may be correct in some cases,
definitive evidence in each case will require the generation of animals with knockouts of
these receptor genes, preferably spatially-restricted (McHugh et al., 1996; Tsien et al.,
1996) knockouts, as well as temporally- and spatially-inducible (Mayford et al., 1996)
and reversible (Mansuy et al., 1998) rescue of such knockouts. In fact, the 5-HTA and
5-HT1B receptor knockouts described in Table 1 were generated by disrupting the
endogenous genes with a "knock-in" of a neomycin-containing cassette with a
translational stop codon (Zhuang et al., 1999). This cassette was flanked by loxP sites
(Tsien et al., 1996), and tissue-specific rescue of receptor expression was achieved for
both 5-HTlA and 5-HTlB by expressing the Cre recombinase under the control of specific
promoters (Zhuang et al., 1999). Behavioral analysis of these mice is in progress
(Zhuang et al., 1999). These and other similar tissue-specific rescue experiments with
knockout animals should allow the determination of brain regions necessary for the
contribution of a particular receptor to a given behavior.
These recent studies notwithstanding, the current state of expression and
functional data suggests that multiple cells could express one or more type of serotonin
receptor, coupled to similar or different second messenger signaling mechanisms,
leading to a hopelessly complicated array of possibilities for how behavioral responses
are mediated by serotonin in the mammalian brain. In my opinion, the current
reductionist approaches of molecular neuroscience cannot on their own clarify the
picture completely. What is needed is an integrative approach that includes in vivo
functional imaging of neural circuits with the ability to detect temporal and spatial
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changes in the activity of the various signaling pathways. Promising advances such as
PET imaging of receptor localization (Drevets et al., 1999; Meltzer et al., 1999) lend
hope to the future possibility of a coherent picture of serotonin receptor expression and
function.
C. elegans Serotonin Receptors
The C. elegans genomic sequence contains at least 18 receptors that show similarity to
the class A amine receptors of the rhodopsin-like receptor family (Bargmann, 1998).
However, in the absence of functional characterization in heterologous systems, these
could well be receptors for acetylcholine, dopamine, tyramine, histamine, or
octopamine. Nevertheless, a systematic sequence comparison seeking receptors more
homologous to vertebrate and invertebrate serotonin receptors than to receptors
activated by the other neurotransmitters has been performed and has identified 11
candidate metabotropic serotonin receptor homologs in C. elegans (T. Niacaris and L.
Avery, personal communication; and my unpublished observations). Two of these
respond to serotonin in heterologous expression systems and are tentatively classified
as 5-HTA (Olde and McCombie, 1997) and 5-HT 2 receptors (Hamdan et al., 1999)
based on sequence and pharmacology. In addition, there are two genes with good
homology to mammalian 5-HT3 ionotropic receptors. If even a subset of these receptors
prove to be responsive to serotonin, there is likely to be a complicated pattern of
receptor expression and function even within the context of the mere 302 neurons of the
C. elegans nervous system (White et al., 1986).
Recent advances in the ability to isolate C. elegans mutants carrying deletions in
a given gene (Jansen et al., 1997; Liu et al., 1999) can now be coupled with cell-specific
rescue of these receptor knockouts. The number of available cell-specific promoters is
growing rapidly. These techniques should greatly facilitate the analysis of serotonergic
neurotransmission within the context of the completely defined neural circuit of
C. elegans (White et al., 1986).
Chloride Channels
The novel type of serotonin receptor (MOD-1) described in Chapter 2 is a serotonin-
gated chloride channel. Therefore, I present here a discussion of the general properties
of chloride channels followed by an analysis of determinants of the two properties of
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MOD-1 that have never before been observed in a single channel - ligand specificity
for serotonin and ion selectivity for chloride.
There are four major classes of chloride channels. The first three are mentioned
here only briefly as they are not directly relevant to neuronal function. See Kozlowski
(1999) for review.
(1) CIC: These channels have 12 transmembrane regions, are expressed ubiquitously,
and have roles in maintenance of cell volume and stabilization of skeletal muscle
membrane potential. There are 7 subtypes within this family.
(2) CFTR: There is only one member in this family - the product of the cystic fibrosis
gene - and it is expressed in the heart and nearly all types of epithelial cells and is
involved in transepithelial transport.
(3) Ca 2 ' activated: These channels are activated by increases in intracellular Ca 2 .
concentrations typically triggered by neurotransmitters signaling through second
messenger systems. These channels are expressed in smooth muscles and play a role
in neurotransmitter-mediated smooth muscle contraction.
(4) GABA/glycine: These are ligand-gated ion channels that belong to the same Cys-
loop superfamily that includes the nicotinic acetylcholine receptor (nAChR) and 5-HT3.
They are expressed exclusively in neuronal tissue, are gated by the neurotransmitters
GABA or glycine, and are involved primarily in neuronal inhibition. These channels and
the features that define them are discussed in more detail below.
Structure-function of the Cys-loop ligand-gated ion channel superfamily
The ligand-gated ion channels in the Cys-loop superfamily are all of very similar size
(420-480 amino acids) and have the same deduced secondary structure and membrane
topology - a large N-terminal extracellular domain, followed by three closely spaced
transmembrane regions, followed by a large C-terminal globular domain, and ending
with a fourth transmembrane domain and a very short extracellular tail. The N-terminal
domains of these channels always have two cysteine residues separated by 13 amino
acids that form the Cys-loop signature of this channel family (see Kozlowski, 1999 for
review). This Cys-loop has been shown by mutagenesis studies to be involved in
subunit assembly (Sumikawa and Gehle, 1992) and ligand binding (Rajendra et al.,
1995; Gready et al., 1997).
The assembly of a functional channel in the membrane requires five subunits -
this has been demonstrated for the GABAA (Nayeem et al., 1994) and glycine
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(Langosch et al., 1988) chloride channels, and the nAChR cation channel (Cooper et
al., 1991; Unwin, 1993; Karlin and Akabas, 1995).
For the nAChR, the second transmembrane region (M2) from each of the five
subunits forms the lining of the pore of the channel (Unwin, 1993; Unwin, 1995).
Numerous mutagenesis studies of M2 show involvement of this region in formation of a
functional pore (reviewed in Karlin and Akabas, 1995). Similar mutagenesis studies
have been conducted for the GABAA (Tierney et al., 1996; Tierney et al., 1998) and
glycine (Bormann et al., 1994) channels, and for the invertebrate glutamate-gated
chloride channels (Etter et al., 1996; Etter et al., 1999). There is evidence that the
amino-third of M1 contributes to the pore (Akabas and Karlin, 1995; Zhang and Karlin,
1997)
In Chapter 3, we describe the cloning of a novel serotonin-gated ionotropic
receptor, a serotonin-gated chloride channel (MOD-1). MOD-1 is far more similar to
GABA- and glycine-gated chloride channels than to 5-HT3 serotonin-gated non-selective
cation channels (Chapter 3, Figure 2B). For this reason, I will now review the features
important for a channel to be gated by serotonin and to conduct chloride ions.
Determinants of agonist specificity
The precise sequence and structural determinants for agonist specificity are poorly
understood. Domain-swapping experiments with the nAChR and 5-HT3 receptors have
shown that the N-terminal extracellular domain contains within it all the necessary
determinants to bind acetylcholine (Eisele et al., 1993). By analogy, it is thought that the
ligand-specificity of all channels in this family is contained in this N-terminal extracellular
domain. As mentioned above, the Cys-loop has been implicated in ligand binding for
some of the channels in this family (see above), while others do not appear to use the
Cys-loop for ligand binding (Vandenberg et al., 1993). For the GABAA receptor, several
residues in the extra-cellular loop have been shown to be important for binding to GABA
(Boileau et al., 1999; Westh-Hansen et al., 1999). Similarly, using alanine scan analysis,
a single Arg residue in the N-terminal extracellular domain has been shown to be
important for binding serotonin by 5-HT, receptors (Yan et al., 1999). However, these
few sequence motifs are not sufficient to allow the classification of members within this
family according to their ligand specificities. The ligand that gates a particular channel
must be determined empirically. For example, the MOD-1 channel (Chapter 2) is
annotated in the C. elegans genome as a GABA-gated chloride channel, based on
overall sequence homology (The C. elegans Sequencing Consortium, 1998) .
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Furthermore, MOD-1 has a Thr residue at the position corresponding to the Arg residue
critical for serotonin binding in the 5-HT 3 receptor. But as we show in chapter 3, MOD-1
is gated by serotonin and not by GABA.
Determinants of ion selectivity
More precise information is available about the regions and specific residues that allow
a channel to discriminate between anions and cations. While there are many studies
that have mutated residues in the M2 region to determine the relevance of those
residues to various intricacies of channel conductance, in my opinion there have been
just two reports (Galzi et al., 1992; Keramidas et al., 2000) that address the selectivity
question in a thorough manner. I will present the salient features from these two reports.
(Figures 2B and 2C from Chapter 3 present the sequences relevant to the discussion
below.)
Galzi et al. (1992) sought to convert the cation-selective nAChRX7 channel into
an anion-selective channel. First, they tested a chimeric channel in which the segment
linking M1 to M2 and a part or all of M2 of nAChRa7 was exchanged for the
corresponding region from the glycine a1 chloride channel subunit. This exchange
resulted in a channel that did not respond to acetylcholine. Then, instead of exchanging
this entire stretch, they performed site-directed mutagenesis to convert six specific
residues within this stretch to match the corresponding residues from the glycine aX1
channel. In addition, they also inserted at the corresponding position a proline residue,
located just before the beginning of the M2 region in GABA- and glycine-gated chloride
channels but absent in nAChR and other cation channels. This mutant channel changed
completely from cation-selective to anion-selective. To determine the minimum
requirement for this change, the number of altered amino acids was progressively
reduced until a minimum of three changes required to complete the transformation were
found - the inclusion of the proline residue, the conversion of the very next amino acid
from Glu to Ala, and conversion of a Val deep within the M2 region to Thr. Furthermore,
in the absence of the proline insertion, the six other mutations do not affect the ion
selectivity of the channel. The proline residue appears to be critical for the ion selectivity
conversion since it brings about a conformational change to the constricted region of the
pore (Corringer et al., 1999). The authors suggest that the reason the swap of the entire
region failed is that determinants on the non-luminal face of M2 important for tertiary or
quaternary structure might have been perturbed.
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Keramidas et al. (2000) showed that the transformation was achievable in the
other direction. Mutagenesis of the very same three residues in the glycine a1 chloride
channel subunit to the corresponding residues from nAChRa7, i. e., deletion of the
proline, conversion of the next Ala residue to Glu, and changing Thr within the M2 to
Val, converted the channel from being anion-selective to cation-selective.
In the published version of Chapter 3, we made the conservative claim that we
could not confidently predict the ion selectivity of the MOD-1 channel from sequence
comparisons. However, MOD-1 has the key Pro and Ala residues at the corresponding
positions (Chapter 3, Figure 2C), indicating that MOD-1 is quite likely to be a chloride
channel. Our reason for not making this claim based merely on sequence rests on the
fact that ligand-specificity for serotonin has never before been associated with a
chloride channel.
The Chloride Switch
Unlike cation channels that are always excitatory in their actions, GABA- and glycine-
gated chloride channels are not always inhibitory. For example, during the early
development of the rat hippocampus, GABA- and glycine-gated chloride channels are
initially excitatory (Cherubini et al., 1991). These GABAA chloride channels switch to
their adult inhibitory state about a week after birth (Cherubini et al., 1991). The switch
does not require any modification of the GABAA channel per se but rather is brought
about a simple shift in the gradient of C- ions across the neuronal cell membrane
(Rivera et al., 1999). Early on, Cl- ions are present at high concentrations inside the cell
and therefore when the GABAA channel opens, Cl- ions exit the cell leading to
depolarization. At about a week after birth, a K+/C- cotransporter is expressed in these
GABAergic cells, and the activity of this cotransporter lowers the Cl- concentration inside
the cell (Rivera et al., 1999). From this point onwards, as long as the K*/Cl-
cotransporter is functional, whenever the GABAA channel is activated, it leads to
neuronal inhibition.
What is the physiologic relevance of this dramatic shift during development in the
neuronal activity of GABAA channels? In the developing cerebral cortex, GABA
depolarizes postsynaptic neurons sufficiently to induce Ca2* influx through NMDA
receptors (Cherubini et al., 1991). This influx of Ca2 * has been shown to be important for
control of gene expression and neurotrophin production in particular (Berninger et al.,
1995), thus possibly playing a role in neuronal growth and the establishment of new
connections . Furthermore, in the hippocampus GABA-mediated depolarization also
26
leads to synchronous cell firings (Serafini et al., 1995), which may play a role in activity-
dependent reinforcement of nascent synaptic connections.
There are also instances where GABAA channels continue to exhibit excitatory
actions even in the adult nervous system. I will not describe these cases as they are not
directly relevant to the issue at hand, and furthermore the example just described
illustrates the basic principle. This property of chloride channels to be either excitatory
or inhibitory depending on the cellular environment is relevant to the in vivo function of
the MOD-1 serotonin-gated chloride channel that we describe in Chapter 3. The
electrophysiological characterization of MOD-1 in Chapter 3 does not allow us to predict
how MOD-1 might function in vivo. Whether MOD-1 acts in an excitatory or inhibitory
manner is of fundamental importance to understanding how the neural circuit in
C. elegans brings about the enhanced slowing response. In Appendix 2, I discuss
experiments that might help determine whether the MOD-1 serotonin-gated chloride
channel activates or inhibits neuronal signaling in vivo.
Serotonin Reuptake Transporters
The ability to control precisely the circumstances that permit release of a particular
neurotransmitter would be useless if it were not for the ability also to rapidly stop the
said neurotransmitter from continuing to signal. The first mechanism for such
termination of neuronal signaling was determined for acetylcholine - the degradative
enzyme, acetylcholinesterase, destroys acetylcholine within milliseconds of its release
(Cooper et al., 1996). This enzyme is abundant at cholinergic synapses and is always
active. Therefore, the strength and duration of cholinergic signaling depends only on
when and how much acetylcholine was released, ignoring for the moment the various
postsynaptic mechanisms that also modulate cholinergic signaling. Surprisingly, the
mechanism for acetylcholine removal is the exception rather than the rule (Cooper et
al., 1996). All other neurotransmitters are cleared from the synaptic cleft by uptake into
neighboring cells or reuptake into the neurons that release the neurotransmitter. Cloned
vertebrate reuptake transporters exist for serotonin (Blakely et al., 1991), dopamine
(Giros et al., 1991), epinephrine (Apparsundaram et al., 1997), norepinephrine
(Pacholczyk et al., 1991), GABA (Guastella et al., 1990), glycine (Liu et al., 1992), and
glutamate (Pines et al., 1992). Histamine is the only major neurotransmitter that does
not have a cloned uptake transporter but histamine uptake has been observed in
several cell preparations, including for example, photoreceptor cells (Stuart et al., 1996).
The transporters for GABA, glycine, and glutamate belong to one family of transporters
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that bears little resemblance to the family of transporters for dopamine, serotonin,
epinephrine, and norepinephrine.
The notoriety of the serotonin reuptake transporter (SERT) is primarily the result
of the "biogenic amine hypothesis" of depression - which states that the underlying
biological basis for depression is a deficiency of central noradrenergic or serotonergic
systems - and the numerous inhibitors of serotonin reuptake that have proven to be
effective antidepressants, such as imipramine (Tofranil), clomipramine (Anafranil),
fluoxetine (Prozac), paroxetine (Paxil), and sertraline (Zoloft) (Baldessarini, 1996). We
have now come to appreciate that the biogenic amine hypothesis is too simplistic and
that the relationship between biogenic amines and depression is complex. Defects in
various neurotransmitters systems can lead to depression. Depression is not just one
disorder but a collection of disorders with distinct causes. Moreover, none of the
neuromodulatory systems of the brain work in isolation but instead interact at various
levels. Nevertheless, the remarkable efficacy of selective serotonin reuptake inhibitors
(SSRIs), such as fluoxetine, paroxetine, and sertraline, in alleviating depression
suggests that enhancement of serotonergic neurotransmission must account for at least
some of the therapeutic mechanism of these drugs.
In the nine years since the first mammalian SERT was cloned, nearly all of what
we know about SERTs has come from studies in heterologous expression systems,
primarily mammalian cell culture or Xenopus oocytes. The predicted secondary
structure of SERTs places them within the family of Na*/C-dependent transporters with
12 transmembrane domains (TMD) that includes transporters for dopamine and
norepinephrine. This 12 TMD topology has been confirmed by measuring the reactivity
of selected lysine and cysteine residues with extracellular reagents (Chen et al., 1998).
These transporters until recently were thought to function as monomers in the plasma
membrane. But coimmunoprecipitation studies with tagged SERT polypeptides
suggests a tetrameric structure for SERTs (Kilic and Rudnick, 2000). Site-directed
mutagenesis of putative N-glycosylation sites in the extracellular loop between the third
and fourth transmembrane domains decreases serotonin uptake (Tate and Blakely,
1994). In these studies, the Km for transport was unaffected while the Bm (substrate
concentration for half-maximal binding) was vastly reduced, allowing the authors to
conclude that N-glycosylation is likely to be important for either the expression or
maintenance of expression of SERTs in the plasma membrane.
For each serotonin molecule transported, one Na* and one C ion is transported
into the cell and one K+ ion is transported out (Rudnick and Clark, 1993). The Na* and
CI ions are transported along the same permeation pathway as serotonin (Galli et al.,
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1997). The substituted-cysteine accessibility method (Akabas et al., 1992) has been
used to demonstrate that TMD3 has residues required for the binding and transport of
serotonin (Chen et al., 1997). Studies of cross-species chimeras between the rat and
human SERTs have implicated TMD12 in substrate recognition (Barker et al., 1994) and
binding to tricyclic antidepressants (Barker and Blakely, 1996). Changing a specific Asp
residue within TMD1 affects the binding of dopamine to the dopamine transporter
(Kitayama et al., 1992). This Asp is absolutely conserved in serotonin, dopamine, and
GABA transporters. Hence, based on a model for binding of catecholamines to B-
adrenergic receptors (Strader et al., 1989), Kitayama et al. (1992) proposed that the
Asp residue in these transporters might bind to the protonated NH 2 group on dopamine,
serotonin, or GABA. Consistent with this hypothesis, mutating the corresponding Asp
residue in rat SERT and human norepinephrine transporter leads to loss of uptake
activity (Barker and Blakely, 1998); these authors confirmed that surface expression of
these mutated transporters was unaffected. Nevertheless, binding studies with ligand
derivatives are required to confirm that this Asp residue is indeed required for binding to
the ligand.
Initially, it was thought that SERTs and other neurotransmitter transporters are
always on the plasma membrane of the cell and ready to perform their uptake duties
whenever substrate is present. But studies using HEK cells transfected with human
SERT suggest that some of the canonical sites for protein kinases present on the
cytoplasmic domains of SERTs are used by PKC to downregulate the expression of
SERT on the plasma membrane (Qian et al., 1997). Similar modulation of expression
has been reported for GABA (Quick et al., 1997) and norepinephrine (Apparsundaram
et al., 1998) transporters. Furthermore, real-time visualization of GFP-tagged dopamine
transporters has shown that this modulation of transporter activity occurs by transporter
internalization rather than by reduced insertion of SERT molecules into the membrane
(Daniels and Amara, 1999). Interestingly, SERT phosphorylation and sequestration is
blocked by the addition of transportable substrates including serotonin (Ramamoorthy
and Blakely, 1999). These observations suggest that activity-dependent modulation of
transporter activity might occur.
Recently, SERTs have been shown to exhibit channel-like behavior with non-
stoichiometric ion flow (Mager et al., 1994; Galli et al., 1997; Petersen and DeFelice,
1999) suggesting that at high serotonin concentrations (-0.3 mM) SERTs may function
as serotonin channels, i. e., participate in an electrically non-neutral process where the
primary charge carrier is the serotonin cation. The presence of such high serotonin
concentrations at synapses may not be so unreasonable (Bunin and Wightman, 1998),
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particularly when SERT inhibitors raise serotonin concentrations in the synaptic cleft,
hence leading to the possibility that SERTs functioning as ion channels may have a
physiological function.
in vivo SERT function
SERT is abundantly expressed in the raphe nuclei in the midbrains of both humans
(Austin et al., 1994) and rats (Lesch et al., 1993), where serotonergic cells are found
(see above), and is coincident with the expression of tryptophan hydroxylase
(McLaughlin et al., 1996), the enzyme specific for serotonin biosynthesis (see above).
One study using 3 S-labeled riboprobes has reported SERT expression in the substantia
nigra, globus pallidus, and superior colliculi of the adult mouse brain (Bengel et al.,
1997) and other studies have demonstrated transient expression of SERT in non-
serotonergic cells during development in the rat (Hansson et al., 1998). Several studies
report that chronic administration of certain drugs can affect the levels of SERT in the
brain of animals. Specifically, in rats, clomipramine increases the level of SERT mRNA
(Hansen and Mikkelsen, 1998) while fenfluramine and the tryptophan hydroxylase
inhibitor p-Chlorphenylalanine decrease levels of SERT mRNA (Rattray et al., 1994;
Rattray et al., 1996).
Recently, SERT knockout mice have been generated (Bengel et al., 1998). The
authors found it surprising that these mice had few developmental defects, given prior
reports of mothers treated with either serotonin or SSRIs such as fluoxetine or sertraline
giving birth to pups with abnormal craniofacial or cardiac morphogenesis (as reported in
Bengel et al., 1998). These findings underscore our ignorance about the spectrum of
effects that any drug might have in vivo, even if the drug is termed "selective" based on
in vitro and ex vivo assays. Chapter 4 describes our similar findings about the
discrepancies between the phenotype of C. elegans lacking SERT and the effects of the
"selective" serotonin reuptake inhibitor fluoxetine on C. elegans behavior.
These SERT-'- mice have an enhanced sensitivity to the effect of 3, 4-
methylenedioxymethamphetamine ("Ecstasy") on locomotory behavior (Bengel et al.,
1998). In addition, they also have vastly reduced levels of serotonin in their brains
(Bengel et al., 1998), indicating that there are likely to be regulatory pathways that
coordinate serotonin and SERT expression levels. Two other reports analyzing these
mice have since emerged (Fabre et al., 2000; Li et al., 2000): they both demonstrate
that 5-HTlA and 5-HT1B receptor expression levels are dramatically reduced in these
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SERT- mice. Whether this decrease is a direct result of lack of SERT expression or the
indirect effect of loss of serotonin expression remains to be determined. These
SERT-'- mice are the subject of intense investigations by numerous groups, and there
will most certainly be a great deal more reported on the various other characteristics of
these mice, including their performance in behavioral assays. In the meantime, the
findings presented in chapter 4 constitute the only other report of in vivo consequences
of mutations in a SERT.
SERTs in Human Disease
There are over 100 published reports that link polymorphisms at the human SERT locus
to several human disorders ranging from late-onset Alzheimer's Disease and
Parkinson's disease to numerous psychiatric disorders. In many of these reports, I
found the data supporting the associations tenuous and unconvincing. The following
study was a striking exception.
Three polymorphisms have been reported in the SERT locus to date. One of
these is a 44-bp deletion within repeat elements in the regulatory sequence -1 kb
upstream of the gene transcription initiation site (Heils et al., 1996). The promoter with
the deletion (the short allele) is less efficient than the long allele at driving the
expression of a luciferase reporter gene in mammalian cells (Lesch et al., 1996). To
discount the possibility that these results were artifacts of either variable transfection
efficiencies or the lack of distant regulatory elements, Lesch et al., (1996) cultured
lymphoblast cell lines from human subjects with either the short or the long SERT allele
and found that the steady-state mRNA levels were 1.4- to 1.7-fold higher in cells
containing the long allele. The authors then utilized three different personality trait
assessment scales to evaluate 504 subjects from two independent groups and found
that the shorter allele was strongly associated with various anxiety-related indices, such
as neuroticism, tension, and harm-avoidance. The study also revealed many traits that
showed no association, indicating that there was no overall systematic bias in the
testing protocol. The authors had astutely chosen their 504 subjects to include 459
siblings from 210 independent families. Of these, 78 sib-pairs had different genotypes
for the SERT locus. When these sib-pairs were analyzed for association of the SERT
allele to the various traits examined, there was no statistically significant decrease in the
index of association between the short allele and anxiety-related traits. Given that
siblings are by definition genetically more homogenous, such differences between the
siblings are strong indications of true genetic transmission.
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What I find compelling about this case is that the "disorder" allele is only slightly
different from the "normal" allele. I find it more plausible to consider subtle changes in
neuromodulatory pathways as the basis for not only behavioral dysfunction but also
perhaps individuality and personality. Furthermore, most genetically inherited behavioral
variations in humans are likely to be polygenic traits and hence severe loss of function
in a single molecule is unlikely to be the cause of complex traits.
Concluding Remarks
In this introductory chapter I have attempted to outline the topics pertinent to the
chapters that follow and to provide a broader context for the work that I have done. The
discussion presented here of learning and memory in Aplysia and serotonin- and food-
related behaviors in C. elegans should be pertinent to Chapter 2, which describes the
genetic, cellular, and physiological basis for the enhanced slowing response of
C. elegans. The sections on serotonin receptors and chloride channels are directly
relevant to Chapter 3, wherein the cloning and characterization of a serotonin-gated
chloride channel is described. Finally, the section surveying the structure-function, in
vivo roles, and connections to human disorders of SERTs should provide the framework
for the findings described in Chapter 4, which presents the cloning of a C. elegans
SERT and its characterization in the context of serotonin uptake, a genetic pathway for
behavior, and fluoxetine pharmacology.
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Table 1. Mammalian Serotonin Receptor Subtype Localization and Function
Receptor Localizationa Proposed Knockout
Subtype function' phenotype
5-HT1A Hippocampus' Anxiety Less reactive'
Emotion3  More anxious'
Amygdalai Less aggressive
Raphe Nuclei7
5-HT1B Substantia Nigral'5  Regulation of More reactive6
Striatum' motor function4' 9  Less anxious6
Frontal Cortex' More aggressive
Raphe Nuclei7
5-HTl Caudate Nucleus Unknown
5-HT1E Amydala Unknown
Frontal Cortex
5-HT1F Dorsal Raphe migraine
Hippocampus
Cortex
5-HT 2A8  Basal Ganglia' Motor control,
Emotion9
Cortex' Cognition9
5-HT 2B 8  Amygdala, Cerebellum Smooth muscle Lethal; required
also in smooth muscle contractions for heart
development'0
5-HT 2C Choroid Plexus Cerebrospinal Seizure-prone12
fluid production Obese3
Cortex, Hippocampus,
Substantia Nigra_
5-HT3A Widespread in CNS and Nausea Defective in pain
PNS Vasodilation perception
Pain
5-HT 3B Caudate Nucleus Emotions &
Amygdala Stress/Threat
Hippocampus response9
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Receptor Localizationa Possible Knockout
Subtype functionb phenotype
5-HT4  Basal Ganglia Nausea
GABAergic & cholinergic Cognition
neurons14  enhancement
5-HTA see text see text Increased
exploratory
behavior,
Diminished
response to LSD"
5-HTSB unknown unknown
5-HT6  Widespread in CNS 16  unknown Chewing,
yawning, and
stretching
syndrome
5-HT7  Hippocampus, Smooth muscle
Thalamus, relaxation
Hypothalamus Circadian rhythm
Brainstem17
aLocalization data were obtained by either in situ hybrizidation experiments and/or
radiolabelled agonist binding. In most cases, only the most prominent areas are listed.
Many of these receptors have low level expression in other brain areas as well.
bProposed function refers to the function of the brain region indicated by the expression
data and the effects of agonists and antagonists. Only the most prominent effects are
listed.
'Palacios et al., 1990; 2Frackowiak, 1994; 3Aggleton, 1993, Scott et al., 1997; 4 Ramboz
et al., 1996, Crocker, 1997; 51n patients with Parkinson's disease, the dopamine-
containing neurons in the substantia nigra are lost (Damier et al., 1999); 6Zhuang et al.,
1999; 7See text; '5-HT2 A and 5-HT2 B receptors are widely expressed in peripheral
tissues where they mediate the contractile responses of various smooth muscle organs;
9Martin, 1996; * Nebigil et al., 2000; "Lower levels than in choroid plexus; 12Applegate
and Tecott, 1998; 13Tecott et al., 1995; 14Gerald et al., 1995, Waeber et al., 1996;
15Grailhe et al., 1999; 16Gerard et al., 1996, Gerard et al., 1997; '7Shen et al., 1993,
Eglen et al., 1997
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Chapter 2
C. elegans Locomotory Rate is Modulated by the Environment through a
Dopaminergic Pathway and by Experience through a Serotonergic Pathway
Elizabeth R. Sawin, Rajesh Ranganathan, and H. Robert Horvitz
Published in Neuron 26, 619-31 (2000)
My experimental contributions to this chapter are contained within Figures 4C,
4D, 5B, 5C (with Beth Sawin's help), and 5D. I was the primary author of the text
of this chapter.
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Summary
Caenorhabditis elegans modulates its locomotory rate in response to its food,
bacteria, in two ways. First, well-fed wild-type animals move more slowly in the
presence of bacteria than in the absence of bacteria. This basal slowing
response is mediated by a dopamine-containing neural circuit that senses a
mechanical attribute of bacteria and may be an adaptive mechanism that
increases the amount of time animals spend in the presence of food. Second,
food-deprived wild-type animals when transferred to bacteria display a
dramatically enhanced slowing response that ensures that the animals do not
leave their newly encountered source of food. This experience-dependent
response is mediated by serotonergic neurotransmission and is potentiated by
fluoxetine (Prozac). The basal and enhanced slowing responses are distinct and
separable neuromodulatory components of a genetically tractable paradigm of
behavioral plasticity.
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Introduction
An important function of the nervous system is to allow animals to respond
flexibly to changing environmental stimuli. Such behavioral plasticity is
manifested in numerous ways. In associative learning, associations between
stimuli are recorded by the nervous system, and the stored information is used to
alter behavioral outputs (Kupfermann and Kandel, 1995). In forms of non-
associative learning, habituation and dishabituation alter the strength of reflexive
responses based on an animal's past experience of repetitive or noxious stimuli,
respectively, and sensitization enhances the response to a baseline stimulus
after exposure to a novel or stronger stimulus. Another form of behavioral
plasticity, also referred to as an alteration in behavioral state or as behavioral
arousal, occurs when an animal's responsiveness to specific stimuli is altered as
a result of a change in its internal state, a change that is often influenced by the
animal's environment or past experience (Flicker et al., 1981). Understanding the
mechanisms that produce such flexibility in behavioral output has been a major
challenge in neurobiology.
Behavioral plasticity often involves the alteration of the properties of
neurons and synapses. These alterations can be caused by the actions of
neuromodulators, such as dopamine and serotonin. In both invertebrate and
vertebrate nervous systems, dopamine plays a critical role as a neuromodulator
by altering the intrinsic properties of neurons within circuits, both pre-synaptically
(Cameron and Williams, 1993; Harris-Warrick et al., 1995) and post-synaptically
(Barnes et al., 1994; Maguire and Werblin, 1994; Pereda et al., 1994). Genetic
analyses of dopaminergic neurotransmission in Drosophila melanogaster
(Tempel et al., 1984; Neckameyer, 1998) and mice (Drago et al., 1998, and
references cited therein) have implicated dopamine in locomotory and spatial
learning behaviors. Furthermore, the disruption of dopaminergic systems in
human brains is involved in disorders such as Parkinson's disease (Marsden,
1992) and has been suggested to be involved in schizophrenia (Hietala and
Syvalahti, 1996, and references cited therein), and dopaminergic neurons
contribute to the circuitry involved in human motivation, reward, and drug
addiction (Koob, 1992; Self and Nestler, 1995).
Serotonin is also an important neuromodulator in many animals. In the
sensitization of defensive reflexes in the leech (Sahley, 1995, and references
cited therein) and in Aplysia californica (Hawkins et al., 1993, and references
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cited therein), the application of the sensitizing stimulus releases serotonin and
enhances the strength of reflex pathways. Serotonin mediates changes in
behavioral state associated with food-deprivation in the leech (Groome et al.,
1993; Brodfuehrer et al., 1995) and social dominance in the lobster (Kravitz,
1988). Serotonergic neurotransmission is implicated in numerous human
processes and diseases (Osborne and Hamon, 1988; Takada and Curzon, 1995;
Lucki, 1998, and references cited therein). Prozac (fluoxetine) and other selective
serotonin re-uptake inhibitors used in the clinic to treat many of these human
disorders are thought to work by primarily affecting serotonergic
neurotransmission (Wong and Bymaster, 1995).
The simple anatomy, genetics, and behavior of the nematode
Caenorhabditis elegans make this animal attractive for analyses of behavioral
plasticity (Brenner, 1974; Wood et al., 1988). The chemotaxis response of
C. elegans to volatile attractants adapts to the presence of high levels of certain
attractants while animals maintain the ability to respond to other attractants
(Colbert and Bargmann, 1995). C. elegans is capable of non-associative learning
in the form of habituation when repeated mechanical stimulation is applied,
dishabituation when the noxious stimulus of electric shock is administered, and
sensitization when stronger mechanical stimulation is administered prior to the
baseline stimulus (Rankin et al., 1990; Wicks and Rankin, 1997). Several hours
of starvation affects C. elegans thermotaxis (Hedgecock and Russell, 1975; Mori,
1999), and olfaction (Colbert and Bargmann, 1997).
Several dopaminergic (Sulston et al., 1975) and serotonergic (Horvitz et
al., 1982; Desai et al., 1988; Loer and Kenyon, 1993; E. R. S., and H. R. H,
unpublished data) neurons have been identified in C. elegans. Locomotion and
egg laying in C. elegans involves dopaminergic signaling (Schafer and Kenyon,
1995; Weinshenker et al., 1995), and serotonin affects several C. elegans
behaviors, including locomotion, egg-laying, and pharyngeal pumping (Horvitz et
al., 1982; Trent et al., 1983; Avery and Horvitz, 1990; Schafer and Kenyon,
1995). Furthermore, the selective serotonin re-uptake inhibitor fluoxetine
(Prozac) affects C. elegans egg laying (C. Johnson, personal communication;
Weinshenker et al., 1995), nose contraction (Choy and Thomas, 1999), and
locomotory rate (Nurrish et al., 1999).
We have identified and analyzed a new paradigm for C. elegans
behavioral plasticity. This paradigm provides a model for how behavioral state is
controlled and how it affects the response to a specific stimulus. We observed
55
AJ
that well-fed C. elegans hermaphrodites when washed free of bacteria and later
re-introduced to bacteria moved more slowly than when transferred to an
environment without bacteria. Furthermore, this slowing response to bacteria was
enhanced if the animals were not well fed but rather had been deprived of food
for only 30 minutes. We note that in earlier experiments that have studied the
effect of food withdrawal on C. elegans behavior, a brief 30 minutes absence
from bacteria did not effect a behavioral change (Colbert and Bargmann, 1997;
Mori, 1999), suggesting that our paradigm may involve a distinct mechanism of
plasticity. We found that the responses of well-fed and food-deprived animals
represent two distinct and separable modulatory behaviors and that dopamine
and serotonin function in a non-overlapping manner to mediate the behaviors of
well-fed and food-deprived animals, respectively.
Results
Locomotory Rate Decreases in the Presence of Bacteria
We quantified the locomotory rate of wild-type C. elegans hermaphrodites
moving on an agar surface of a Petri plate by counting the number of bends in
the anterior body region during a 20 second interval. Animals that had been
continuously cultured on the bacterium Escherichia coli (well-fed) were washed
free of bacteria and then transferred to assay plates containing or lacking a
bacterial lawn. Well-fed animals that were transferred to assay plates containing
bacteria moved more slowly upon re-entering the bacterial lawn than well-fed
animals that were transferred to assay plates lacking bacteria (p<0.0001,
Student's t-test) (Figure 1A, black bars). We refer to this response of well-fed
animals after their re-entry into the bacterial lawn as the "basal slowing
response."
Food-deprived Animals Show More Pronounced Slowing in Response to
Bacteria
The strength of an animal's slowing response to bacteria depended on the
animal's recent experience, in particular on whether the animal had been
removed from bacteria 30 minutes before the behavioral assay (food-deprived).
We compared the locomotory rate of well-fed animals to that of food-deprived
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animals on assay plates containing or lacking a bacteria lawn. We found that
food-deprived animals showed a more pronounced slowing response to the
presence of bacteria than did well-fed animals (p<0.0001, Student's t-test)
(Figure 1A, gray bars). We refer to this response of food-deprived animals after
their re-entry into the bacterial lawn as the "enhanced slowing response."
The enhanced slowing response was a specific modulatory response
rather than physiological exhaustion resulting from food-deprivation, since food-
deprived animals in the absence of bacteria moved as rapidly as well-fed animals
in the absence of bacteria (Figure 1A). These results indicate that C. elegans can
use information about its prior exposure to bacteria to alter its behavior when it
re-encounters bacteria.
The Basal Slowing Response Requires Dopamine
To explore the mechanisms underlying the basal and enhanced slowing
responses, we examined several C. elegans mutant strains with defects in
neurotransmission. We first examined the behavior of animals bearing mutations
in one or more of three genes known to affect biogenic amine synthesis: cat-2,
cat-4, and bas-1. cat-2(e 1112) ( catecholamine defective) and cat-4(e1141)
mutants do not show the formaldehyde-induced fluorescence (FIF) indicative of
the neurotransmitter dopamine (Sulston et al., 1975). cat-4 mutants also are
reduced in serotonin expression (Desai et al., 1988; Weinshenker et al., 1995),
whereas cat-2 mutants have normal levels of serotonin (G. Garriga, personal
communication; E. R. S. and H. R. H., unpublished data). cat-2 encodes a
tyrosine hydroxylase, an enzyme required for the biosynthesis of dopamine (Lints
and Emmons, 1999). cat-4 encodes a GTP cyclohydrolase I (C. Loer, personal
communication), an enzyme required for the synthesis of a co-factor needed for
dopamine and serotonin biosynthesis (Kapatos et al., 1999). bas-1(ad446) (
biogenic amine synthesis defective) mutants have reduced serotonin levels (Loer
and Kenyon, 1993) and also lack the FIF indicative of dopamine (E. R. S. and H.
R. H., unpublished data). bas-1 encodes an aromatic amino acid decarboxylase,
an enzyme needed for the biosynthesis of serotonin and dopamine (C. Loer,
personal communication). Thus, cat-4 and bas-1 mutants appear to be deficient
in both dopamine and serotonin, while cat-2 mutants are deficient in only
dopamine.
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We found that animals with mutations in any of these three genes were
completely defective in the basal slowing response (Figures 1B-D, black bars).
For example, in the presence of bacteria the locomotory rate of well-fed cat-2
mutants (Figure 1 B, black bars) on bacteria was significantly faster (p<0.0001,
Student's t-test) than that of well-fed wild-type animals that had been assayed in
parallel. We generated a bas-1(ad446); cat-4(e1141) strain and found that the
double mutant was indistinguishable from the single mutants with respect to the
defect in the basal slowing response (Figure 1 E, black bars). All of these mutants
moved at the same rate as wild-type hermaphrodites in the absence of bacteria
(Figures 1A-1 E). Hence, the lack of the basal slowing response of these mutants
was not a result of a general enhancement of locomotory rate or physical vigor
but rather was likely to be a consequence of their common defect in dopamine
expression. Moreover, the existence of mutants defective in the basal slowing
response argues that the slowing of locomotory rate of well-fed animals on a
bacterial lawn is a specific behavioral response to the presence of bacteria rather
than a physical inability to move faster on a bacterial lawn.
The Enhanced Slowing Response Requires Serotonin
In addition to a defect in the basal slowing response, animals with mutations in
bas-1 or cat-4, but not cat-2, were also defective in the enhanced slowing
response (compare Figures 1B-D, gray bars, to Figure 1A, gray bars). That cat-2
mutants displayed a normal enhanced slowing response suggested that
dopamine was not needed for this behavior and that the loss of serotonin
biosynthesis in the bas-1 and cat-4 mutants was responsible for the defect in the
enhanced slowing response. These results also suggested that this experience-
dependent modulatory behavior was not just a stronger form of the basal slowing
response. In support of this hypothesis, other treatments that affected the
enhanced slowing response did not affect the basal slowing response (see
below).
bas-1(ad446); cat-4(e1141) mutants were more defective in their
enhanced slowing response (Figure 1 E, gray bars) than was either of the single
mutants (Figures 1C and 1 D, gray bars). A plausible explanation for the
increased defect is that the double mutants are more defective in serotonin
biosynthesis than is either single mutant. It is unlikely, however, that the double
mutants completely lack serotonin, since they do not have the developmental
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defects seen in animals with a large deletion in the tph-1 gene, which encodes a
tryptophan hydroxylase, an enzyme essential for serotonin biosynthesis (Sze et
al., 2000). Alternatively, it is conceivable that bas-1 and cat-4 are both involved in
the biosynthesis of a signaling molecule other than dopamine or serotonin and
the increased loss of that molecule led to the increased behavioral defect in the
double mutant. We consider this second possibility unlikely, since we could
restore wild-type basal and enhanced slowing responses to the double mutant by
pre-incubating the animals in dopamine or serotonin, respectively (see below).
Exogenous Dopamine Restores the Basal Slowing Response of cat-2 and
bas-1; cat-4 Mutants
We tested the ability of exogenous dopamine to restore the basal slowing
response to cat-2(e 1112) and bas-1( ad446); cat -4(e1141) mutants. Prior to the
behavioral assay, we incubated wild-type, cat-2(e 1112), and bas-1(ad446);
cat-4(e1141) animals on bacteria-containing plates with 2 mM dopamine and
then examined the basal slowing response of these animals. Pre-incubation on
plates containing dopamine caused cat-2 and bas-1; cat-4 mutants to exhibit a
nearly normal basal slowing response (Figure 2). For example, control cat-2
mutants pre-treated without dopamine had a significantly higher locomotory rate
(Figure 2A, asterisks) than control wild-type animals pre-treated without
dopamine, whereas cat-2 mutants pre-treated with dopamine did not have a
significantly different locomotory rate from wild-type animals pre-treated with
dopamine (denoted by an "R" for Rescue; see Experimental Procedures for
rescue criteria). C. elegans locomotion can be inhibited by high concentrations of
dopamine (Schafer and Kenyon, 1995). Therefore, the concentration of
dopamine used in this experiment was titrated so that it did not affect the
locomotory rate of well-fed wild-type animals either in the absence or presence of
bacteria (Figure 2), thereby allowing us to conclude that the rescue by dopamine
in this assay was not the result of a general dopamine-induced locomotory
slowing that bypassed the modulatory response to the stimulus of bacteria. Also,
pre-incubation on dopamine-containing plates did not decrease the locomotory
rate of either mutant class in the absence of bacteria (Figures 2A and 2B); thus, it
is unlikely that the slowing of the dopamine-treated cat-2 and bas-1; cat-4
mutants in response to bacteria resulted from a hypersensitivity of the mutants to
dopamine. Pre-treatment with exogenous serotonin did not rescue the defect in
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the basal slowing response of well-fed cat-2 or bas-1; cat-4 mutants (Figure 2),
suggesting that the effect of dopamine was specific and that exogenous
serotonin cannot bypass the need for dopamine in the basal slowing response.
The CEP, ADE, and PDE Dopaminergic Neurons Sense Mechanosensory
Stimuli Required for the Basal Slowing Response
The C. elegans hermaphrodite has eight dopaminergic neurons: the four CEPs,
the two ADEs, and the two PDEs (Sulston et al., 1975). Ultrastructurally, the
eight dopaminergic neurons have ciliated endings embedded in the cuticle,
indicating likely mechanosensory functions (Ward, 1973; Perkins et al., 1986;
White et al., 1986). The CEP sensory processes extend to the tip of the nose, the
ADE sensory endings are located laterally in the anterior third of the body, and
the PDE sensory endings are located laterally in the posterior body region.
To test if these dopaminergic sensory neurons were required for the basal
slowing response, we ablated combinations of dopaminergic neurons in young
larvae and examined the locomotory behavior of the resulting adults. Among the
single cell-type ablations, only the ablation of the four CEPs resulted in a
detectable defect in the basal slowing response (Figure 3A) and this defect was
only modest. Among the double cell-type ablations, animals lacking the four
CEPs and the two PDEs moved slightly faster than mock-ablated controls (Figure
3B). Animals lacking the four CEPs and the two ADEs did not show a defect in
the basal slowing response; perhaps a larger number of experiments is
necessary to obtain a statistically significant difference; alternatively the lack of a
defect in these animals could have a biological basis. Ablating all three classes of
dopaminergic neurons resulted in animals that were completely defective in the
basal slowing response (Figure 3B). This result implied that these three classes
of dopaminergic neurons function redundantly to mediate the basal slowing
response.
If these dopaminergic neurons were directly involved in sensing the
presence of bacteria, only those neurons with sensory endings in contact with
bacteria might be required for the basal slowing response. Since C. elegans
moves through bacteria lying on either its left or right side (White et al., 1986), we
were able to test this hypothesis by ablating only the dopaminergic neurons
having sensory endings on one side of the animal's body. Since the sensory
endings of the CEP neurons are located in the tip of the animal's nose, the entire
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circumference of which is in contact with bacteria, we ablated all four CEP
neurons. We found that the ADE and PDE neurons were required only on the
side of the animal's body in contact with bacteria (Figure 3C). When animals lay
on the unoperated side they responded normally to bacteria, but when these
same animals lay on the opposite, operated side, they were defective in the
basal slowing response.
To explore the nature of the stimulus detected by the dopaminergic
neurons, we tested if substances other than bacteria could elicit the basal
slowing response. We found that wild-type hermaphrodites slowed their rate of
locomotion as they crawled through a three-dimensional matrix of sterile
Sephadex G-200 beads (Figure 4A). G-200 Sephadex beads (20-50 pm) are
much larger than bacteria and cannot be ingested by C. elegans. Therefore, any
stimulus presented by these beads had to be sensed on the exterior of the
animal. We found that cat-2(e 1112) dopamine-deficient mutants did not exhibit
the basal slowing response to the Sephadex beads (Figure 4A). Similarly,
animals in which all the dopaminergic neurons had been ablated by laser
ablation also did not exhibit the basal slowing response to Sephadex beads
(Figure 4B).
These data argue that the slowing response to a non-bacterial stimulus
was also mediated by dopaminergic neurotransmission. Since we added no
bacteria in these experiments (and thus there were presumably no
chemosensory cues associated with bacteria), these results taken together with
the fact that the dopaminergic neurons are likely to be mechanosensory
suggested that dopaminergic neurotransmission is required to respond to a
mechanical attribute of bacteria to elicit the neuromodulatory basal slowing
response.
Exogenous Serotonin Restores the Enhanced Slowing Response of
bas-1; cat-4 Mutants
As discussed above, the enhanced slowing response appears to be independent
of the dopamine-mediated basal slowing response and requires serotonin. We
tested the ability of 2 mM exogenous serotonin to restore the enhanced slowing
response to bas-1; cat-4 mutants. Pre-incubation on serotonin-containing plates
caused bas-1; cat-4 mutants to exhibit a normal enhanced slowing response
(Figure 2B). The concentration of serotonin used in this experiment was titrated
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so that it did not affect the locomotory rate of wild-type animals (Figure 2), or of
bas-1; cat-4 mutants when well-fed (Figure 2B), or of food-deprived bas-1; cat-4
mutants in the absence of bacteria (data not shown), thereby allowing us to
conclude that the slowing caused by serotonin in this assay is a restoration of the
enhanced slowing response and not the result of a general serotonin-induced
locomotory slowing that bypassed the modulatory response to the stimulus of
bacteria. Exogenous dopamine did not rescue the defect in the enhanced
slowing response of bas-1; cat-4 mutants (Figure 2B) but did rescue the basal
slowing response of bas-1; cat-4 mutants (Figure 2B), indicating that the
serotonin rescue of the defect in the enhanced slowing response is specific.
Thus, endogenous dopamine was not required for the enhanced slowing
response (cat-2 mutants; Figure 1 B, gray bars), and exogenous dopamine could
not bypass the need for serotonin in the enhanced slowing response.
The Serotonergic NSMs Are Required for a Full Enhanced Slowing
Response
A number of serotonin-immunoreactive neurons have been reported to be
present in the C. elegans hermaphrodite: the most reproducibly staining neurons
are the bilaterally symmetric pairs of NSMs (Horvitz et al., 1982), HSNs (Desai et
al., 1988), ADFs, PHBs, AlMs, and the single 15 and RIH neurons (E. R. S. and
H. R. H., unpublished data). Expression of a green fluorescent protein (GFP)
reporter of the tph-1 gene is also observed in the NSMs, HSNs, ADFs, AlMs, and
the RIH (Sze et al., 2000).
To test if these serotonergic sensory neurons were required for the
enhanced slowing response, we ablated combinations of serotonergic neurons in
young larvae and examined the locomotory behavior of the resulting adults. After
ablating the NSMs using laser microsurgery, we found that well-fed animals
lacking the NSMs (n=45) exhibited a normal basal slowing response (a change
from 21.9±0.4 body bends/20 seconds (error represents the SEM) on plates with
no bacteria to 14.8±0.5 body bends on plates with bacteria compared to mock
ablated controls (n=45), which changed from 21.3±0.5 body bends to 14.6±0.6
body bends in the respective conditions). However, on plates with bacteria, food-
deprived animals lacking the NSMs (n=45), moved slightly but significantly faster
(7.3±0.6 body bends) than mock-ablated controls (5.1±0.4 body bends; n=45;
p = 0.002, Student's t-test), suggesting that the NSMs contribute to the enhanced
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Islowing response. That the ablation of the NSMs did not cause a defect in the
enhanced slowing response as strong as the one seen in bas-1; cat-4 mutants
(Figure 1 E, gray bars) suggested that other cells, possibly including other
serotonergic neurons, also contribute to the response.
We performed several double, triple, quadruple, quintuple, sextuple, and
septuple ablations (all ablations included both members of the bilaterally
symmetric classes), all of which included the ablation of the NSMs. In none of
these multiple cell-type ablation experiments did we see a statistically significant
defect in the enhanced slowing response beyond the defect seen in the NSM-
ablated animals (Sawin, 1996).
It is possible that the NSMs are the only serotonergic neurons involved in
the enhanced slowing response. For example, the NSMs might have continued
to function even though their nuclei had been ablated; such residual function has
been observed for the M4 neuron after its ablation in older animals (Avery and
Horvitz, 1987). However, we consider this possibility unlikely, since we have
found that the ablation of the NSMs leads to a complete loss of the potentiation
of the enhanced slowing response by fluoxetine (see below). It is also
conceivable that the NSMs provide both positive and negative inputs for the
enhanced slowing response and that the ablation of the cell removes both
classes of inputs leading to a weaker behavioral defect than would be seen if
only the one or the other class of input was individually perturbed. The VC4 and
VC5 neurons may also contain serotonin based on extremely weak
immunoreactivity to anti-serotonin antibodies (G. Garriga, personal
communication). We have observed such weak immunoreactivity in these
neurons only very rarely (E. R. S. and H. R. H., unpublished data). Since
tryptophan hydroxylase GFP reporter expression is not observed in the VC4 and
VC5 neurons (Sze et al., 2000), it is possible that the variable and low level of
serotonin immunoreactivity seen in these neurons is the result of these neurons
taking up serotonin released by other serotonergic neurons (e.g., the HSNs,
which are nearby). Nevertheless, it remains conceivable that the VC4 and VC5
neurons or other serotonergic cells not visualized by available anti-serotonin
antibodies might function in the enhanced slowing response.
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The Enhanced Slowing Response Is Not Triggered by Mechanosensory
Stimuli that Trigger the Basal Slowing Response
We found that food-deprived wild-type hermaphrodites did not slow their
locomotion rate as they crawled through a three-dimensional matrix of sterile
Sephadex G-200 beads (Figure 4C). These data argue that in contrast to the
basal slowing response, which is likely to be triggered by a mechanosensory
stimulus to the surface of the animal, the enhanced slowing response appears
not to be. Moreover, animals attained the food-deprived state even in the
presence of Sephadex beads, since animals that were food-deprived in a three-
dimensional matrix of Sephadex beads and then re-introduced to bacteria still
exhibited the normal enhanced slowing response (Figure 4D). These
observations demonstrate that the physical stimulus provided by Sephadex
beads neither mimics the cues that food-deprived animals normally receive when
re-introduced to bacteria nor prevents animals from attaining the food-deprived
state.
Serotonin Antagonists Blocked the Enhanced Slowing Response
To test further the serotonin-dependence of the enhanced slowing response, we
pre-incubated wild-type animals on Petri plates with two serotonin receptor
antagonists, mianserin hydrochloride (Glennon, 1987) and methiothepin
mesylate (Mylecharane, 1989), and tested these animals for the basal and
enhanced slowing responses. While the specificities of these drugs on
C. elegans behavior have not established, we found that both blocked the
inhibition of locomotion induced by treatment with high concentrations of
exogenous serotonin (data not shown), suggesting that these drugs interfere with
serotonergic neurotransmission in C. elegans. Neither mianserin (20 pM) nor
methiothepin (44 pM) had any effect on the basal slowing response (Figure 5A,
black bars). However, food-deprived animals pre-treated with either drug were
defective in the enhanced slowing response (Figure 5A, gray bars), providing
further support for the role of serotonin in this modulatory behavior.
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Fluoxetine Potentiates the Enhanced Slowing Response
We examined the effects of low concentrations of the selective serotonin re-
uptake inhibitor fluoxetine (Prozac) on the locomotory rate of food-deprived
animals. On plates without bacteria, there was no difference between the
locomotory rates of animals that been food-deprived in the presence or absence
of fluoxetine (Figure 5B). Since fluoxetine is a serotonin re-uptake blocker that
most likely potentiates the concentration of serotonin at synapses, this
observation suggested that in food-deprived animals, in the absence of bacteria,
no serotonin is released and hence no potentiation by fluoxetine occurs. By
contrast, on plates with bacteria, wild-type animals that had been food-deprived
in the presence of fluoxetine moved much more slowly than wild-type animals
that had been food-deprived in the absence of fluoxetine (Figure 5B). This
observation suggests that fluoxetine amplifies the signaling process triggered
when bacteria are encountered by food-deprived animals. We propose that
bacteria trigger the release of serotonin, and fluoxetine amplifies the effect of the
released serotonin by blocking its re-uptake. Furthermore, we postulate that
fluoxetine affects the levels of only serotonin to potentiate the enhanced slowing
response, since on plates containing bacteria, bas-1; cat-4 mutants (which lack
serotonin and dopamine) that had been food-deprived in the presence of
fluoxetine had the same locomotory rate as did bas-1; cat-4 mutants that had
been food-deprived in the absence of fluoxetine (Figure 5B) while cat-2 mutants
(which lack dopamine but not serotonin) were no different from wild-type animals
in this experiment (data not shown).
The NSM-ablated animals were resistant to the effects of fluoxetine. On
plates containing bacteria, NSM-ablated animals that had been food-deprived in
the presence of fluoxetine did not move any more slowly than NSM-ablated
animals food-deprived in the absence of fluoxetine (Figure 5C). These data
suggest that the potentiation of the enhanced slowing response by fluoxetine
depends on the NSMs and that it was serotonin released by the NSMs that was
specifically potentiated by fluoxetine. This result also indicates that if there is
another, as yet unidentified, source of serotonin that modulates this behavior, the
serotonin signaling from that source is not potentiated by the fluoxetine
treatments used in these experiments.
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Food Deprivation Does Not Lead to Serotonin Hypersensitivity
To determine whether the treatment of food-deprivation altered the sensitivity of
the animals to serotonin, we compared the responsiveness of well-fed and food-
deprived animals to exogenous serotonin. High concentrations of exogenous
serotonin decrease the locomotory rate of well-fed C. elegans (Horvitz et al.,
1982). We found that food-deprived worms were not hypersensitive to
exogenous serotonin, since the locomotory rate of well-fed and food-deprived
animals was inhibited by serotonin to the same extent over a range of
concentrations (Figure 5D). This assay for serotonin sensitivity was done in the
absence of food, since the presence of food would have led to the enhanced
slowing response by food-deprived animals. The threshold concentration of
serotonin required to affect well-fed and food-deprived animals was also very
similar (Figure 5D). In addition, the well-fed and food-deprived animals did not
show any significant difference in the kinetics of the response to any of the
concentrations used in Figure 5D (data not shown). These results suggest that
the increased responsiveness of food-deprived animals to bacteria is not a result
of hypersensitivity to a food-induced serotonin signal.
Isolation of Modulation-Defective Mutants
We performed a genetic screen for mutants with defects in the enhanced slowing
response. From a screen of approximately 16,000 haploid genomes, we isolated
17 mutant strains that when food-deprived and re-introduced to bacteria exhibit
an abnormally fast locomotory rate (Figure 6). Our complementation studies
indicated that four of these strains contain mutations in the known genes, bas-1,
goa-1 (G-protein 0, alpha subunit), and dgk-1 (diacylglycerol kinase). goa-1 and
dgk-1 have both been implicated by previous studies to be components of a
serotonin signaling pathway (Mendel et al., 1995; Segalat et al., 1995; Nurrish et
al., 1999). That we isolated alleles of these three genes in this genetic screen
provides further evidence for the need for serotonin signaling in the enhanced
slowing response.
All 17 mutant strains display the same locomotory rate as do the wild type
on plates without bacteria, whether they were well-fed or food-deprived (Sawin,
1996). bas-1(n2948) and bas-1(n3008) mutants also showed a strong defect in
the basal slowing response (Sawin, 1996), as expected given our
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characterization of the bas-1(ad446) mutant (Figure 1C). Of the remaining 15
strains, 3 - n3007, n3033, and goa-1(n3055)) - also have weak defects in the
basal slowing response (Sawin, 1996) . We assayed goa-1(n363) mutants (the
n363 allele results in a complete loss-of-function of the gene; Segalat et al.,
1995) and found that they have a more severe defect in both the basal and
enhanced slowing responses than does our new goa-1(n3055) mutant (Sawin,
1996). This defect in basal slowing response of the goa-1 mutants suggests that
the G-protein encoded by goa-1 might be involved not only in a serotonergic
signaling pathway but also in a dopaminergic pathway.
Thus far, we have genetically mapped two of the mutations (n3034 and
n3076) to small regions on chromosome V and I, respectively (see Chapter 3 and
5 respectively). These genetic positions are distinct from the location of all genes
implicated to date in the basal and enhanced slowing responses (Sawin, 1996).
These mutations define two new genes, mod-1 and mod-6 (modulation of
locomotion defective).
Discussion
Food is a powerful stimulus that affects many C. elegans behaviors, including
pharyngeal pumping (Avery and Horvitz, 1990), defecation (Liu and Thomas,
1994), and egg laying (Horvitz et al., 1982; Trent et al., 1983; Weinshenker et al.,
1995). A prolonged withdrawal from food can affect C. elegans behavior (Colbert
and Bargmann, 1997; Mori, 1999). We report that a brief 30 minute period of
food-deprivation, a period insufficient to affect the other behaviors that have been
studied (Colbert and Bargmann, 1997; Mori, 1999); and E .R. S. et al.,
unpublished data), elicits a robust change in behavior, namely the response to
the presentation of the stimulus of food. In other words, 30 minutes of food
deprivation can cause C. elegans to exist in an alternative behavioral state that
allows it to respond appropriately to changes in the availability of food by
modulating its locomotory rate. A dopamine-dependent process acts to reduce
the locomotory rate of well-fed animals in response to a mechanosensory
stimulus from bacteria. A serotonin-dependent process causes food-deprived
animals to respond with an enhanced slowing of locomotory rate upon being
transferred to bacteria. Both of these modulatory behaviors seem likely to be of
adaptive significance (see below).
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The ability of C. elegans to respond with differing intensities to the same
environmental stimulus depending on the animal's state is similar to examples of
behavioral plasticity seen in many animals. In the leech, a prolonged period
without feeding results in an increase in the frequency of swimming and biting
behaviors (O'Gara et al., 1991). Food-deprived leeches also exhibit other
behavioral responses that are distinct from the responses of satiated leeches
(Groome et al., 1993; Brodfuehrer et al., 1995). Food-induced arousal in Aplysia
leads to an increase in the speed and strength of biting responses (Rosen et al.,
1989). Similarly, a mammal's internal state can modulate the animal's
responsiveness to various environmental stimuli (Kupfermann and Schwartz,
1995).
We have shown that our paradigm for behavioral plasticity in C. elegans
involves dopamine and serotonin and is affected by fluoxetine. We propose that
this experience-dependent modulatory behavior of C. elegans provides a simple
model for the control of behavioral state and the related phenomena of
motivation and mood.
The Basal Slowing Response Involves a Mechanosensory Stimulus
Mediated by Dopamine
Recently, using the assay for locomotory rate we developed (Sawin, 1996) and
used in the studies described in this paper, Duerr et al. (1999) observed that
cat-1 mutants, which are defective in loading pre-synaptic vesicles with
monoamines, do not show the basal slowing response. This observation is
consistent with our finding that dopamine-deficient mutants are defective in the
basal slowing response. The apparent redundant function of the different
dopaminergic neurons in the basal slowing response, established by our laser-
ablation experiments, is similar to redundancies seen in other sensory systems in
C. elegans. For example, three classes of mechanosensory neurons function
together to sense touch to the nose (Kaplan and Horvitz, 1993), and four partially
redundant cell types are required for direct chemotaxis to many attractants
(Bargmann and Horvitz, 1991).
Since the dopaminergic neurons involved in the basal slowing response
appear to sense a mechanical attribute of both bacteria and the Sephadex matrix
(perhaps surface tension or pressure exerted on the cuticle), we suggest that in
the basal slowing response the dopaminergic neurons transduce a
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mechanosensory stimulus through interneurons and motor neurons to effect a
slowing of locomotory rate (Figure 7A).
C. elegans is capable of discerning several attractive chemical cues in its
search for food (Colbert and Bargmann, 1997). Why then might C. elegans sense
bacteria mechanically? Perhaps while the chemosensory system is used to find
new distant bacterial food sources, the mechanosensory system we have
identified allows the animal to remain in the vicinity of the food source once that
source has been reached.
The Enhanced Slowing Response Is Modulated by Serotonin and Is Distinct
from the Basal Slowing Response
The process that allows food-deprived C. elegans to respond more strongly when
transferred to bacteria is distinct from the process that well-fed C. elegans uses
to respond to bacteria. The results of our rescue, ablation, and antagonist
experiments strongly indicate that the experience-dependent enhanced slowing
response is not simply a stronger form of the basal slowing response but rather is
completely distinct. We therefore expect that complete loss of the enhanced
slowing response would result in food-deprived animals having the same
locomotory rate on plates with bacteria as they do on plates without bacteria. For
this reason, we conclude that none of the mutants tested or the treatments
performed completely abolished the enhanced slowing response.
If, as discussed above, serotonergic cells other than the NSMs are
required for the enhanced slowing response, then the complete lack of
potentiation of the enhanced slowing response by fluoxetine in NSM-ablated
animals suggests that fluoxetine acts only on the NSMs and not on any of the
other serotonergic cells involved. Given that the unique ultrastructure of the
NSMs suggests that they might be neurosecretory (Albertson and Thomson,
1975), it is possible that fluoxetine acts on only neurosecretory cells in
C. elegans. Alternatively, a non-serotonergic modulatory pathway insensitive to
fluoxetine may act in parallel to the serotonergic pathway to transduce the
signal(s) required for the enhanced slowing response.
69
i
The Food-deprivation Signal Is Likely to Act Upstream of the Serotonin-
responsive Circuit
We sought to determine whether information about food-deprivation was stored
in cells pre- or post-synaptic to the serotonergic synapses in the animal. If
serotonin were released as an indicator of the presence of bacteria, then food-
deprivation could result in diminished levels of serotonin release and perhaps a
consequent sensitization of serotonin receptors by pathways well established for
G-protein coupled receptors (Lefkowitz, 1993). If so, when animals are exposed
to bacteria after food-deprivation, release of serotonin would resume and,
because serotonin receptors had become sensitized, the same amount of
released serotonin would have a greater behavioral effect. We do not believe that
such a mechanism is responsible for the enhanced slowing response, since food-
deprived and well-fed animals had similar sensitivities to exogenous serotonin.
Rather, these findings suggest that the enhanced slowing response is regulated
by a mechanism that does not depend either on altering the number of serotonin
receptors on the cells that directly respond to serotonin or on enhancing the
sensitivity of the serotonin receptors or any of the downstream components of
the relevant signaling pathway(s).
One alternate model is that serotonin is released as an indicator of the
absence of bacteria, i. e., during the 30 minute period of food-deprivation.
Without such serotonin release, the enhanced slowing response could not occur.
However, we observed that food-deprived animals did not move more slowly
than well-fed animals on plates without bacteria and that the locomotory rate of
food-deprived animals on plates without bacteria was unaffected by the
fluoxetine treatment during food-deprivation. Given these observations, such a
model would necessitate proposing that the re-introduction to food provides a
permissive signal that allows the increased levels of serotonin in the synaptic
cleft to effect a greater slowing of locomotory rate.
Instead, we favor a simpler model. We propose that the effect of food-
deprivation is to increase the amount of serotonin released when food is re-
encountered. Such an increase in serotonin release could be achieved by
several possible molecular mechanisms, including an increase in the number of
pre-synaptic vesicles that fuse to release serotonin or a faster fusion and
exocytosis process of the normal number of pre-synaptic vesicles.
70
A
It is not obvious how the food-deprived state of an animal might lead to an
increase of serotonin release from serotonergic neurons when bacteria are
encountered. The information about food-deprivation could be stored in the
serotonergic neurons themselves, through several possible molecular
mechanisms, including transcriptional, translational, or post-translation changes
of specific genes and proteins. One possible manifestation of such changes
could be a depolarization in the resting membrane potential of the serotonergic
neurons such that the neurons are primed to release serotonin when the next
bacterial stimulus is encountered. Alternatively, the food-deprivation state could
be stored anywhere in the nervous system upstream of or parallel to the
serotonergic cells. Another possibility is that some non-neuronal physiological
state, such as the extent to which the pharynx or the intestine is filled, is changed
by food-deprivation, and such a change is detected and transduced by the
nervous system. The serotonergic NSMs are plausible candidates to sense the
presence of food, since these neurons have apparent mechanosensory endings
(Albertson and Thomson, 1975), which could sense either bacteria in the pharynx
or pharyngeal movements that occur during feeding.
In a simple model for the serotonergic regulation of the enhanced slowing
response, serotonergic neurons (perhaps only the NSMs) might both detect the
presence of food and store information about prior food-deprivation; these two
inputs would then be integrated within these cells to regulate neural activity
(Figure 7B). Alternatively, a serotonergic circuit, which may or may not include
the NSMs, might mediate either the stimulus of bacteria or the food-deprivation
signal, while another circuit responds to the other input, and the two inputs are
integrated downstream of the serotonergic neurons. As discussed above,
another modulatory pathway may act in parallel to the serotonergic pathway, and
such redundancy could account for our failure to identify any pharmacological
treatment, laser-ablation protocol, or mutation that completely abolished the
enhanced slowing response. Such branched pathways are conceivable but are
not the simplest interpretation of the data.
Adaptive Significance of the Basal and Enhanced Slowing Responses
Both the basal and the enhanced slowing responses could well be important for
the survival of C. elegans in the wild. C. elegans eats bacteria, which in turn feed
on decaying organic material in the soil, and the C. elegans population increases
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until the food source is exhausted, at which point the population disperses
(Nicholas, 1984). As discussed above, the basal slowing response could provide
a mechanism to increase the likelihood that an animal will remain in the presence
of a proximal bacterial food source. The enhanced slowing response would
increase the certainty that an animal that had briefly wandered from or exhausted
its food supply would, upon locating a fresh food supply, remain in the vicinity of
that food source. In other words, the basal slowing response ensures that a well-
fed animal will remain in the presence of food and continue feeding, while the
enhanced slowing response ensures that an animal away from a food source for
30 minutes, for which food is likely to be even more important, stops when it
encounters a new food source. Perhaps in its natural habitat a food-deprived
animal is unwilling to forage further afield in search of a better or larger food
source, or some alternative joy, since it risks going too far from a recently
discovered and vital food source, whereas a well-fed animal may be willing to
chance an exploration of its environment.
Our finding that C. elegans can modulate the rate of an ongoing motor
program based on environmental conditions and its recent experience highlights
the behavioral flexibility that is possible even with a nervous system comprising
only 302 neurons of 118 distinct types (White et al., 1986). We have readily
isolated a collection of mutations with defects in the enhanced slowing response
and identified new genes involved in this paradigm of behavioral plasticity. We
believe that the further dissection of this modulatory behavior at the level of
defined cells, neurotransmitters, and genes will lead to an understanding of the
complex mechanisms an animal uses to alter its behavioral output based on its
prior experience.
Experimental Procedures
Strains and Strain Constructions
Nematodes were grown in non-crowded conditions at 20 0C as described by
Brenner (1974), except that E. coli strain HB101 instead of OP50 was used as
the food source, since thin bacterial lawns of uniform thickness were more
reliably generated with overnight growth of HB1 01 (data not shown); such
uniformity was critical for reproducible results in the locomotory rate assays.
Wild-type animals were C. elegans strain N2. Mutant strains used were CB1 112
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cat-2(e1112) II, CB1141 cat-4(e1141) V (Sulston et al., 1975), MT7988
bas-1(ad446) Ill (Loer and Kenyon, 1993), MT8943 bas-1(ad446) Il1;
cat-4(e1141) V, MT363 goa-1(n363) 1, MT7990 bas-1(n2948) 111, MT7991
dgk-1(n2949) X, MT8201 mod(n3006), MT8203 mod(n3007), MT8202
bas- 1 (n3008), MT8539 mod(n3032), MT8630 mod(n3033), MT8541
mod-1(n3034) V, MT8623 mod(n3052), MT8624 mod(n3053), MT8625
mod(n3054), MT8626 goa-1(n3055) 1, MT8627 mod(n3056), MT8628
mod(n3057), MT8689 mod(n3074), MT8690 mod(n3075), and MT8720
mod-6(n3076) 1.
Locomotory Rate Assays
Assay plates were prepared by spreading the E. coli strain HB101 in a ring with
an inner diameter of approximately 1 cm and an outer diameter of approximately
3.5 cm on NGM agar (Brenner, 1974) in 5 cm Petri plates. Assay plates were
always freshly spread with bacteria, incubated overnight at 370C, and allowed to
cool to room temperature before use. Plates for measuring locomotory rate in the
absence of bacteria were also incubated at 370C. Only synchronized young adult
hermaphrodites (16 hours after the late L4 larval stage) were tested. In all cases,
plates were coded so that the experimenter was blind to the genotype or the
laser-ablation state of the animal and to the neurotransmitter content of the pre-
treatment plate.
For well-fed animals, locomotory rate was measured by removing five
animals from plates with ample bacteria, washing the animals twice in S basal
buffer (Brenner, 1974), and transferring them to an assay plate in a drop of buffer
using a capillary pipette. If the assay plate contained a ring-shaped bacterial
lawn, the animals were transferred to the clear zone at the center of the ring. The
drop of buffer used to transfer the animals was absorbed with a Kimwipe. Five
minutes after transfer, the number of body bends in 20 second intervals was
sequentially recorded for each of the five animals on the assay plate. This
slowing response of well-fed animals was not an artifact of the wash step, since
animals transferred directly from the culture plates to assay plates also exhibited
the basal slowing response (data not shown). Since food-deprived animals (see
below) were washed, we washed all the animals to enable direct comparisons.
For food-deprived animals, 5-15 animals were washed free of bacteria in
S basal buffer (two washes) and then transferred to 5 cm NGM agar plates that
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had no bacteria but had a ring of high osmolarity fructose on the outer edge. The
drop of buffer used to transfer the animals was absorbed with a Kimwipe. The
animals were incubated on these plates for 30 minutes at room temperature.
C. elegans avoids high osmolarity (Culotti and Russell, 1978), and this avoidance
reflex prevented the animals from swimming off the agar and dying on the plastic
edge of the Petri plate. The high osmolarity ring was created by adding
approximately 100 pl of a 4 M fructose solution to the outer circumference of the
agar surface and waiting approximately 5-10 minutes for this solution to dry into
the plate. To make the high osmolarity ring visible, we added a small amount of
bromophenol blue to the fructose solution. The presence of the high osmolarity
ring or the bromophenol blue had no effect on the behavior of animals in the
locomotory rate assays (data not shown). At the end of 30 minutes of food-
deprivation, five worms were transferred in a drop of S basal buffer to assay
plates and locomotory rate was measured as described above for well-fed
animals.
Locomotory rate measurements for mock- and laser-ablated animals were
done in a similar fashion, except that only one animal was transferred to each
assay plate. Its locomotory rate was tested in the presence of bacteria, it was
allowed to recover for 2-3 hours on plates containing bacteria, and then
transferred, as described above, to food-deprivation plates. After five minutes on
the food-deprivation plates, the locomotory rate of these well-fed animals in the
absence of food was recorded; these locomotory rates were not different from
locomotory rates on regular assay plates without bacteria that did not have the
high osmolarity ring (data not shown). After 30 minutes the food-deprived
animals were transferred to assay plates containing ring-shaped bacterial lawns,
and the locomotory rate was again recorded. For the ablation and serotonin-
antagonist experiments (Figure 5B and 5C), locomotory rate data for food-
deprived animals on plates without bacteria were not collected, since we have
never observed any difference between the behaviors of well-fed and food-
deprived animals on plates without bacteria. For the unilateral ablations, there
was no systematic bias to the order in which the sides were assayed, since the
plates were coded prior to the locomotory assay and the experimenter did not
know when assaying a given side whether or not the neurons had been ablated
on that side.
Sephadex G-200 beads (Sigma Chemicals) were re-suspended in S basal
buffer at 30 mg/ml and autoclaved for 45 minutes. Approximately 200 pl of this
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mixture was transferred to an agar plate. Excess buffer that pooled at the edge of
the Sephadex was removed with a Kimwipe. The rate of locomotion was
measured two minutes after transferring the animals to the Sephadex matrix. The
food-deprivations on Sephadex were performed by washing the animals twice in
S basal buffer and transferring them to a 5 cm plate whose surface was
completely covered by a layer of Sephadex beads. Thirty minutes later, animals
were transferred to assay plates.
Statistical analysis was performed using the unpaired Student's t-test of
the Statview program.
Laser Ablations
Neurons were ablated during the second larval stage using a laser microbeam,
as previously described (Avery and Horvitz, 1987, 1989; Bargmann and Horvitz,
1991). Behavioral assays of young adult animals were performed two days later.
Mock-ablated animals were transferred to agar pads and anesthetized in parallel
to the animals that underwent laser ablation.
Successful identification and ablation of the dopaminergic neurons was
confirmed using the FIF technique of Sulston et al. (1975), which generates
fluorescence in the cell bodies of dopaminergic neurons, with modifications
adapted from Jagdale and Gordon (1994). The eight dopaminergic cell bodies
were routinely visible in animals of the first, second, and third larval stages.
To confirm that the behavioral phenotype we observed in our presumptive
CEP-ablated ADE-ablated PDE-ablated animals was specifically caused by
ablation of those neurons and not by accidental damage to neighboring cells, we
ablated the nearest neighbors of the dopaminergic neurons in two animals. We
ablated all cells adjacent to dopaminergic neurons (RID, ALA, URX, FLP, ADA,
AQR, PVD, PVM, and SDQL) (n=2) except for the sheath cells of the
dopaminergic neurons and cells that are post-synaptic to dopaminergic neurons.
These animals showed a normal basal slowing response (Sawin, 1996).
Similarly, for the NSM-ablation experiments, we ablated 12 (n=3) and MC (n=4)
and saw no effect on the enhanced slowing response (Sawin, 1996).
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Neurotransmitter and Drug Pre-treatment
50 mM solutions of serotonin creatinine sulfate complex (Sigma) or dopamine
hydrochloride (RBI) were prepared fresh in M9 buffer (Brenner, 1974). 400 pl of
these solutions or of M9 buffer was added to each 5 cm plate containing
approximately 10 ml of agar and a bacterial lawn to obtain an equilibrium
concentration of approximately 2 mM of each neurotransmitter. The plates were
allowed to dry at room temperature with their lids removed for 1 hour and then
40-50 animals of each genotype that had been picked as L4 animals 16-20 hours
earlier were transferred to each plate. The animals were incubated on these
plates for either 2 hours (bas-1; cat-4 rescue experiments) or 6-7 hours (cat-2
rescue experiments) at 200C and then assayed according to our standard
locomotory rate assay with the modification that the food-deprivation plates
contained the appropriate neurotransmitter. The assay plates did not contain the
neurotransmitters. For both cat-2 and bas-1; cat-4 mutants pre-treatment with
dopamine resulted in the appearance of the FIF indicative of dopamine in the cell
bodies of eight neurons in the positions of the dopaminergic neurons of the wild
type (data not shown). For these drug experiments, pre-treatment was
considered to rescue the mutant phenotype if the data from mutants were not
statistically different (p>0.05) from the data from wild-type assayed in parallel
under the same conditions; p=0.49 for rescue by dopamine of the basal slowing
response of cat-2 mutants; p=0.28 for rescue by dopamine of the basal slowing
response of bas-1; cat-4 mutants; p=0.1 for rescue by serotonin of the enhanced
slowing response of bas-1; cat-4 mutants.
Plates containing Methiothepin mesylate (RBI) and mianserin
hydrochloride (RBI) were prepared in a manner similar to the serotonin- and
dopamine-containing plates. Animals were incubated for 30 minutes on either
plates with bacteria and the antagonist or on plates without bacteria but
containing antagonist and then assayed according to our standard locomotory
rate assay. The assay plates did not contain the antagonists.
Fresh NGM agar plates, containing either no fluoxetine or 75 [tg/ml
fluoxetine (Sigma) were prepared the day before the assays and stored overnight
in the dark. The fluoxetine stock (300 jig/ml) was dissolved in water and added
after the agar solution had cooled to just above gelling temperature. Animals
were incubated for 30 minutes on plates without bacteria and with or without
fluoxetine and then tested on assay plates (without fluoxetine). For testing the
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response of NSM-ablated animals, the locomotory rates of mock-ablated and the
NSM-ablated animals were assayed, one animal at a time, first on plates with
bacteria after food-deprivation in the absence of fluoxetine, then on plates with
bacteria after food-deprivation in the presence of fluoxetine. Then all the animals
were tested as a group, first on plates without bacteria after food-deprivation in
the absence of fluoxetine, then on plates without bacteria after food-deprivation
in the presence of fluoxetine. The animals were allowed to recover on plates with
bacteria for 1-2 hours between each of the four conditions.
To examine the serotonin response of food-deprived versus well-fed
animals, we prepared fresh NGM agar plates with the appropriate amounts of
serotonin. The serotonin stock was dissolved in water and added after the agar
solution had cooled to just above gelling temperature. After incubating the plates
overnight at room temperature, we placed a single food-deprived or well-fed
animal on a plate, and the locomotory rate of the animal was recorded at the start
of every minute for five minutes.
Mutant Screen
N2 hermaphrodites (L4) were mutagenized with EMS (Brenner, 1974), and their
F2 progeny were food-deprived for 30 minutes and then transferred to the center
of large Petri plates spread with E. coli strain HB101 in the form of a ring-shaped
lawn. After 5-10 minutes, the assay plates were examined for worms that had
both reached the outer edge of the bacterial lawn and were moving rapidly. Such
animals were picked to individual plates and their progeny were retested. Prior to
detailed behavioral analysis, each strain was outcrossed at least twice.
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Figures
Figure 1. Modulation of Locomotory Rate of Wild-type Animals and Dopamine-
and/or Serotonin-deficient Mutants
Well-fed and food-deprived animals were transferred to assay plates with or
without a bacterial lawn, and five minutes later the locomotory rate of each
animal was recorded. Food-deprived animals were transferred to plates without
bacteria 30 minutes prior to the transfer to locomotory assay plates (see
Experimental Procedures for details). In this and all subsequent figures, unless
otherwise stated, each trial involved testing at least five animals in each of the
conditions; a given animal was tested in only one of the conditions.
(A) The wild-type basal (black bars) and enhanced (gray bars) slowing
responses. Eleven trials with wild-type animals. See Results for p values.
(B) - (E) Mutants defective in the basal and/or enhanced slowing responses. p
values were calculated by comparing the combined data for the mutants from all
the separate trials to the combined data for the wild-type animals assayed in
parallel in each condition of each separate trial. Wild-type data from these
parallel trials are not shown, since in no case were these data significantly
different from the data in Figure 1A.
(B) Ten trials with cat-2(e 1112) mutants.
(C) Four trials with bas-1(ad446) mutants.
(D) Five trials with cat-4(e 1141) mutants.
(E) Six trials with bas-1(ad446); cat-4(e1141) mutants.
Error bars represent the SEM; **p=0.0002, ***p<0.0001, Student's t-test.
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Figure 2. Dopamine Pre-treatment Rescues the Defect in the Basal Slowing
Response of Dopamine-deficient Mutants and Serotonin Pretreatment Rescues
the Defect in the Enhanced Slowing Response of Serotonin-deficient Mutants
Following pre-incubation on bacteria-containing plates with no neurotransmitter
(Buffer) or with dopamine or serotonin, animals were transferred directly to assay
plates and locomotory rate was measured (A and B, black bars) or to food-
deprivation plates with buffer, dopamine, or serotonin for 30 minutes and then to
assay plates and locomotory rate was measured (B, gray bars); R = Rescued
(see Experimental Procedures for details of rescue criteria).
(A) Rescue of the defect in the basal slowing response of cat-2 mutants (four
trials). Abbreviation: WT, wild type.
(B) Rescue of the defect in the basal and enhanced slowing responses of bas-1;
cat-4 mutants (four trials).
Error bars represent the SEM; ***p<0.0001, Student's t-test.
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Figure 3. Dopaminergic Neurons Function Redundantly to Sense
Mechanosensory Stimuli
(A) and (B) Basal slowing response of animals with dopaminergic neurons
ablated. The dopaminergic neurons indicated were ablated in larvae two days
before the behavioral experiment. In parallel, an equivalent number of mock
ablated-animals were also tested. A given animal was tested first in the presence
of bacteria and then in the absence of bacteria (see Experimental Procedures for
details).
(A) Twenty-three CEP-ablated, 14 ADE-ablated, and 13 PDE-ablated animals
were assayed.
(B) Fifteen CEP-ablated ADE-ablated, 21 CEP-ablated PDE-ablated, 20 ADE-
ablated PDE-ablated, and 17 CEP-ablated ADE-ablated PDE-ablated animals
were assayed.
(C) Only dopaminergic neurons in contact with bacteria were required for the
basal slowing response. The locomotory rates of five animals in which CEPDUR,
CEPVUR, ADEL, and PDEL had been ablated and six animals in which
CEPDUR, CEPVUR, ADER, and PDER had been ablated were recorded in the
presence and absence of bacteria with animals lying first on one side and then
on the other (the order in which the sides were tested was random; see
Experimental Procedures for details).
Error bars represent the SEM; *p=0.01; **p=0.0009; ***p<0.0001, Student's t-
test.
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Figure 4. The Basal Slowing Response Involves a Mechanosensory Stimulus,
while the Enhanced Slowing Response Does Not
(A) Response of wild-type and cat-2 animals to Sephadex beads. Thirty-five wild-
type and 35 cat-2 animals were assayed in three trials.
(B) Animals with dopaminergic neurons ablated do not respond to Sephadex
beads. Five animals in which the CEPs, ADEs, and PDEs had been ablated and
five mock-ablated animals were tested in each of the two conditions. A given
animal was tested first in the presence of Sephadex and then in the absence of
Sephadex (see Experimental Procedures for details).
(C) Food-deprived wild-type animals do not slow in response to Sephadex
beads. Twenty animals were tested in each condition in four trials.
(D) Animals food-deprived in the presence of Sephadex beads exhibit a normal
enhanced slowing response. Twenty animals were tested in each condition in
four trials.
Error bars represent the SEM; ***p<0.0001, Student's t-test.
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Figure 5. The Enhanced Slowing Response Involves Serotonin, Is Potentiated by
Fluoxetine, and Is Not a Result of Serotonin Hypersensitivity
(A) Serotonin antagonists disrupted the enhanced slowing response. Mianserin
hydrochloride was at 20 pM, and methiothepin mesylate was at 44 pM (five
trials).
(B) The potentiation of the enhanced slowing response by fluoxetine requires
endogenous serotonin. Twenty wild-type animals and 20 bas-1; cat-4 mutants
were tested in each condition in four trials.
(C) The potentiation of the enhanced slowing response by fluoxetine acts through
the NSMs. Locomotory rates of seven mock-ablated and eight NSM-ablated
animals were assayed in each of the four conditions (see Experimental
Procedures for order of conditions tested). The effect of the NSM-ablations on
the enhanced slowing response in the absence of fluoxetine was statistically
significant (p=0.044). The p values denoted by the asterisks in Figure 5B and 5C
were calculated by comparing the fluoxetine-treated animals to untreated animals
of the same genotype or ablation state.
(D) Dose response of serotonin sensitivity. Twenty animals were tested at each
concentration over 20 trials (one animal per condition per trial). Well-fed or food-
deprived animals were transferred to plates (no bacteria) with the indicated
concentration of serotonin, and locomotory rate after five minutes was plotted.
Error bars represent the SEM; ***p<0.0001, Student's t-test.
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IFigure 6. Mutants Defective in the Enhanced Slowing Response
At least twenty animals were tested for each genotype in at least four trials.
p values were calculated by comparing the combined data for the mutants from
all the separate trials to the combined data for the wild-type animals assayed in
parallel in each condition of each separate trial. Wild-type data from these
parallel trials are not shown, since in no case were these data significantly
different from the representative data for the wild type shown in the first column.
Error bars represent the SEM; ** 0.001 <p<0.05; ***p<0.0001, Student's t-test.
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Figure 7. Models for the Basal and Enhanced Slowing Responses
(A) In well-fed animals, the three classes of dopaminergic neurons (CEPs, ADEs,
and PDEs) function redundantly to sense a mechanosensory stimulus from
bacteria and then modulate the motor circuit to effect the basal slowing response.
(B) In food-deprived animals, serotonergic neurons sense the current level of
food in the pharynx and integrate this information with information about the past
experience of food-deprivation. The serotonergic neurons then release an
increased amount of serotonin, which inhibits the motor circuit to a greater extent
than in the basal slowing response to effect the enhanced slowing response (see
Discussion for details).
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Chapter 3
MOD-1 is a serotonin-gated chloride channel that modulates C. elegans
locomotory behaviour
Rajesh Ranganathan, Stephen C. Cannon, and H. Robert Horvitz
Published in Nature 408, 470-475 (2000)
Dr. Cannon performed the HEK cell recordings shown in figure 5. I performed the
rest of the experiments.
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Summary
The neurotransmitter and neuromodulator serotonin (5-HT) functions by binding
either to metabotropic G-protein coupled receptors (for example, 5-HT, 5-HT2, 5-HT 4
to 5-HT 7), which mediate "slow" modulatory responses through numerous second
messenger pathways', or to the ionotropic 5-HT 3 receptor, a non-selective cation
channel that mediates "fast" membrane depolarizations2 . Here we report that the
gene mod-1 (for modulation of locomotion defective) from the nematode
Caenorhabditis elegans encodes a new type of ionotropic 5-HT receptor, a 5-HT-
gated chloride channel. The predicted MOD-1 protein is similar to members of the
nicotinic acetylcholine receptor (nAChR) family of ligand-gated ion channels, in
particular to GABA (y-aminobutyric acid)- and glycine-gated chloride channels. The
MOD-1 channel has distinctive ion selectivity and pharmacological properties. The
reversal potential of the MOD-1 channel is dependent on the concentration of
chloride ions but not of cations. The MOD-1 channel is not blocked by calcium ions
or 5-HT3a-specific antagonists but is inhibited by the metabotropic 5-HT receptor
antagonists mianserin and methiothepin. mod-1 mutant animals are defective in a
5-HT-mediated experience-dependent behavior3 and are resistant to exogenous
5-HT, confirming that MOD-1 functions as a 5-HT receptor in vivo.
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Results and Discussion
The locomotory rate of a well-fed C. elegans hermaphrodite slows when it
encounters bacteria (the basal slowing response3 ); this slowing response is
enhanced markedly if the animal has been deprived of food for 30 minutes before
the encounter (the enhanced slowing response3 ) (Fig. 1a). A genetic screen for
mutants defective in the enhanced slowing response led to the identification of the
gene mod-1, which is defined by the mutation n30343. On Petri dishes with bacteria,
the locomotory rate of food-deprived mod-1 mutants is significantly faster than that
of the wild type (strain N2) (Fig. 1 a, grey bars). On dishes without bacteria, the
locomotory rate of food-deprived mod-1 mutants is not different from that of food-
deprived wild-type animals (Fig. 1a, grey bars). Well-fed mod-1 mutants show no
defect in their basal slowing response to bacteria (Fig. 1a, black bars).
The swimming behavior of mod-1(n3034) mutants was not affected by
exogenous 5-HT treatment, whereas exogenous 5-HT inhibits wild-type C. elegans
locomotion4 ; and this phenotype was semi-dominant in a time-dependent manner
(Fig. 1b), which aided our cloning of the mod-1 gene (see below). This 5-HT
resistance of mod-1 mutants is consistent with the observation that the enhanced
slowing response is mediated by 5-HT signaling3 and the hypothesis that mod-1
mutants are deficient in 5-HT signaling3.
We used standard genetic three-factor mapping scoring the 5-HT resistance
of mod-1 mutants to locate mod-1 to a -400 kilobase (kb) region on chromosome V.
Cosmid C38E12 from this region rescued the recessive aspect of the Mod-1 mutant
phenotype of 5-HT resistance, as assayed by the response to exogenous 5-HT after
5 min (Fig. 1c). We narrowed the rescuing activity to a 5.5-kb fragment (Fig. 1c) and
found that this fragment contained a single predicted gene. We isolated several
complementary DNAs (cDNAs) with SL1 trans-spliced leaders, which are found at
the 5' ends of many C. elegans transcripts6 , and thereby determined the complete
mod-1 transcription unit (Fig. 2a). Genomic subclones lacking all or part of this
transcription unit did not rescue the Mod-1 phenotype of 5-HT resistance (Fig. 1c).
MOD-1 is similar to members of the nicotinic acetylcholine receptor (nAChR)
family of ligand-gated ion channels, in particular to GABA- and glycine-gated
chloride channels (Fig. 2b). We found a single-base transition mutation in the mod-1
coding sequence in n3034 mutants (Fig. 2b, c), in which Ala 281 (codon GCT) is
changed to a valine (GTT) within the predicted M2 transmembrane domain of the
MOD-1 protein; the M2 domain is thought to be critical for channel function. We used
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site-directed mutagenesis to introduce this C-to-T (A281V) mutation into the 5.5-kb
minimal rescuing fragment and generated transgenic animals carrying
extrachromosomal arrays of this fragment, Ex[MOD-1 (A281 V)]. These transgenic
animals displayed resistance to exogenous 5-HT (Fig. 3a), confirming that the
A281V mutation in MOD-1 is sufficient to cause 5-HT-resistance.
To determine the effect of eliminating mod-1 function, we analyzed two
deletion alleles of mod-1, nr2043 (ref. 7) and ok103 (Fig. 2a), which were obtained
by screening libraries of mutagenized animals to identify large deletions in the mod-1
genomic locus". Both mod-1(nr2043) and mod-1(ok103) mutants, when deprived of
food, were defective in the enhanced slowing response (Fig. 3b), whereas neither
was defective in the basal slowing response (data not shown). Both deletion mutants
were resistant to exogenous 5-HT (Fig. 3a). The 5-HT-resistance caused by the two
deletion alleles was completely recessive throughout the 20-min time course (Fig.
3a; and data not shown), consistent with our observation that animals heterozygous
for large chromosomal deficiencies that uncover the mod-1 genomic locus are not
5-HT-resistant (data not shown). The molecular nature of the mod-1(nr2043) and
mod-1(ok103) mutations suggests that they are null alleles. As null alleles confer the
same phenotype as that conferred by the Ex[MOD-1 (A281V)], mod-1 (n3034) is likely
to be a dominant-negative allele.
MOD-1 protein is predicted to contain a large extracellular amino terminus
with two cysteine residues separated by 13 amino acids, a feature conserved in the
nAChR family and that may have a role in subunit assembly and insertion into the
membrane9 (Fig. 2b). There are four predicted transmembrane regions (M1-M4) and
a large cytoplasmic domain between M3 and M4 (Fig. 2b). The M2 domain may
participate in forming the pore of the channel after these nAChR family members
assemble as multimeric complexes in the cell membrane 0 . In other family members,
the residues in and around the M2 domain are involved in establishing ion
selectivity'0 . We could not confidently predict the ion selectivity of the MOD-1
channel from sequence comparisons.
We examined the ability of MOD-1 to form functional channels in voltage-
clamped Xenopus laevis oocytes. Oocytes injected with mod-1 complementary RNA
(cRNA) and voltage-clamped at -70 mV responded to an application of 1 pM 5-HT
with a large, rapidly developing, non-oscillatory inward current (Fig. 4a), whereas
control oocytes injected with water showed no such response to application of any
agonist (data not shown). Applications of 1,000 RM glycine, acetylcholine, GABA,
glutamate, or histamine - all neurotransmitters that can activate ion channels"-
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did not elicit an inward current in mod-1-injected oocytes (Fig. 4a; and data not
shown). Similarly, 10 [tM ivermectin failed to elicit any current in MOD-1-injected
oocytes (data not shown). Ivermectin, an anthelmintic drug that activates glutamate-
gated chloride channels in nematodes14 , can activate a rat al p2y2S- GABA-gated
chloride channel'5 and enhances acetylcholine-evoked responses of the human
nAChRax7 receptor'". Dopamine, octopamine or tyramine did not result in MOD-1 -
dependent inward currents at 100 pM, but elicited small responses at millimolar
concentrations (data not shown). mod-1 mutants did not have defects associated
with impaired dopamine or octopamine signaling (ref. 3; and M. Alkema, R.R., and
H.R.H., unpublished observations). We conclude that 5-HT is most likely to be the
native ligand for the MOD-1 channel. 5-HT dose-response experiments using
oocytes showed that the MOD-1 channel has an effector concentration for half-
maximal response (EC50) of 1.0 L 0.1 pM (Fig. 4b), which is lower than that of the
human 5-HTsa channel (2.9 L 0.1 jtM)17. Unlike the 5-HT 3, channel2, the MOD-1
channel was not blocked by calcium (Fig. 4c). High concentrations of granisetron
(Fig. 4d) and ondansetron (data not shown), both of which are potent antagonists of
the 5-HT3a channel", did not affect the action of 5-HT on MOD-1 channels. Taken
together, these results indicate that the MOD-1 channel is very different from the 5-
HT 3a channel.
Pre-treatment of wild-type C. elegans with mianserin or methiothepin - 5-HT
receptor antagonists - prevents food-deprived animals from exhibiting the wild-type
enhanced slowing response after they encounter bacteria3 . Therefore, even though
both compounds have so far been considered to be primarily antagonists of
metabotropic 5-HT receptors19 ,20 , we tested their effects on MOD-1 in oocytes. The
MOD-1 channel was inhibited by mianserin and methiothepin, with inhibition
constants (K,) of -19 pM and -32 pM, respectively (Fig. 4e; and data not shown).
Pre-treatment of mod-1 mutants with mianserin or methiothepin did not further affect
the defective enhanced slowing response of these animals (data not shown).
Mianserin and methiothepin may therefore interfere with the enhanced slowing
response of C. elegans by antagonizing the MOD-1 5-HT-gated channel.
We tested the effect on channel function of the MOD-1 (A281 V) substitution in
the mod-1(n3034) mutant. When cRNA encoding MOD-1 (A281V) was injected into
oocytes, no 5-HT-gated responses were observed (Fig. 4f). When the mutant cRNA
was co-injected with roughly a fourfold excess of wild-type mod-1 cRNA, the
magnitude of the current through the wild-type channels was markedly reduced
compared to that of oocytes that had been injected in parallel with the same amount
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of only the wild-type cRNA (Fig. 4f). These findings suggest that the MOD-1 channel
is multimeric, and that mutant MOD-1(A281V) channel subunits may interfere in a
dominant manner with the function of wild-type MOD-1 channel subunits.
Alternatively, MOD-1(A281V) channel subunits might interfere with wild-type MOD-1
channel function in a non-specific manner, for example, by affecting assembly,
transport or stability of all membrane proteins. Our genetic data support the
hypothesis that mod-1(n3034) encodes a dominant-negative form of MOD-1.
Current-voltage (I-V) relationships revealed that the 5-HT-dependent current
from MOD-1 -expressing oocytes reverses direction (in ND-96 bath solution; see
Methods) near -20 mV (data not shown), significantly different from the near 0 mV
reversal potential of the 5-HT3a non-selective cation channel (ref. 2; and our
unpublished data). The chloride reversal potential (Eci) in Xenopus oocytes is
approximately -20 mV (ref. 21), consistent with the hypothesis that MOD-1 is a
chloride channel. Moreover, when external sodium chloride was replaced with
choline chloride, there was no change in the MOD-1 reversal potential (data not
shown), indicating that sodium was not the primary charge carrier through the
MOD-1 channel.
We directly tested whether changes in the concentration of chloride ions
affected the reversal potential of the MOD-1 channel. To avoid activities of chloride
channels endogenous to the Xenopus oocyte" and to be able to manipulate the
concentrations of ions on both sides of the membrane, we conducted these
experiments using human embryonic kidney 293 (HEK293) cells transiently
transfected with a mod-1 cDNA. We found that the peak /-V relationship showed no
evidence of rectification (Fig. 5a), indicating that there was no voltage-dependent
block by divalent cations or small organic molecules. Mock-transfected control
HEK293 cells did not have any 5-HT-gated responses (data not shown). We also
found that a 10-fold change in external chloride concentration shifted the reversal
potential by 53 mV (Fig. 5b), in good agreement with the theoretical shift of 58 mV
predicted by the Nernst equation if the MOD-1 channel were perfectly selective for
chloride ions. These data establish that MOD-1 is a 5-HT-gated chloride channel.
As the M2 region of the MOD-1 channel is similar to those of GABA- and
glycine-gated chloride-selective channels (Fig. 2c) and these show that these
channels are permeant to anions other than chloride22 , we determined whether
MOD-1 channels were also permeant to several anions. We measured the MOD-1
reversal potential in Xenopus oocytes, substituting chloride ions with an equivalent
concentration of six other anions of various sizes. These measurements established
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that the rank order of anion permeability for MOD-1 channels was thiocyanate (Ere, <
-40 mV) > bromide = iodide > chloride (Erev =-20 mV) >> fluoride > aspartate >>
gluconate (Erev > +50 mV) (data not shown). This rank order is in agreement with the
rank order for GABA- and glycine-gated chloride channels22, suggesting that the
permeation properties of the MOD-1 channel are similar to those of GABA- and
glycine-gated chloride channels.
We generated a green fluorescent protein (GFP) reporter of mod-1 by
inserting the gfp gene2 1 into the mod-1 minimal genomic rescuing fragment between
the M3 and M4 regions (Fig. 2a). We obtained stable chromosomally integrated lines
of this construct, as previously described24 , and showed them to be rescued for the
mod-1 mutant phenotype (data not shown). mod-1::GFP reporter expression was
observed in the cell bodies and axons (the latter presumably as a consequence of
reporter overexpression) of several neurons in the head, ventral cord and tail of the
animal (data not shown). No reporter expression was observed in any muscle cells.
These observations indicate that the MOD-1 5-HT-gated chloride channel probably
functions in neurons in C. elegans.
Voltage-clamp recordings from isolated embryonic Retzius cells from the
medicinal leech Hirudo medicinalis indicate that 5-HT applications can result in
hyperpolarizing chloride currents25. Recordings from dialyzed whole cells and
outside-out patches from these Retzius cells suggest that the 5-HT-gated chloride
current is a consequence of a direct gating of a channel rather than the output of an
indirect mechanism requiring second messenger cascades2 . Our molecular
identification and characterization of MOD-1 support this conjecture and
demonstrate directly the existence of a 5-HT-gated chloride channel. We show that
this channel acts as a 5-HT receptor in vivo and that its function is necessary for a
5-HT-mediated experience-dependent modulation of behavior. If mammalian
counterparts of MOD-1 exist, their identification and characterization might provide
insights concerning the myriad neurobiological effects of 5-HT and define new
targets for the development of human pharmaceuticals.
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Methods
Mapping and cloning of mod-1
We mapped mod-1 using standard procedures27 (see Supplementary Information for
details). We performed germline transformation experiments28 by injecting the
various constructs along with 80 gg ml- pL15EK (which contains the wild-type lin-15
gene) into a mod-1(n3034); in-15(n765ts) strain and scoring stable transgenic lines,
which produced non-Lin progeny. Rescued lines had at least half the animals
exhibiting normal sensitivity to 5-HT at 5 min in assays of 5-HT resistance.
Behavioral assays
Locomotory rate was assayed as previously described3. In Figs 1a and 3b, each trial
involved testing at least five animals for each of the conditions; a given animal was
tested for only one condition. P values were calculated by comparing the combined
data for the mutants from all the separate trials to the combined data for the wild-
type animals assayed in parallel for each condition of each separate trial. To assay
5-HT resistance, we placed 20 animals in 200 pl of 33 mM 5-HT (creatinine sulphate
salt, Sigma) dissolved in M9 buffer2 7 in 96-well microtiter wells and scored the
swimming behavior of such animals as active or immobile every minute for 20 min
for the time-course experiments, at 5 min for germline transformation rescue
experiments, or at 20 min (Fig 3a). In this assay, an animal was scored as immobile
if it did not exhibit any swimming motion for a period of 5 seconds.
Electrophysiological studies of MOD-1
An EcoR I/EcoR I fragment containing a full-length mod-1 cDNA, including the 5' and
3' UTRs, was cloned into an EcoR I site of the vector pGEMHE 29 for oocyte
expression and into the EcoR I site of vector GW1 -CMV (British Biotech.) for
transfection into HEK293 (ATCC # CRL-1533) cells. Capped cRNA for the oocytes
was synthesized as described29 and dissolved in water. RNA concentrations were
determined by agarose gel electrophoresis and absorption spectroscopy. Xenopus
oocytes were collected and injected with 50 ni RNA as described29, and two-
electrode voltage-clamp recordings were performed 1-3 days later at room
temperature (22-250C) as described 29 . All compounds and wash solutions were
106
applied to oocytes using a gravity-assisted perfusion system. The standard bath
solution for the agonist, antagonist, and dose-response experiments was ND-96 (in
mM): 96 NaCl, 2 KCI, 0.3 CaCl2, 1 MgCl 2, 5 HEPES (pH 7.6). In Fig. 4b, each oocyte
was sequentially subjected to 5-s treatments of increasing concentrations of 5-HT
with 30 s of wash between applications. This protocol was continued from 10 nM to
1 iM and then only one concentration higher than 1 gM was tested on any particular
oocyte, since concentrations greater than 1 pM 5-HT led to desensitization and a
decrease in the maximal response elicited by subsequent 5-HT applications.
Responses from separate oocytes were combined by normalizing the amplitudes of
each oocyte's responses to the various 5-HT concentrations to that elicited by 1 tM
5-HT. The normalized data were fit to the function y- Vmax [x"(k + xe)] with a Hill
coefficient (n) = 1 and then re-normalized to a maximal value of 1 by dividing by Vmax.
In Fig. 4c, 5-HT3 -injected oocytes were first tested in buffer containing 0.3 mM Ca**
and then 10 mM Ca**, as the 5-HT3a-injected oocytes recovered very slowly from the
10 mM Ca** treatment. mod- 1-injected oocytes were tested in both orders. The
concentration of Ca** was varied in both the 5-HT and wash solutions. The 5-HT 3,
traces were filtered digitally off-line at 5 Hz to reduce noise. For the experiments
shown in Fig. 4d and 4e, the antagonists were present in both the 5-HT and wash
solutions.
HEK293 cells were transiently transfected and whole-cell voltage-clamp
recordings were performed the next day as described30 . The output was filtered at 10
kHz and sampled at 20 kHz using a Digidata 1200 interface. The patch pipette was
coated with Sylgard, and the tip was heat-polished to a final tip resistance in bath
solution of 0.5-2 MQ. The HEK293 cell was lifted from the dish with the recording
pipette, and 5-HT was applied from a pressure-controlled spritzer pipette in the
presence of a continuously flowing bath solution. The internal (patch pipette) solution
contained (in mM) 130 KAsparate, 10 KCl, 1 MgCl2 , 10 EGTA, 10 HEPES (pH 7.4).
The external solution contained (in mM) 2 CaCl2, 1 MgCl 2 , 10 HEPES (pH 7.4), with
varying proportions of sodium Gluconate and NaCl, resulting in a final concentration
of 140 mM of both Na* cations and gluconate plus Cl- anions. Data analysis was
performed off-line using Clampfit software (Axon), and curve fitting was
accomplished using Origin (Microcal) or KaliedaGraph (Adelbeck) software.
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Supplementary Information
A281V may block channel pore
When the alpha helix that forms the M2 domain of MOD-1 is viewed in a helical-
wheel configuration', Ala-281 is on the side of the alpha helix analogous to the pore-
facing side of the nAChR 2 . Moreover, Ala-281 is in a position analogous to that of
Ser-252 in nAChRca and Thr-265 in GABA-A @1, both of which have been predicted
to face the lumen of the channel pore as a result of their accessibility to modification
by polar sulfhydryl reagents2. We suggest that the addition of the two methyl side
groups caused by the A281V substitution predicted in mod-1(n3034) mutants alters
the pore of the channel and prevents ion flow.
mod-1 deletion mutants
The ok103 deletion removes 4135 bp, starting four bp after the first exon. The
nr2043 deletion removes 1209 bp, starting 146 bp 5' of exon 3, and adds the
sequence ATAAGTTTTTT. If the end of exon 2 splices onto the next available splice
acceptor site at the start of exon 6, an additional 15 unrelated amino acids would be
present before the protein ends at a premature stop codon. The cDNA predicted by
the C. elegans Genome Sequencing Project3 omits the first and seventh exons and
does not include the first 54 bp of the second exon.
Methods
Mapping and cloning of mod-1
mod-1 was mapped to LG V based upon its two-factor linkage to dpy- 11 unc-76 V.
The following three-factor data were obtained: dpy- 11 (14/36) mod-1 (22/36) unc-76,
dpy- 11 (27/40) mod-1 (13/40) unc-42, mod-1 (0/32) unc-42 (32/32) sma- 1, dpy- 11
(38/74) stP23 (25/74) mod-1 (11/74) unc-42, dpy- 11 (38/74) pkP5056 (25/74) mod-1
(11/74) unc-42, dpy- 11 (36/45) mod-1 (6/45) pkP520 (3/45) unc-42, let-434 (19/33)
mod-1 (14/33) unc-42. stP23, pkP5056, and pkP520 are Tc1 -transposon
polymorphisms present in strains RW7000 and KR1787, respectively3. All mapping
experiments were performed by mating each homozygous recombinant with wild-
type (N2) males and scoring the F1 cross progeny for semi-dominant 5-HT
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resistance at 20 min. The presence of the Tcl polymorphisms was assayed by
performing PCRs with a Tcl -specific primer and a primer from genomic sequence
adjacent to the Tcl insert site on crude whole-worm lysates prepared from each
homozygous recombinant strain.
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Figures
Figure 1 Phenotypic characterization and cloning of mod-1
a, mod-1(n3034) mutants were defective in the enhanced slowing locomotory
response exhibited by food-deprived wild-type animals'. Ten trials were performed
for each genotype. Error bars represent s.e.m.; asterisks: P<0.0001, Student's t-test.
b, Time course of response to 33 mM 5-HT. The resistance to exogenous 5-HT of
mod-1(n3034) mutants was recessive at early time-points and was semi-dominant at
later time-points.
c, Genetic and physical maps of the relevant region of linkage group V. Cosmid
C38E12 and subclones shown in bold rescued mod-1; +, rescue; -, no rescue.
Numbers in parentheses represent the fraction of transgenic lines tested that
rescued mod-1.
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Figure 2 Sequence analysis of mod-1
a, mod-1 intron-exon structure. Open boxes, coding regions; lines, untranslated
regions, arrow, direction of transcription; SL1, SL1 trans-spliced leader. The ok103
and nr2043 deletions are depicted (See Supplementary Information), and the
positions of the n3034 mutation and insertion site of the gfp gene are indicated.
b, Amino-acid sequence alignment of MOD-1 with a C. elegans predicted protein
(P41849) that is 'most similar to MOD-1, human GABAA receptor P1 subunit
(A40336), human glycine receptor P subunit (NP_000815.1), and the human 5-HT3a
subunit (BAA08387). The putative signal sequence and M1-M4 regions are
underlined, and the Cys-Cys loop is indicated (S-S). Amino acids conserved
between MOD-1 and at least one other protein are shown in black boxes.
mod-1(n3034) is a C-to-T mutation resulting in a A281V substitution.
c, Alignment of the M2 regions from MOD-1, human GABAA a1 subunit (A60652),
human GABAA P1 subunit, human glycine al subunit (NP_000162), human glycine
P1 subunit, 5-HT3a, 5-HT3b (AF080582), and human nAChR a subunit (P02708).
Dots, residues likely to be facing the pore in the nAChR10 ; arrows, residues likely to
be facing the pore in the GABAA receptor 0; circles, residues conserved in cation
channels that are not conserved in MOD-1.
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Figure 3 mod-1 deletion alleles caused 5-HT resistance and defects in the
enhanced slowing response
a, 5-HT sensitivity, scored after 20 min in 33 mM 5-HT. Ex[MOD-1(A281V)] is an
extrachromosomal array containing the wild-type lin-15 gene and the mod-1
genomic locus encoding the A281V mutant form of the MOD-1 protein. Control
transgenic lines with extrachromosomal arrays containing wild-type lin-15 and mod-1
genes were not resistant to 5-HT (data not shown).
b, mod-1 deletion mutants were defective in the enhanced slowing response. Ten
trials were performed for each genotype. Error bars represent s.e.m.; asterisks:
P<0.0001, Student's t-test.
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Figure 4 MOD-1 is a 5-HT-gated ion channel distinct from the 5-HT3a channel
Recordings from Xenopus oocytes voltage clamped at -70 mV in standard ND-96
bath solution, except in c where Ca'* concentrations were varied. Bars, durations of
agonist application.
a, 1 pM 5-HT elicited a rapidly developing inward current from oocytes injected with
mod-1 cRNA. Representative trace from an oocyte treated with 1 mM Gly, ACh, and
GABA, and 1 gM 5-HT in ND-96 (n=5). The order of agonist application was not
important (data not shown).
b, 5-HT dose response curve; ECo = 1.0 ± 0.1 pM. n 4 for each concentration;
error bars represent s.e.m.
c, Extracellular calcium did not block the MOD-1 channel. Representative traces
from oocytes injected with mod-1 (n=3) or 5-HT3a (n=2) cRNA and treated with 1 jM
(mod-1) or 10 [tM (5-HT3a) 5-HT.
d, The 5-HT3a-specific blocker granisetron did not block MOD-1. Representative
traces from oocytes injected with mod-1 or 5-HT3a cRNA (n=2 for each) and treated
with 1 ptM (mod-1) or 10 [tM (5-HT3) 5-HT in the presence or absence of 130 pM
granisetron.
e, Mianserin blocked the MOD-1 channel. Representative traces from mod-1-
injected oocytes (n=5) treated with 0.5 pM 5-HT in the presence or absence of 50
jiM mianserin.
f, The MOD-1 (A281 V) mutant channel has a dominant-negative effect.
Representative traces from oocytes injected with wild-type mod-1 cRNA (WT),
mod-1 cRNA encoding the A281V mutant protein (A281V), or 4 parts WT to 1 part
A281V (WT+A281V) (n 4 for each class). Wild-type oocytes were treated with 1
pM 5-HT; A281V and WT+A281V oocytes were treated with 10 jiM 5-HT. 1 [M 5-HT
did not elicit any response from either A281V or WT+A281V oocytes.
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Figure 5 MOD-1 is a 5-HT-gated chloride channel
Whole-cell recordings from HEK293 cells transfected with a mod-1 cDNA.
a, The I-V relationship of the maximal responses from a representative cell when the
external solution contained 120 mM NaGluconate and 20 mM NaCI, resulting in [CI
]out = 26 mM, [Na+],n = 0, and [Cl, = 12 mM (see Methods for complete salt
compositions). Erev = -9.1 mV. Inset, raw traces for this cell at each of the nine
voltage steps from -50 mV to +30 mV. Bar, duration of 100 nM 5-HT application.
b, The reversal potential varied linearly with log[ClI]Ot. Each data point represents
Erev of a single cell at one particular [Cli-]out as in a.
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Chapter 4
Mutations in the C. elegans Serotonin Reuptake Transporter MOD-5 Reveal
Serotonin-Dependent and -Independent Activities of Fluoxetine
Rajesh Ranganathan, Elizabeth R. Sawin, Carol Trent, and H. Robert Horvitz
Submitted for publication to Cell
Carol Trent characterized the initial 5-HT-uptake defect in n822 and n823
mutants (Figure 1A); Beth Sawin confirmed these uptake defects with anti-5-HT
antibodies (Figure 1 B), established that these mutants exhibited a
hyperenhanced slowing response (parts of Figure 2A), performed the NSM
ablations (Figure 2B), and analyzed the mod-5; cat-4 double mutants (Figure
2D). I performed the rest of the experiments and wrote the text.
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Summary
We isolated two mutants defective in the uptake of exogenous serotonin (5-HT) into
the neurosecretory motor neurons (NSMs) of C. elegans. These mutants were
hypersensitive to exogenous 5-HT and hyperresponsive in the experience-
dependent enhanced slowing response to food modulated by 5-HT. The two allelic
mutations defined the gene mod-5 (modulation of locomotion defective), which
encodes the only serotonin reuptake transporter (SERT) in C. elegans. The selective
serotonin reuptake inhibitor (SSRI) fluoxetine (Prozac) potentiated the enhanced
slowing response, and this potentiation required mod-5, establishing a 5-HT- and
SERT-dependent behavioral effect of fluoxetine in C. elegans. By contrast, other
responses of C. elegans to fluoxetine were independent of MOD-5 SERT and 5-HT.
Further analysis of the MOD-5-independent behavioral effects of fluoxetine should
lead to the identification of novel targets of fluoxetine and could facilitate the
development of more specific human pharmaceuticals.
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Introduction
The activity of serotonin (5-HT), a key neuromodulator, is mediated postsynaptically
through metabotropic (Martin et al., 1998) and ionotropic (Maricq et al., 1991;
Ranganathan et al., 2000) 5-HT receptors and their downstream signaling
components (Hille, 1992). 5-HT modulates several behaviors of the nematode
Caenorhabditis elegans, including egg laying and locomotion (Horvitz et al., 1982;
Trent et al., 1983; Avery and Horvitz, 1990; Schafer and Kenyon, 1995). 5-HT also
mediates the enhanced slowing response exhibited by food-deprived nematodes
upon encountering bacteria (Sawin et al., 2000).
5-HT neurotransmission can be regulated by the removal of 5-HT from the
synaptic cleft by a serotonin reuptake transporter (SERT) (Cooper et al., 1996).
Na*/CI -dependent SERTs were cloned first from rats (Blakely et al., 1991; Hoffman
et al., 1991) and subsequently from other species (Mortensen et al., 1999 and
references cited therein), including humans and Drosophila melanogaster. SERT
antagonists, such as the selective serotonin reuptake inhibitors (SSRIs) fluoxetine
(Prozac), paroxetine (Paxil), and sertraline (Zoloft), are broadly used in the treatment
of psychiatric disorders (Schloss and Williams, 1998). Therefore, in addition to the
basic question of SERT function and regulation, it is of particular clinical importance
to understand SERT function in vivo. SERT-deficient mice do not show gross
developmental defects but have reduced 5-HT levels in the brain (Bengel et al.,
1998), are insensitive to 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")-
induced hyperactivity (Bengel et al., 1998), and show a brain region- and gender-
specific reduction in the density and expression of 5-HTia receptors (Li et al., 2000).
However, no obvious behavioral defects or abnormal responses to SSRIs in these
SERT-/- mice have been reported.
In this paper, we report the isolation of two C. elegans SERT-deficient
mutants and describe studies of these mutants revealing that the C. elegans SERT
is required for the experience-dependent enhanced slowing response and that the
SSRI fluoxetine can act on both 5-HT and SERT-dependent and 5-HT- and
SERT-independent targets.
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Results
Isolation of Mutants Defective in 5-HT Uptake
Formaldehyde-induced fluorescence (FIF) histochemistry indicates that the
C. elegans neurosecretory motor neurons (NSMs), located in the pharynx, contain
5-HT in their cell bodies and axonal processes (Horvitz et al., 1982). FIF in the
NSMs was more readily observed when animals were preincubated with exogenous
5-HT prior to the staining protocol (Horvitz et al., 1982; and our unpublished results).
This observation suggested that the NSMs possess an active uptake system that
can concentrate 5-HT from the extracellular environment.
We performed a genetic screen for mutants lacking FIF in the NSMs following
preincubation with exogenous 5-HT (see Experimental Procedures). Two mutations
that failed to complement each other, n822 and n823, were isolated. n822 and n823
mutants lacked FIF in the NSM cell bodies after 5-HT preincubation but retained FIF
in the NSM axonal processes (Figure 1A). Nomarski optics (Ellis and Horvitz, 1986)
revealed that these mutants had NSM cell bodies in their usual positions (data not
shown).
5-HT can also be detected in C. elegans using anti-5-HT antisera, which have
proven to be more sensitive than FIF and have allowed the reliable detection of
endogenous 5-HT in the NSMs and other neurons without requiring preincubation
with exogenous 5-HT (Desai et al., 1988; Loer and Kenyon, 1993; Sawin et al.,
2000). We used anti-5-HT antisera to evaluate 5-HT reuptake in n822 and n823
mutants. Since endogenous 5-HT masks 5-HT reuptake in NSMs visualized using
anti-5-HT antisera, we used a cat-4(e1141) (catecholamine defective) genetic
background to reduce endogenous 5-HT levels (Desai et al., 1988; Weinshenker et
al., 1995). cat-4 encodes GTP cyclohydrolase I (C. Loer, personal communication)
which is required for the synthesis of a biopterin co-factor needed for dopamine and
5-HT biosynthesis (Kapatos et al., 1999).
We counted the number of immunoreactive NSMs in cat-4 single and
n822; cat-4 and n823; cat-4 double mutants with or without exogenous 5-HT
preincubation. While NSMs in the cat-4 mutants were capable of 5-HT uptake, the
NSMs in n822; cat-4 and n823; cat-4 double mutants were partially defective in 5-HT
uptake (Figure 1B), confirming our FIF observations. For example, we observed no
brightly-fluorescing NSMs in n823; cat-4 mutants preincubated with 5-HT, while 43%
of the NSMs in cat-4 mutants had bright immunofluorescence (Figure 1 B, black
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bars). That a slight increase in NSM immunoreactivity was observed in n822; cat-4
and n823; cat-4 mutants upon 5-HT preincubation suggests that the n822 and n823
mutations do not lead to a complete loss of 5-HT uptake. While previous reports
(Desai et al., 1988; Loer and Kenyon, 1993; Weinshenker et al., 1995) did not detect
5-HT immunoreactivity in cat-4 mutants, we routinely observed a small percentage
of 5-HT-positive NSMs in cat-4 mutants in the absence of 5-HT preincubation
(Figure 1 B). Our data argue that the cat-4 mutation does not lead to a complete loss
of 5-HT, consistent with the conclusions of Desai et al. (1988) and Avery and Horvitz
(1990) but not with those of Loer and Kenyon (1993) and Weinshenker et al. (1995).
For this reason, previous conclusions about the actions of fluoxetine (Weinshenker
et al., 1995; Choy and Thomas, 1999) based on the assumption that cat-4 mutants
completely lack 5-HT need to be revisited (see below).
5-HT-Uptake Mutants Exhibit a Hyperenhanced Slowing Response
Since n822 and n823 mutants were defective in 5-HT uptake, we sought to
determine if these mutants were abnormal in their responses to endogenous 5-HT
release. We tested the 5-HT-dependent enhanced slowing response (Sawin et al.,
2000) of these mutants. Whereas well-fed wild-type animals slow their locomotory
rate slightly in response to bacteria (the basal slowing response) food-deprived wild-
type animals display a greater degree of slowing of locomotory rate in response to
bacteria (the enhanced slowing response) (Sawin et al., 2000; and Figure 2A).
Strikingly, n822 and n823 mutants exhibited a hyperenhanced slowing response: on
Petri plates with bacteria, the locomotory rates of food-deprived n822 and n823
mutants slowed significantly more than did those of food-deprived wild-type animals
(Figure 2A, gray bars). On Petri plates without bacteria, the locomotory rates of food-
deprived n822 and n823 mutants were not significantly different from those of food-
deprived wild type animals (Figure 2A, gray bars). Well-fed n822 and n823 mutants
exhibited no defect in the 5-HT-independent dopamine-dependent basal slowing
response to bacteria (Figure 2A, black bars) (Sawin et al., 2000). Genes involved in
the enhanced slowing response are called mod (modulation of locomotion defective)
(Sawin et al., 2000), and we named the gene defined by the allelic mutations n822
and n823 mod-5. The hyperenhanced slowing responses of these mod-5 mutants
were presumably a consequence of a defect in the clearing of 5-HT from the
relevant synapses by uptake into serotonergic neurons, thereby leading to increased
5-HT signaling and a greater inhibition of locomotion.
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Ablation of the Serotonergic NSMs or Decrease in Endogenous 5-HT
Suppresses mod-5 Mutations
Ablation of the serotonergic NSMs with a laser microbeam leads to a defect in the
enhanced slowing response (Sawin et al., 2000). Since the NSMs were defective in
5-HT uptake in mod-5 mutants (see above), we tested whether ablation of the NSMs
affected the hyperenhanced slowing response of mod-5 mutants. On Petri plates
with bacteria, food-deprived NSM-ablated mod-5(n823) mutants exhibited an
enhanced slowing response that was significantly reduced in comparison to that of
food-deprived mock-ablated mod-5(n823) mutants (Figure 2B, gray bars). Well-fed
NSM-ablated mod-5(n823) mutants were not significantly affected in their basal
slowing response to bacteria (Figure 2B, black bars). Ablation of the 15 neuron,
another pharyngeal neuron, had no effect on the enhanced slowing response of
mod-5 mutants (data not shown), indicating that the effect of the NSM-ablations was
not a consequence of the ablation protocol per se.
We reasoned that the ablation of the NSMs probably led to a loss of 5-HT
needed for the hyperenhanced slowing exhibited by mod-5 mutants. To test this
hypothesis, we tested whether cat-4 mutants, which have decreased 5-HT levels
(see above), could suppress the mod-5 phenotype. cat-4 mutants are defective in
the enhanced slowing response (Sawin et al., 2000; and Figure 2C), and the
reduced 5-HT in these mutants is the cause of this defect (Sawin et al., 2000).
On Petri plates with bacteria, the locomotory rate of food-deprived
mod-5(n823); cat-4 double mutants was significantly faster than that of food-
deprived mod-5(n823) mutants (compare Figure 2C to Figure 2A gray bars) but
similar to that of NSM-ablated mod-5(n823) mutants (Figure 2B), suggesting that for
the enhanced slowing response the ablation of the NSMs is equivalent to a reduction
in 5-HT levels in the animal. That the locomotory rate of food-deprived mod-5(n823);
cat-4 double mutants was significantly slower than that of cat-4 mutants (Figure 2C)
is likely a consequence of the effect of residual 5-HT in cat-4 mutants (Figure 1 B).
We propose that when food-deprived mod-5 mutants encounter bacteria, the
NSMs release 5-HT and this 5-HT is inefficiently cleared, thus causing the
hyperenhanced slowing response.
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mod-5 Mutants Are Hypersensitive to Exogenous 5-HT
Exogenous 5-HT inhibits wild-type C. elegans locomotion (Horvitz et al., 1982). To
determine if mod-5(n822) and mod-5(n823) mutants were abnormal in their
response to exogenous 5-HT, we used a liquid swimming assay (Ranganathan et
al., 2000). In this assay, mod-5(n822) and mod-5(n823) mutants were hypersensitive
to exogenously added 5-HT (Figure 2D), presumably because this 5-HT was not
efficiently cleared from the relevant synapses.
MOD-5 Is Similar to SERTs
We used the 5-HT hypersensitivity of mod-5 mutants in the liquid swimming assay to
map and clone the gene. We mapped mod-5 to a -2.0 map unit interval on
chromosome 1, between fog-1 and unc- 11 (Figure 3A) (see Experimental
Procedures). We noted an open reading frame, Y54E10A_154.A, in this region
predicted to encode a protein with similarity to serotonin reuptake transporters
(SERTs). As loss of SERT function would provide a simple explanation for both the
defective 5-HT uptake and 5-HT hypersensitivity of mod-5 mutants, we decided to
determine if Y54E1OA_154.A was mod-5.
We generated an eight kilobase (kb) polymerase chain reaction (PCR)
product from the genomic region spanning the first eight exons of Y54E1OA_154.A
(Figure 3A) and encoding the first 507 amino acids of the corresponding predicted
protein. This construct robustly rescued the 5-HT hypersensitivity phenotype of
mod-5(n823) mutants in 16 of 20 transgenic lines tested (data not shown). We
obtained a partial cDNA clone of Y54E1OA_154.A using reverse transcriptase-PCR
(RT-PCR) and determined the 5' and 3' ends of the cDNA using 5'- and 3'-rapid
amplification of cDNA ends (RACE), respectively. The 5' end of the cDNA contained
an SL1 trans-spliced leader, which is found at the 5' ends of many C. elegans
transcripts (Krause and Hirsh, 1987). The 3' end contained a poly-A stretch,
indicating that we had determined the complete Y54E1OA_154.A transcriptional unit
(Figure 3A). This cDNA was capable of rescuing the 5-HT hypersensitivity of mod-5
mutants (see below).
Protein sequence comparisons revealed that the predicted protein encoded
by our full-length cDNA is 44% identical to human SERT (hSERT; Ramamoorthy et
al., 1993) and 45% identical to the other known invertebrate SERT, from Drosophila
melanogaster (dSERT; Corey et al. 1994), which is itself 51 % identical to hSERT
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(Figure 3B). We identified single-base mutations in the Y54E1OA_154.A coding
sequence in mod-5(n822) and mod-5(n823) mutants (Figure 3B). The mutation in
mod-5(n822) is predicted to change cysteine 225 (codon TGT) to an opal stop codon
(TGA). The mutation in mod-5(n823) is predicted to change proline 569 (CCG) to
serine (TCG) within a transmembrane region. We concluded that Y54E1OA_154.A is
mod-5.
Like SERTs from other species (Barker and Blakely, 1998 and references
cited therein), the MOD-5 protein is predicted to contain 12 putative transmembrane
regions (Figure 3B). Much of the sequence conservation is clustered in or around
these transmembrane regions, suggesting that the membrane topology of the
SERTs is important for their function. At position 119 (Figure 3B, diamond) within the
first predicted transmembrane domain, MOD-5 has an aspartate residue that is
conserved in 5-HT, dopamine, and norepinephrine (NE) reuptake transporters but
not in gamma-aminobutyric acid (GABA) reuptake transporters (Barker and Blakely,
1998). This aspartate may be involved in binding to the amino group in 5-HT,
dopamine, and NE (Kitayama et al., 1992). MOD-5 also has other similarities to
hSERT and dSERT (Figure 3B legend).
mod-5(n3314) Is a Null Allele
To determine the phenotypic consequence of completely eliminating mod-5 function,
we screened libraries of mutagenized animals using PCR to identify large deletions
(Jansen et al., 1997) in the mod-5 genomic locus. We isolated a deletion allele,
n3314, that contains a 1688 base pair (bp) deletion in the mod-5 genomic locus
(Figure 3A). The altered open reading frame (ORF) is predicted to encode the first
42 amino acids of MOD-5 and, if the end of exon 2 splices onto the next available
splice-acceptor site at the start of exon 8, an additional 18 out-of-frame amino acids
before ending at a premature stop codon.
n3314 displayed both a hyperenhanced slowing response and 5-HT
hypersensitivity in the liquid swimming assay and failed to complement mod-5(n822)
and mod-5(n823) for both these behaviors (data not shown), confirming that n3314
is an allele of mod-5. mod-5(n3314) mutants were more hypersensitive to 5-HT than
were mod-5(n822) and mod-5(n823) mutants (Figure 2D). mod-5(n3314) mutants
also exhibited a more severe hyperenhanced slowing response than did the
nonsense mod-5(n822) and the missense mod-5(n823) mutants (Figure 2A). On
Petri plates without bacteria, the locomotory rate of mod-5(n3314) mutants was not
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different from that of the wild type (Figure 2A). Well-fed mod-5(n3314) mutants
showed no defect in their basal slowing response to bacteria (Figure 2A). Given the
stronger behavioral defects of mod-5(n3314) mutants and the molecular nature of
the n3314 deletion, we believe that n3314 is a null allele of mod-5 and that both
mod-5(n822) and mod-5(n823) are partial loss-of-function alleles. mod-5(n822),
which is predicted to encode only the first 225 amino acids of MOD-5, is not a null
allele, based on comparisons of the phenotypes of mod-5(n822), mod-5(n3314), and
mod-5(n822)/mod-5(n3314) trans-heterozygous animals (Figures 2A and 2D; and
data not shown). This activity of mod-5(n822) might be a consequence of the
presence of full-length mod-5 RNA transcripts produced by read-through of the stop
codon. Alternatively, it is conceivable that the first 225 amino acids of MOD-5 retain
partial SERT function. This latter possibility is consistent with our rescue of the 5-HT
hypersensitivity of mod-5(n823) mutants with a construct that encodes only the first
507 amino acids of MOD-5, suggesting that all 671 amino acids of MOD-5 are not
essential for at least some aspects of SERT function.
Since we had isolated the mod-5 cDNA using RT-PCR and RACE, we sought
to confirm that the protein encoded by this cDNA could function in vivo. We
constructed a mini-gene in which the mod-5 cDNA was placed under the control of
2.7 kb of genomic DNA upstream to the first predicted methionine of mod-5.
mod-5(n3314) animals transgenic for extrachromosomal arrays consisting of this
mini-gene construct were no longer 5-HT hypersensitive (data not shown),
confirming that we had defined a functional mod-5 gene and that the mod-5 cDNA
could encode a functional SERT and was suitable for 5-HT-uptake assays in a
heterologous system (see below).
MOD-5 Functions as a SERT in Mammalian Cells
Using retroviral-mediated gene transfer (see Experimental Procedures), we
generated human embryonic kidney 293 (HEK293) cell lines that stably expressed
MOD-5. Using these cell lines, we performed uptake assays similar to those
previously done for other SERTs (Ramamoorthy et al., 1993; Demchyshyn et al.,
1994). The uptake of [3H]5-HT by MOD-5-expressing cell lines was saturable,
indicating that the accumulation of [3H]5-HT in the cells was facilitated by MOD-5
(Figure 4A). MOD-5-mediated [3H]5-HT transport was strictly dependent on Na* ions
(Figure 4B), as has been observed for 5-HT transport by hSERT (Ramamoorthy et
al., 1993), rat SERT (rSERT; Blakely et al., 1991; Hoffman et al., 1991), and dSERT
132
(Demchyshyn et al., 1994). By contrast, MOD-5 did not display a strict dependence
on Cl- ions (Figure 4B), whereas both hSERT and rSERT, but not dSERT, do display
such strict dependence (Blakely et al., 1991; Hoffman et al., 1991; Ramamoorthy et
al., 1993; Demchyshyn et al., 1994).
MOD-5-mediated [3H]5-HT transport occurred in a concentration-dependent
and saturable manner (Figure 4C), with a Km = 150 ± 8 nM, a value similar to those
reported for other SERTs (K, range = 280 - 630 nM) (Blakely et al., 1991; Hoffman
et al., 1991; Ramamoorthy et al., 1993; Corey et al., 1994; Demchyshyn et al., 1994;
Chang et al., 1996; Padbury et al., 1997; Chen et al., 1998; Mortensen et al., 1999).
We tested the specificity of MOD-5 by assaying the ability of MOD-5 to
transport various radiolabelled neurotransmitters besides 5-HT. MOD-5-mediated
uptake was highly specific for [3H]5-HT and inefficient at translocating radiolabelled
GABA, glutamate, glycine, NE, histamine, and dopamine (Figure 4D). We also
tested the ability of these neurotransmitters to inhibit [3H]5-HT uptake via MOD-5.
None of the six neurotransmitters tested, even when present at 100 pM,
substantially inhibited the uptake of 50 nM 5-HT (data not shown). We also tested
whether octopamine or tyramine, two invertebrate-specific neurotransmitters, could
inhibit [3H]5-HT transport; we could not test MOD-5-mediated uptake of these
neurotransmitters, as radiolabelled octopamine and tyramine are not available.
Tyramine (100 RM) partially inhibited (54% ± 10% of control) the transport of
[3H]5-HT (50 nM) by MOD-5; octopamine (100 pM) did not inhibit (86% ± 12% of
control) MOD-5-mediated [3H]5-HT (50 nM) transport. By comparison, dSERT-
mediated transport of 100 nM [3H]5-HT was reduced to 95% ± 15% of control by 200
ptM tyramine and to 82% ± 15% of control by 200 pM octopamine (Corey et al.,
1994). These data suggested that there are subtle differences in the properties of
MOD-5 and dSERT.
We tested whether MOD-5-mediated [3H]5-HT transport was inhibited by
tricyclic antidepressants, SSRIs, and non-specific monoamine transporter inhibitors
(Blakely et al., 1991; Ramamoorthy et al., 1993; Demchyshyn et al., 1994). The rank
order of potency for inhibition of MOD-5-mediated [3H]5-HT transport was
imipramine (K = 89 ± 58 nM) = fluoxetine (K = 133 ± 90 nM) = paroxetine (K = 179
64 nM) > desipramine (K, = 334 ± 115 nM) > citalopram (K, = 994 ± 298 nM) >>
cocaine (K = 4076 ± 349 nM) (Figure 4E). This rank order is different from that of
other SERTs (for example, the rank order of potency for inhibition of hSERT-
mediated [3H]5-HT transport is paroxetine > fluoxetine > imipramine = citalopram >>
cocaine; Ramamoorthy et al., 1993), and for some of the inhibitors the K values
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were higher than those reported for the other SERTs (Blakely et al., 1991; Hoffman
et al., 1991; Ramamoorthy et al., 1993; Corey et al., 1994; Demchyshyn et al., 1994;
Chang et al., 1996; Padbury et al., 1997; Chen et al., 1998; Mortensen et al., 1999).
Taken together, the specificity of MOD-5-mediated transport for 5-HT, the
dependence of such transport on Na* and Cl~ ions, and the inhibition of 5-HT
transport by SSRIs establish that MOD-5 is a C. elegans SERT (CeSERT).
MOD-5 Is Likely the Only SERT in C. elegans
To determine if MOD-5 is the only SERT in C. elegans, we analyzed the C. elegans
genomic sequence for other potentials SERTs and performed in vivo assays of 5-HT
uptake in mod-5 mutants. We found 15 Na*/CI -dependent neurotransmitter
transporter-like predicted ORFs in the completed C. elegans genomic sequence
(The C. elegans Sequencing Consortium, 1998). Only two of these ORFs, T23G5.5
and T03F7.1, are nearly as similar (43% and 41% identity, respectively) to hSERT
as is MOD-5 CeSERT, and only MOD-5 CeSERT and T23G5.5 have an aspartate
corresponding to aspartate 119 in MOD-5 CeSERT, a conserved residue likely to be
functionally important for amine transport (see above). T23G5.5 is a dopamine
reuptake transporter and is very inefficient at transporting 5-HT (Jayanthi et al.,
1998). Hence, from sequence analysis, it appeared likely that MOD-5 CeSERT is the
only SERT in C. elegans. This finding is consistent with the observation that to date
only one SERT gene per species has been identified.
If there existed a second SERT in C. elegans, serotonergic neurons in
mod-5(n3314) mutants might be able to take up exogenously added 5-HT. It is also
conceivable that non-serotonergic cells possess a SERT activity. We tested both
these possibilities using anti-5-HT antisera to detect the uptake of 5-HT. To eliminate
endogenous 5-HT, we used the tph-1(mg280) mutant, which contains a deletion in
the tryptophan hydroxylase gene and is hence defective in an enzyme essential for
5-HT biosynthesis (Sze et al., 2000). tph-1 mutants appear to completely lack 5-HT
(Sze et al., 2000; Table 1), and are unlikely to be perturbed in the levels of other
biogenic amines, since tryptophan hydroxylase functions in only 5-HT biosynthesis
(Cooper et al., 1996; Sze et al., 2000).
To identify cells capable of 5-HT uptake, we examined the head, ventral cord,
gut, and tail of tph-1 mutants pretreated with 5-HT and observed 5-HT
immunofluorescence in only the serotonergic neurons (see below; and data not
shown). To examine more carefully the requirement of MOD-5 CeSERT for 5-HT
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uptake by serotonergic neurons, we scored the NSMs for 5-HT uptake, since these
neurons are the most brightly staining serotonergic neurons in the animal following
incubation with exogenous 5-HT. Without 5-HT pretreatment, both tph-1 single and
mod-5(n3314); tph-1 double mutants had no NSMs that were 5-HT positive (Table
1). By contrast, when pretreated with 5-HT, tph-1 mutants displayed robust 5-HT
staining in the NSMs, while mod-5(n3314); tph-1 double mutants showed none
(Table 1). We observed similar results for the serotonergic ADF neurons in the head
and for the hermaphrodite-specific neurons (HSNs) in the mid-body (data not
shown). Thus, no other transporter appeared to transport 5-HT into serotonergic
neurons in the absence of the MOD-5 CeSERT. We also examined the head, ventral
cord, gut, and tail of mod-5(n3314); tph-1 double mutants pretreated with 5-HT and
observed no 5-HT immunofluorescence anywhere in the animal (data not shown),
indicating that no other cells display 5-HT uptake activity in the absence of MOD-5
CeSERT.
These 5-HT uptake experiments taken together with the analysis of the
C. elegans genomic sequence suggest that MOD-5 is the only SERT in C. elegans.
mod-5 Interacts Genetically with mod-1 and goa-1
Mutants defective in the 5-HT-mediated enhanced slowing response defined several
mod genes (Sawin et al., 2000). One of these genes, mod-1, encodes a novel
ionotropic 5-HT receptor, a 5-HT-gated chloride channel (Ranganathan et al., 2000).
On Petri plates with bacteria, the locomotory rate of food-deprived mod-1 mutants is
substantially faster than that of the wild type (Sawin et al., 2000; Ranganathan et al.,
2000; also Figure 5A, gray bars). By contrast, mod-5 mutants exhibit a
hyperenhanced slowing response (Figure 5A).
To define the genetic pathway in which mod-1 and mod-5 act in the enhanced
slowing response, we characterized mod-5(n3314); mod-1(ok103) double mutants.
mod-1(ok103) is a null allele by genetic and molecular criteria (Ranganathan et al.,
2000). If the function of the MOD-1 5-HT receptor were essential for the effects of
5-HT not cleared from synapses in mod-5 mutants, then eliminating mod-5 function
should have had no effect in a mutant that lacked mod-1 function, i. e.,
mod-5(n3314); mod-1(ok103) double mutants should exhibit the same phenotype as
mod-1(ok103) single mutants. However, the enhanced slowing response of
mod-5(n3314); mod-1(ok103) double mutants was intermediate to the responses of
mod-1(ok103) and mod-5(n3314) single mutants (Figure 5A, gray bars). This
observation suggests that the 5-HT signaling triggered by bacteria in the enhanced
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slowing response acts via at least two parallel 5-HT signaling pathways, a MOD-1-
dependent pathway and a MOD-1-independent pathway. This observation is also
consistent with the observation that mod-1(ok103) single mutants were not
completely defective in the enhanced slowing response (Figure 5A).
Animals carrying mutations in the G-protein gene goa-1 (Go, _G-protein 0,
alpha subunit) (Mendel et al., 1995; Segalat et al., 1995) are also defective in the
enhanced slowing response (Sawin et al., 2000; also Figure 5A). Since GOA-1
animals are resistant to 5-HT in assays of locomotion (Segalat et al., 1995; and our
unpublished observations), pharyngeal pumping (Segalat et al., 1995), and egg
laying (Mendel et al., 1995; Segalat et al., 1995), we tested whether the MOD-1-
independent pathway might involve goa-1. As with mod-5; mod-1 double mutants,
the enhanced slowing response of mod-5(n3314) goa-1(nl 134) double mutants was
intermediate to the responses of mod-5(n3314) and goa-1(n 1134) single mutants
(Figure 5A, gray bars), indicating that 5-HT signaling triggered by bacteria in the
enhanced slowing response does not act solely through goa-1. By contrast, food-
deprived mod-5(n3314) goa-1(nl 134); mod-1(ok103) triple mutants exhibited very
little slowing in response to bacteria (Fig 5A). These observations suggested that
MOD-1 and GOA-1 act in two parallel pathways that together mediate the response
to the excess 5-HT signaling in mod-5(n3314) mutants.
Fluoxetine Blocks 5-HT Uptake in vivo
Since fluoxetine blocked [3H]5-HT transport in mammalian cells expressing MOD-5
CeSERT (see above), we tested whether fluoxetine could block 5-HT uptake in vivo
in C. elegans (Table 1). We pretreated tph-1 mutants with fluoxetine, incubated the
animals with 5-HT, and scored the number of 5-HT-positive NSMs. We observed, for
example, few 5-HT-positive NSMs when tph-1 mutants were pretreated with 0.22
mM fluoxetine (Table 1), a concentration sufficient to potentiate the enhanced
slowing response (see below). Furthermore, tph-1 mutants pretreated with as little
as 0.44 mM fluoxetine, a concentration lower than that required for all the MOD-5
CeSERT-independent effects of fluoxetine (see below), were as defective in 5-HT
uptake as were untreated mod-5(n3314); tph-1 double mutants (Table 1). These
observations suggested that fluoxetine can block 5-HT uptake in C. elegans in vivo
and does so by inhibiting MOD-5 CeSERT.
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The Potentiation of the Enhanced Slowing Response by Fluoxetine Requires
MOD-5 CeSERT and 5-HT
When wild-type animals that have been food-deprived in the presence of 0.22 mM
fluoxetine encounter bacteria, they slow their locomotory rate more than if they had
been food-deprived in the absence of fluoxetine (Sawin et al., 2000; see Figure 5A) .
This fluoxetine-mediated potentiation of the enhanced slowing response resembles
the hyperenhanced slowing response exhibited by mod-5(n3314) mutants (Figure
5A), suggesting that fluoxetine causes this potentiation by blocking MOD-5 CeSERT
function. If so, mod-5(n3314) mutants should be resistant to the potentiating effect of
fluoxetine on the enhanced slowing response. Since food-deprived mod-5(n3314)
mutants exhibit an extreme hyperenhanced slowing response that cannot be further
potentiated by fluoxetine treatment (Figure 5A and data not shown), we used
mod-5(n3314); mod-1 (ok103) double mutants to test this hypothesis. These double
mutants are partially suppressed for the hyperenhanced slowing response exhibited
by mod-5(n3314) animals (Figure 5A, gray bars), and therefore a potentiation of the
enhanced slowing response could be observed.
The enhanced slowing response of mod-1(ok103) mutants was potentiated by
fluoxetine (Figure 5A, hatched bars), indicating that fluoxetine can potentiate the
enhanced slowing response in the absence of MOD-1 5-HT receptor function. This
observation was consistent with the phenotype of mod-5(n3314); mod-1(ok103)
double mutants in this assay, which suggested that there are MOD-1-independent
5-HT pathways through which the enhanced slowing response is effected. By
contrast, mod-5(n3314); mod-1(ok103) double mutants were completely resistant to
the potentiating effect of fluoxetine on the enhanced slowing response (Figure 5A,
hatched bars). Therefore, the MOD-5 CeSERT is likely the only in vivo target in
C. elegans on which fluoxetine acts to potentiate the enhanced slowing response.
Since fluoxetine-mediated potentiation of the enhanced slowing response is
MOD-5 CeSERT-dependent, it is also likely to be 5-HT-dependent, as we previously
suggested (Sawin et al., 2000) based on the observation that enhanced slowing
response bas-1(ad446); cat-4 double mutants (bas: biogenic amine sjynthesis
defective) is resistant to such potentiation. However, our studies of egg laying by
tph-1 mutants suggest that the resistance of cat-4 animals to the effects of high
concentrations of fluoxetine is likely not to be caused by a deficiency in 5-HT in
these animals (see below). Since tph-1 mutants display sluggish locomotion (data
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not shown), they could not be assayed for resistance to the fluoxetine-mediated
potentiation of the enhanced slowing response.
We sought to determine if it is the 5-HT-deficiency of bas-1; cat-4 double
mutants that renders these animals resistant to the potentiating effect of fluoxetine.
The defect in the enhanced slowing response of bas-1; cat-4 double mutants in the
absence of fluoxetine treatment can be rescued by preincubating the animals on
Petri plates containing 2 mM 5-HT (Sawin et al., 2000; and Figure 5B), a
pretreatment sufficient for the detection of 5-HT in the NSMs of cat-4 (Figure 1 B)
and tph-1 (Table 1) mutants. When bas-1; cat-4 mutants were preincubated with
5-HT and then food-deprived in the presence of fluoxetine, they exhibited a
potentiated enhanced slowing response (Figure 5B). Therefore, restoration of 5-HT
to bas-1; cat-4 mutants is sufficient for fluoxetine to potentiate the enhanced slowing
response of these mutants. We conclude that the effect of fluoxetine on the
enhanced slowing response is dependent not only on MOD-5 CeSERT but also on
5-HT.
Fluoxetine Induces Nose Contraction and Paralysis in mod-5 and tph-1
Mutants
Treatment of C. elegans with high concentrations (0.25 - 1 mg/ml; 0.7 - 2.9 mM) of
fluoxetine leads to paralysis (Choy and Thomas, 1999), contraction of nose muscles
(Choy and Thomas, 1999), and stimulation of egg laying (Weinshenker et al., 1995).
The concentrations of fluoxetine required for these effects are at least 2.5 fold higher
than that required to detect a block of 5-HT uptake in vivo (see above) and for the
potentiation of the enhanced slowing response (Figure 5B and Sawin et al., 2000). If
the only in vivo target for fluoxetine were MOD-5 CeSERT, mod-5 mutants could be
paralyzed, have contracted noses, and display excessive egg laying. mod-5 mutants
exhibit none of these characteristics (data not shown), suggesting that either MOD-5
CeSERT is not the sole target of fluoxetine in C. elegans or that an altered
developmental program compensates for the animals growing up without a SERT. In
the latter case, mod-5(n3314) mutants would be expected to be resistant to the
effects of fluoxetine. Therefore, we tested mod-5(n3314) mutants for their responses
to high concentrations of fluoxetine.
mod-5(n3314) mutants retained wild-type sensitivity to fluoxetine in assays of
paralysis induced by fluoxetine treatment (Figure 5C). There was no difference in the
time-course of paralysis at any of the concentrations tested (data not shown). These
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observations suggest that fluoxetine-induced paralysis in C. elegans is not caused
by the lack of 5-HT uptake from synapses. Fluoxetine-treated wild-type and
mod-5(n3314) mutant animals assumed a rigid body posture (data not shown), as
observed by others (Choy and Thomas, 1999). By contrast, 5-HT-treated animals
assumed a relaxed and flaccid body posture (data not shown), suggesting that the
mechanisms of locomotory inhibition by 5-HT and fluoxetine are distinct. 5-HT has
been proposed to decrease excitatory input to the locomotory muscles (Nurrish et
al., 1999). Given the two distinct body postures, we suggest that fluoxetine may
directly or indirectly increase excitatory input or decrease inhibitory input to the
locomotory muscles.
When treated with fluoxetine for 20 minutes, a similar proportion of wild-type
and mod-5(n3314) mutant animals had contracted noses (100% at 2.9 mM, and ~
25% at 1.5 mM). Thus, the effect of fluoxetine on nose contraction also appears to
act via a MOD-5 CeSERT-independent pathway. This conclusion is consistent with
the conclusion by Choy and Thomas (1999) that fluoxetine-mediated nose
contraction is 5-HT-independent, although their hypothesis was based on studies of
cat-1(e 1111) mutants, which are defective in signaling by several biogenic amines
(Duerr et al., 1999), and cat-4 mutants, which we found to not completely lack 5-HT
(Figure 1B).
That the effects of high concentrations of fluoxetine on nose-contraction and
paralysis were independent of MOD-5 CeSERT suggested that fluoxetine acts either
on another SERT or on a distinct non-SERT target(s). As discussed above, we think
that MOD-5 is the only SERT in C. elegans, making it likely that a non-SERT
target(s) of fluoxetine mediates the MOD-5 CeSERT-independent effects. Such non-
SERT targets may or may not be part of a serotonergic signaling pathway. We
decided to explore the requirement for 5-HT by testing whether fluoxetine can act in
animals that lack 5-HT. The 5-HT-deficient mutants that have been used in
numerous prior studies (e. g., Weinshenker et al., 1995; Choy and Thomas, 1999;
Sawin et al., 2000), such as cat-1, cat-4, and bas-1 mutants, all affect multiple
biogenic amines. None has been shown to cause a complete loss of 5-HT function.
We therefore tested tph-1 mutants, which appear to completely lack 5-HT (see
above), for their response to fluoxetine.
100% of tph-1 animals displayed contracted noses after treatment with 2.9
mM fluoxetine for 20 minutes. These data confirm the hypothesis of Choy and
Thomas (1999) that this effect of fluoxetine is 5-HT-independent. We found that
fluoxetine treatment paralyzed tph-1 mutants to a similar extent as wild-type animals
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(data not shown), suggesting that paralysis by high concentrations of fluoxetine is
also a 5-HT-independent process.
Fluoxetine Stimulates Egg Laying in mod-5 and tph-1 Mutants
In 1.5 mM fluoxetine, mod-5(n3314) mutants were stimulated to lay eggs to nearly
the same extent as was the wild type (Figures 6A and 6B, black bars), suggesting
that fluoxetine can stimulate egg laying via one or more MOD-5 CeSERT-
independent pathways. Nevertheless, mod-5(n3314) mutants were hypersensitive to
exogenous 5-HT in assays of egg laying (Figures 7A and 7B), suggesting that
MOD-5 CeSERT can affect serotonergic synapses that regulate egg laying.
mod-5(n3314) mutants and wild-type animals contain similar numbers of eggs (25.7
± 2.8 and 26.3 ± 2.2, respectively), indicating that this hypersensitivity to exogenous
5-HT was not a consequence of differences in basal egg-laying rates between wild-
type animals and mod-5 mutants but rather a result of excess 5-HT signaling in
mod-5(n3314) mutants.
Given that the stimulation of egg laying by fluoxetine did not require the
MOD-5 CeSERT, we wondered whether this stimulation required 5-HT. tph-1
mutants were partially resistant to the stimulation of egg-laying by fluoxetine (Figures
6A and 6C) indicating that 5-HT mediated some but not all of the egg-laying
response to fluoxetine. By contrast, cat-4 mutants were completely resistant to
fluoxetine-induced egg laying (Figures 6A and 6D), as reported by Weinshenker et
al. (1995).
The reduction in egg laying by tph-1 mutants in response to fluoxetine (Figure
6C) is unlikely to be caused by a lower number of eggs within tph-1 mutants or the
inability of egg-laying muscles in tph-1 mutants to respond to stimulatory input: tph-1
mutants contain more eggs than do wild-type animals (Sze et al., 2000; and data not
shown) and tph-1 mutants laid about the same number of eggs in response to
exogenous 5-HT as did wild-type animals (Figure 7C). That mod-5(n3314) and tph-1
mutants laid a significant numbers of eggs in response to fluoxetine argues that the
mechanism(s) through which fluoxetine stimulates egg laying in C. elegans is not
only MOD-5 CeSERT-independent but also, in part, 5-HT-independent.
The serotonergic HSN motor neurons innervate the egg-laying muscles and
drive egg laying (Trent et al., 1983; Desai et al., 1988). egl-1(n1084) mutants, which
lack the HSNs (Desai et al., 1988), released some eggs in the
140
absence of fluoxetine (Figure 6E, gray bars), presumably because these animals
were severely bloated with eggs. However, treatment with fluoxetine had no effect
on egg laying in egl-1 mutants (Figures 6E, black bars). These observations indicate
that the HSNs are required for the stimulation of egg laying by fluoxetine.
Discussion
The C. elegans gene mod-5 encodes a homolog of human SERT, a molecule of
major importance in human neurobiology and psychiatric disease. MOD-5 CeSERT
acts in a pathway that includes both a novel type of 5-HT receptor, the 5-HT-gated
chloride channel MOD-1, and the G-protein GOA-1. We have identified a C. elegans
modulatory behavior - the potentiation of the enhanced slowing response - in
which fluoxetine (Prozac) affects 5-HT signaling by antagonizing MOD-5 CeSERT.
We have also identified C. elegans behaviors in which fluoxetine acts independently
of both SERT and 5-HT. These behaviors can now be analyzed to define SERT- and
5-HT-independent pathways affected by fluoxetine.
MOD-5 Probably Acts Upstream of MOD-1 and GOA-1
mod-5 mutants, which exhibit a hyperenhanced slowing response, are opposite in
phenotype to all other mod mutants, which were isolated on the basis of their failures
to exhibit the enhanced slowing response (Sawin et al., 2000). These opposite
phenotypes allow genetic epistasis experiments to be performed to help define a
genetic pathway for this behavior.
We performed such epistasis analysis with the genes mod-1, goa-1, and
mod-5 (Figure 5A). The phenotypes of mod-5 goa-1 and mod-5; mod-1 double
mutants were intermediate between those of either mod-5 or goa- 1 or mod-5 or
mod-1 single mutants, respectively; mod-5 goa-1; mod-1 triple mutants were almost
completely defective in the enhanced slowing response. The intermediate
phenotypes of these double mutants with mod-5 indicate that mod-1 and goa-1 act
in parallel pathways for the enhanced slowing response (Figure 8A). mod-1 and
goa-1 probably both act downstream of mod-5 (Figure 8A), since in the absence of
both mod-1 and goa- 1, the presence or absence of mod-5 has little effect.
Since mod-5 encodes a SERT and mod-5 mutants are defective in the
loading of 5-HT into serotonergic neurons, it is likely that MOD-5 CeSERT functions
in neurons that synthesize and release 5-HT. That mod-1 probably acts downstream
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Iof mod-5 and encodes a 5-HT receptor (Ranganathan et al., 2000), suggests that
MOD-1 acts in cells that are postsynaptic to the serotonergic neurons in which
MOD-5 functions (Figure 8B). Alternatively, MOD-1 could be a presynaptic 5-HT
receptor, acting in the same serotonergic cells as MOD-5. We consider this latter
possibility unlikely given that a mod-1::GFP reporter that rescues the mod-1 mutant
phenotype (Ranganathan et al., 2000) is not expressed in the NSM, HSN, and ADF
serotonergic neurons (R.R. and H. R. H., unpublished data). Moreover, expression
of this mod- 1::GFP reporter was observed in certain non-serotonergic neurons (data
not shown) that are likely to be direct postsynaptic partners of some of the
serotonergic neurons (White et al., 1986). Similarly, since goa-1 mutants are
resistant to the effects of exogenous 5-HT (Mendel et al., 1995, Segalat et al., 1995;
and our unpublished data), the functions of this G-protein required for responding to
5-HT are likely to be downstream of the serotonergic neurons in which MOD-5
functions (Figure 8B).
The molecular features of the MOD-5, MOD-1, and GOA-1 combined with our
genetic epistasis analysis lead us to propose a simple model for the enhanced
slowing response in which MOD-5 acts upstream of both MOD-1 and GOA-1, which
in turn act in parallel to each other (Figure 8B). While this model places MOD-1 and
GOA-1 within the same cells (Figure 8B), our data are also consistent with a model
in which these proteins act in parallel in different neurons in the animal, possibly
responding to distinct presynaptic serotonergic neurons.
Fluoxetine-Induced Egg Laying Is Only Partially 5-HT-Dependent
Weinshenker et al. (1995) observed that cat-4 mutants do not lay eggs in response
to fluoxetine and argued that fluoxetine is likely to stimulate egg laying by affecting a
5-HT signaling pathway, possibly by inhibiting a SERT. However, we found that
mod-5 null mutants are stimulated to lay eggs by fluoxetine. Moreover, we observed
that tph-1 mutants, which appear to completely lack 5-HT, were only partially
resistant to fluoxetine. Weinshenker et al. (1995) argued that the resistance of cat-4
mutants to fluoxetine is unlikely to be a consequence of their deficiency in dopamine.
However, it is possible that the biopterin cofactor generated by the GTP
cyclohydrolase I enzyme encoded by the cat-4 gene (C. Loer, personal
communication) participates in the biosynthesis of small molecules in addition to
dopamine and 5-HT. In fact, cat-4 animals have an altered cuticle (Loer and Kenyon,
1993), a characteristic not found in bas-1 mutants, which also have reduced levels of
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both 5-HT and dopamine (Loer and Kenyon, 1993; and our unpublished results).
Moreover, bas-1 mutants, unlike cat-4 mutants, were not resistant to fluoxetine-
induced egg laying (data not shown). Hence, the resistance of cat-4 mutants to
fluoxetine-induced egg-laying need not be a consequence of their deficiency in
either 5-HT or dopamine. In addition, we have shown that cat-4 mutants retain some
5-HT immunoreactivity (Figure 1 B). For these reasons, the cat-4(e1141) mutation
cannot be considered as a null for 5-HT function.
tph-1 mutants were partially resistant to fluoxetine-induced egg laying, while
mod-5(n3314) mutants were not at all resistant. Since we have shown that MOD-5 is
likely the only SERT in C. elegans, these observations suggest that fluoxetine-
mediated stimulation of egg-laying through non-SERT pathways still involves 5-HT
signaling. We propose that 5-HT signaling serves as a requisite permissive signal for
the egg-laying circuitry to respond in full to a fluoxetine-stimulated non-5-HT signal.
This model is consistent with the hypothesis that 5-HT promotes and maintains the
active phase of egg laying (Waggoner et al., 1998). Alternatively, 5-HT could be
required during development for the neuromusculature to be competent to respond
fully to fluoxetine.
Potentiation of the Enhanced Slowing Response by Fluoxetine Requires
MOD-5 CeSERT and 5-HT
The therapeutic effect of fluoxetine in human patients is thought to be mediated
primarily by a block in 5-HT uptake by hSERT. However, fluoxetine causes a variety
of adverse side effects, including headaches, sexual dysfunction, and sleep
disorders (Baldessarini, 1996). It remains important to resolve whether these side
effects result from the action of fluoxetine on hSERT or from the action of fluoxetine
on non-hSERT target(s).
We have shown that high concentrations of fluoxetine have effects on both
mod-5 and tph- 1 mutants. Our results demonstrate that in C. elegans effects of
fluoxetine previously thought to be 5-HT-dependent are MOD-5 CeSERT-
independent and, to varying degrees, 5-HT-independent (Figure 8C). It has recently
been proposed, based on the identification of fluoxetine-resistant mutants and the
cloning of a novel family of C. elegans transmembrane proteins required for
responses to fluoxetine, that some of these side-effects of fluoxetine could involve
5-HT-independent targets (Choy and Thomas, 1999; Schafer, 1999). Our
demonstration in this study that there is a SERT- and 5-HT-dependent effect of
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fluoxetine on C. elegans behavior (Figure 8B) - the potentiation of the enhanced
slowing response - strengthens the argument that non-SERT and non-serotonergic
targets of fluoxetine in C. elegans could well be relevant to the effects of fluoxetine in
humans. Moreover, the potentiation of the enhanced slowing response by fluoxetine
requires much lower doses of fluoxetine than do the other effects of fluoxetine on
C. elegans behavior, arguing that fluoxetine is likely acting on its most sensitive
target, i. e., MOD-5 CeSERT, to bring about the potentiation of the enhanced
slowing response. By contrast, the non-SERT targets that mediate the other effects
of fluoxetine in C. elegans are likely to have either lower binding affinities or lower
bioavailability for fluoxetine.
We propose that the further genetic analysis of the C. elegans behaviors
elicited by fluoxetine in mod-5 and tph-1 mutants will help define SERT- and 5-HT-
independent targets of fluoxetine. Such studies could be instrumental in the
development of pharmaceuticals that modulate 5-HT neurotransmission with fewer
side-effects than those currently in use in the clinic.
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Experimental Procedures
mod-5 Mapping, Cloning, and cDNA
Nematodes were grown at 200C as previously described (Brenner, 1974), except
that E. coli strain HB1 01 rather than OP50 was used as the food source (Sawin et
al., 2000). Wild-type animals were C. elegans strain N2. mod-5(n822) and
mod-5(n823) were isolated from a genetic screen in which clonal populations of F3
animals descended from PO animals mutagenized with ethyl methanesulphonate
(Brenner, 1974) were pretreated with 5-HT (15 min incubation in 500 gI of 13 mM
5-HT followed by two washes with M9) and then examined for the presence of the
NSMs using FIF (Sulston et al., 1975). mod-5(n3314) was isolated from a library of
animals mutagenized with UV/trimethylpsoralen (Jansen et al., 1997). The deletion
library was constructed essentially as described (Jansen et al., 1997; Liu et al.,
1999; P. Reddien, R. R., and H. R. H., unpublished results). mod-5(n3314) was
backcrossed to the wild type six times prior to behavioral assays. mod-5(n823) was
mapped to LG I based upon two-factor linkage to dpy-5 unc-75 1. The following
three-factor data were obtained: mod-5 (47/47) dpy-5 (0/47) unc-75, mod-5 (35/35)
unc-73 (0/35) lin-44 dpy-5, lin-6 (27/27) lin- 17 (0/27) mod-5, lin- 17 (13/13) fog-1
(0/13) mod-5, and fog-1 (3/26) mod-5 (23/26) unc- 11. All mapping experiments were
performed by mating hermaphrodites homozygous for the recombinant chromosome
with mod-5(n823) males and scoring the F1 cross progeny for 5-HT hypersensitivity
at 5 min in 10 mM 5-HT. Germline transformation experiments (Mello et al., 1991)
were performed by injecting various constructs with 80 pg/ml pL15EK (which
contains the wild-type lin-15 gene) into a mod-5(n823); lin-15(n765ts) strain and
scoring 5-HT sensitivity in transgenic lines that produced non-Lin progeny at 22.50C.
Long-range PCR was performed using the Advantage cDNA PCR kit (Clontech).
DNA sequences were determined using an automated ABI 373A DNA sequencer
(Applied Biosystems). RT-PCR was performed with primers corresponding to exons
predicted by Genefinder (The C. elegans Sequencing Consortium, 1998). The 5' and
3' ends of the mod-5 cDNA were determined using 5'- and 3'-RACE kits (Gibco),
respectively. To construct the mod-5 minigene, we used PCR and primers that
contained restriction enzyme sites at their ends to amplify 2.7 kb of the mod-5
promoter region. A Pst I - Bam HI fragment of this PCR product was ligated into the
pPD49.26 vector (A. Fire) digested with Pst I and Bam HI. This mod-5 promoter
construct was then digested with Nco I and Sac I and ligated to an Nco I - Sac I
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fragment of the mod-5 coding region, PCR-amplified in a manner similar to that used
for the mod-5 promoter region.
Laser Microsurgery
Neurons were ablated during the second larval stage using a laser microbeam, as
previously described (Avery and Horvitz, 1987; Bargmann and Horvitz, 1991).
Behavioral assays of young adult animals were performed two days later. Mock-
ablated animals were animals transferred to agar pads and anesthetized in parallel
to the animals that underwent laser ablation. Sawin et al. (2000) describe details
concerning how ablated animals were assayed sequentially in each of the different
behavioral conditions.
Neurotransmitter and Drug Pretreatment and Behavioral Assays
Locomotory rate was assayed and 5-HT-containing plates were prepared as
previously described (Sawin et al., 2000). Fluoxetine (HCI salt, Sigma) was
dissolved in water, and 400 pl of a 25x stock solution were added to each 5 cm
plate, containing -10 ml of agar, to obtain the various final concentrations of
fluoxetine. The plates were allowed to dry at room temperature with their lids
removed for >2 hours.
To assay 5-HT hypersensitivity, we placed 20 animals in 200 pl of 5-HT
solution (creatinine sulphate salt, Sigma, dissolved in M9 buffer; Wood et al., 1988)
in 96-well microtiter wells and scored the swimming behavior of the animals as either
active or immobile at 5 min; an animal was scored as immobile if it did not exhibit
any swimming motion for a period of 5 seconds. Fluoxetine-induced paralysis was
scored in a similar manner at 10 min.
Egg-laying assays were performed as previously described (Trent et al.,
1983). Briefly, one day-old adult animals (staged by picking late L4 animals 36 hours
prior to the assay) were placed in wells of microtiter dishes containing 100 ji of 12.5
mM 5-HT or 500 pg/ml fluoxetine, and the number of eggs laid was counted after 90
minutes.
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5-HT-uptake Assays in vivo
FIF assays were performed as previously described (Sulston et al., 1975). For the
anti-5-HT antisera experiments shown in Figure 1 B, mod-5(n823); cat-4 and cat-4;
lin-15(n765ts) double mutants were grown at 200C, and animals of both genotypes
were incubated separately on plates containing 2 mM 5-HT and bacteria (see Sawin
et al., 2000 for details concerning how plates were prepared) for two hours and then
incubated on plates with bacteria but without 5-HT for 30 min. Controls without
exogenous 5-HT were similarly treated in parallel. Prior to fixation, mod-5(n823);
cat-4 and cat-4; in-15 double mutants preincubated on 5-HT-containing plates were
combined, and mod-5(n823); cat-4 and cat-4; in-15 double mutants preincubated on
control plates were combined. 5-HT staining was performed as previously described
(Desai et al., 1988) using affinity-purified rabbit polyclonal anti-5-HT antisera
(H. Steinbusch, Maastrict University, the Netherlands). The cat-4; lin-15 mutants
were not defective in the uptake of 5-HT (data not shown) and served as internal
controls for each staining reaction. These animals could be distinguished from the
test animals by the Multivulva phenotype caused by lin-15. Neuron with bright
staining in cell bodies, axonal processes, and varicosities were termed "bright" and
neurons with weak staining in just the cell bodies and axonal processes were termed
"weak." For the results in Table 1, the procedure was essentially the same, except
that the animals experienced an additional 1 hr incubation on control or fluoxetine-
containing plates prior to the 2 hr incubation with 5-HT but did not experience the 30
min incubation on plates without drug after the 5-HT preincubation (see Table 1
legend for details). lin-15 adult animals, grown at 22.50C were added to all plates at
the first incubation step, and these animals served as internal controls for the
staining reaction.
MOD-5-mediated Uptake in Mammalian Cells
We obtained a modified version of the MSCVpac vector (Hawley et al., 1994) in
which the pac gene had been replaced with the gfp gene (MSCVGFP; a generous
gift of J. Schwartz). We further modified MSCVGFP as follows: The ends of a Bg/ II -
Mfe I fragment containing the entire mod-5cDNA were blunted using the Klenow
fragment of DNA polymerase I and then ligated to the MSCVGFP vector digested
with Hpa I, placing mod-5 under the control of the retroviral long terminal repeat
promoter (MSCVGFPMOD-5). The Phoenix packaging cell line (ATCC) was used to
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generate virus containing either MSCVGFPMOD-5 or MSCVGFP. HEK293 cells
were infected with these viral stocks in the presence of 4 mg/ml polybrene, and
clones expressing high levels of GFP were isolated using a fluorescence activated
cell sorter (FACstar or FACSvantage; Becton Dickinson). The MSCVGFPMOD-5
clones were then screened for MOD-5 CeSERT-mediated [3H]5-HT uptake activity,
and one clone was chosen for use in all further uptake experiments. Cells were
plated at 106 cells/well of a 6-well dish and allowed to grow overnight before being
assayed. Cells were incubated in prewarmed wash buffer (120 mM NaCl, 10 mM
HEPES pH 7.4, 4.7 mM KCl, 2.2 mM CaCl 2, 1.2 mM KH 2PO 4, 1.2 mM MgSO4, 1.8
mg/ml glucose, 100 jM pargyline, 100 pM ascorbic acid) for 10 min at 370C and the
buffer was then replaced with prewarmed wash buffer plus substrate. In Figure 4B,
the NaCl was substituted with an equivalent amount of sodium gluconate or choline
chloride. Except for the trials shown in Figures 4C and 4D, 50 nM [3H]5-HT was used
as substrate (there was no dilution with non-radioactive substrate in these
experiments). Since micromolar amounts of substrate were used in the trials shown
in Figures 4C and 4D, radiolabelled substrates were diluted with non-radioactive
substrate to maintain a specific activity of 0.1 Ci/mmol. Uptake was allowed to
proceed at 370C for varying times for the time course and for 10 min in all other
experiments. Cells were then washed three times with ice-cold wash buffer,
solubilized in 1% SDS and the radioactivity retained in the cells was determined by
liquid scintillation. Cell numbers, quantified in parallel wells taken through all steps of
the assay, were used to convert counts per minute (cpm) to nmoles per cell per min.
The specific uptake of each substrate for each condition was obtained by subtracting
the average value obtained from at least three trials with the MSCVGFP cell line
from the average value obtained from at least six trials with the MSCVGFPMOD-5
cell line. Inhibitor K values were determined from concentration vs. uptake profiles
after adjustment for substrate concentrations (Cheng and Prusoff, 1973). Statistical
significance was evaluated using the Student's t-test (Statview).
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Tables
Table 1. Fluoxetine phenocopies mod-5 in 5-HT uptake assays in vivo
% 5-HT-positive NSMs
Pretreatment 1
Fluoxetine (mM)
0.22 0.29 0.44
Genotype Pretreatment 2
No
5-HT 5-HT + Fluoxetine
Drug
tph-1 0 98 20 7 0
mod-5; tph- 1 0 0 N/A N/A N/A
In pretreatment 1, animals were incubated for 1 hr on plates containing
no drug or the specified concentration of fluoxetine. In pretreatment 2,
animals from plates with no drug in pretreatment 1 were transferred to
plates containing no drug or 2 mM 5-HT, and animals from plates with
fluoxetine were transferred to plates containing 2 mM 5-HT and the
same specified concentration of fluoxetine as in pretreatment 1. After 2
hours, animals were fixed and stained with anti-5-HT antisera (see
Experimental Procedures for controls included to ensure that lack of
5-HT staining did not result from a failure of the antibody staining
reaction). N/A, not applicable. At least 100 animals were assayed in
each condition for each genotype; > 200 mod-5; tph-1 animals
pretreated with 5-HT in pretreatment 2 were scored. tph-1(mg280) and
mod-5(n3314) were the alleles used.
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Figures
Figure 1. The NSMs of mod-5 Mutants Are Defective in 5-HT Uptake
(A) Wild-type and mod-5(n822) animals preincubated with exogenous 5-HT were
stained using FIF to visualize 5-HT (Sulston et al., 1975). Arrow, NSM cell body.
Arrowheads, NSM axonal processes. No NSM cell bodies were FIF-positive in
mod-5(n822) mutants. The fluorescence seen in the axonal processes may be the
consequence of partial 5-HT reuptake activity (see Figure 1 B).
(B) NSMs in mod-5(n822) and mod-5(n823) mutants show reduced uptake of
exogenous 5-HT. The mutation cat-4(e1141) was included to reduce the levels of
endogenous 5-HT, which would otherwise obscure the detection of 5-HT uptake. At
least 100 animals were tested for each genotype in each condition. See
Experimental Procedures for details. Error bars, SEM.
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Figure 2. Phenotypic Characterization and Cloning of mod-5
(A) mod-5 mutants exhibited a hyperenhanced slowing response. Well-fed (black
bars) and food-deprived (gray bars) animals were transferred to assay plates with or
without a bacterial lawn, and the locomotory rate of each animal was recorded after
5 min; food-deprived animals were transferred to plates without bacteria 30 min prior
to the transfer to locomotory assay plates (see Sawin et al., 2000 for details). At
least 10 trials were performed for each genotype for each condition. For this and all
subsequent panels, each trial involved testing at least five animals for each of the
conditions; a given animal was tested in only one condition. p values were calculated
by comparing the combined data for the mutants from all of the separate trials under
one set of conditions to the combined data for the wild-type animals assayed in
parallel under the same conditions.
(B) mod-5 mutants were hypersensitive to exogenous 5-HT. 5-HT dose-response
curves for wild-type and mod-5 mutant animals were generated from averages of
five trials with 20 animals of each genotype at each concentration in which animals
were scored for movement after 5 min.
(C) The hyperenhanced slowing response exhibited by mod-5(n823) mutants was
suppressed by ablation of the NSMs. No. animals tested: three of each ablation
state when well-fed, seven mock-ablated food-deprived, 12 NSM-ablated food-
deprived.
(D) Decrease in endogenous 5-HT partially suppressed the mod-5 phenotype.
mod-5(n823); cat-4 double mutants displayed an enhanced slowing response
intermediate to that of mod-5(n823) (see Figure 2A) and cat-4 mutants.
(A) - (D) Error bars, SEM. Asterisks, p<0.0001, Student's t-test.
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Figure 3. mod-5 Encodes a Protein Similar to the Human and Drosophila 5-HT
Reuptake Transporters
(A) Top, Genetic map of the mod-5 region of linkage group I (LG I). Bottom, intron-
exon structure of mod-5 (Y54E10A_154.A), inferred from cDNA sequences. Open
boxes, coding regions; lines, untranslated regions, arrow, direction of transcription;
SL1, SL1 trans-spliced leader. The length of the intron between the 8 th and 9 th exons
is not known, since the sequence of this region has not been determined.
Nonetheless, the cDNA we isolated by RT-PCR and RACE (see Experimental
Procedures) and showed to be functional (see Results) suggests that no exons are
missing in the predicted gene structure. The mod-5 open reading frame is 2,016 bp
within a 2,594 bp cDNA. The extent of the 1,688 bp n3314 deletion is depicted.
(B) Amino-acid sequence alignment of MOD-5 CeSERT with human SERT (hSERT)
and Drosophila SERT (dSERT). The 12 predicted transmembrane regions are
underlined. Amino acids conserved between MOD-5 and at least one of the two
other proteins are shown in black boxes, and the two mod-5 point mutations are
indicated. mod-5(n822) is a T-to-A transversion mutation resulting in a C225opal
nonsense substitution, and mod-5(n823) is a C-to-T transition mutation resulting in a
P569S missense substitution. V, potential PKA or PKC phosphorylation sites. Such
sites have been implicated in SERT membrane distribution (Qian et al., 1997;
Ramamoorthy et al., 1998a) and the rate of 5-HT transport (Miller and Hoffman,
1994). *, potential N-linked glycosylation sites (consensus N-x-S/T) . Such sites
have been implicated in proper folding and insertion of SERTs into the membrane
and/or protection from degradation (Tate and Blakely, 1994; Ramamoorthy et al.,
1998b). *, the aspartate residue conserved in SERTs, NETs (norepinephrine
transporters), and DATs (dopamine transporters).
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Figure 4. Physiological Characterization of MOD-5 CeSERT
Experiments were performed using HEK293 cell lines stably transfected with either a
mod-5::gfp (MSCVGFPMOD-5) or a gfp control (MSCVGFP) construct (see
Experimental Procedures for details). Results indicate mean L SEM from at least six
replicate trials with a MOD-5 CeSERT-expressing cell line after subtracting the non-
specific 5-HT uptake from at least three replicate trials with a cell line expressing
GFP from the parent vector lacking mod-5. Except in (A), all assays were performed
for 10 min. In (A) and (B), 50 nM [3H]5-HT was used. In (C) and (D) the radiolabelled
neurotransmitters were present at 0.1 Ci/mmol specific activity. Error bars, SEM.
(A) Time dependence of MOD-5 CeSERT-mediated [3H]5-HT transport.
(B) Dependence of MOD-5 CeSERT-mediated [3H]5-HT transport on Na* and Cl-
ions in the external buffer. Results are shown as a percentage of the normalized
5-HT uptake in standard NaCl-containing buffer. Transport is strictly dependent on
Na+ but only partially dependent on Cl-.
(C) MOD-5 CeSERT-mediated [3H]5-HT transport as a function of 5-HT
concentration. [3H]5-HT uptake was measured at various 5-HT concentrations. Inset,
Eadie-Hoftsee transformation (Stryer, 1995) of the data. Km = 150 ± 8 nM; Vmax =
8.31 x 10-9 nmoles per cell per min. This Vmax value cannot be compared in a
meaningful way with values from other studies in the absence of information about
relative SERT levels on the cell membrane.
(D) MOD-5 CeSERT-mediated transport was specific for [3H]5-HT. Assays were
performed with 1 ptM [3H]5-HT and 50 pM of each of the other radiolabelled
neurotransmitters, and the results are presented as a percentage of normalized 1
pM [3H]5-HT uptake. There was no detectable transport when neurotransmitters
other than 5-HT were added at 1 gM (data not shown).
(E) Antagonism of MOD-5 CeSERT-mediated 5-HT uptake. Inhibition curves for
SSRIs and other transporter inhibitors. Assays were performed for 10 min with 50
nM [3H]5-HT in the presence of varying concentrations of each of the compounds.
The extent of [3H]5-HT uptake is plotted as the percentage of [3H]5-HT uptake
observed in the absence of antagonists vs. log [inhibitor]. See text for K values
calculated from these data. Error bars, SEM.
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Figure 5. mod-5 Genetic Interactions and 5-HT- and MOD-5 CeSERT-Dependence
of the Potentiating Effect of Fluoxetine
(A) Gray bars, the enhanced slowing response of mod-1, goa-1, mod-5 goa-1,
goa-1; mod-1, mod-5; mod-1, and mod-5 goa-1; mod-1 mutants. At least five trials
were performed for each genotype. Hatched bars, the effect of fluoxetine on the
enhanced slowing response of wild-type animals (data reproduced from Sawin et al.,
2000) and mod-1 and mod-5; mod-1 mutants (at least 10 trials for each genotype).
(B) Rescue by 5-HT preincubation (see Experimental Procedures) of the resistance
of bas- 1; cat-4 mutants to the potentiating effect of fluoxetine on the enhanced
slowing response. At least 5 trials were performed with each genotype.
(C) mod-5(n3314) mutants retained normal sensitivity to fluoxetine-mediated
paralysis. Five trials with 20 animals of each genotype at each concentration and the
animals were scored for paralysis after 10 minutes.
(A) - (C) Error bars, SEM. Asterisks, p<0.0001, Student's t-test.
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Figure 6. 5-HT- and MOD-5 CeSERT-independence of Fluoxetine-induced Egg
Laying
Fluoxetine-induced egg laying (n=50 for each genotype).
(A) Wild-type animals.
(B) mod-5(n3314) mutants.
(C) tph-1 mutants.
(D) cat-4 mutants.
(E) egl-1 mutants.
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Figure 7. mod-5(n3314) mutants, but Not tph-1 Mutants, Are Hypersensitive to
Stimulation of Egg Laying by 5-HT
5-HT-induced stimulation of egg laying (n=50 for each genotype).
(A) Wild-type animals.
(B) mod-5(n3314) mutants.
(C) tph-1 mutants.
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Figure 8. Models for the Effects of Fluoxetine on C. elegans Behaviors
(A) MOD-5 CeSERT acts upstream of the MOD-1 5-HT-gated chloride channel and
the GOA-1 G-protein.
(B) The potentiating effect of low concentrations of fluoxetine on the enhanced
slowing response is 5-HT- and MOD-5 CeSERT-dependent. The stimulus of food in
a food-deprived animal results in the release of 5-HT that acts through the MOD-1
5-HT-gated chloride channel and through GOA-1-dependent 5-HT-signaling pathway
that likely acts in parallel to the MOD-1 pathway and results in the slowing of
locomotory rate. Mutations in mod-5 or the application of fluoxetine leads to
inefficient clearing of 5-HT and thus a hyperenhanced slowing response. 5-HTR, a
metabotropic 5-HT receptor that GOA-1 might couple to. O', 5-HT. 0, chloride ions.
(C) The effects of high concentrations of fluoxetine on egg laying, nose contraction
and paralysis are MOD-5 CeSERT-independent. High concentrations of fluoxetine
act on non-SERT targets and on a non-5-HT pathway to paralyze C. elegans and to
lead to the contraction of nose muscles. By contrast, stimulation of egg laying by
fluoxetine is MOD-5 CeSERT-independent but still partially dependent on 5-HT (see
Discussion for details).
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Appendix 1
Supplementary Data for Chapters 2, 3, and 4
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In this chapter, I present additional data that were not included in the published or
submitted versions of Chapters 2-4. These data substantiate the conclusions of
Chapters 2-4 and are cited as data not shown therein.
Results Pertaining to Chapter 2
Serotonin-Pretreated Food-Deprived bas-1; cat-4 Mutants Exhibit Normal
Locomotion in the Absence of Bacteria
Serotonin preincubation restores the enhanced slowing response of bas-1; cat-4
mutants, while dopamine preincubation does not (Chapter 2, Figure 2B, gray bars).
Serotonin pretreatment does not affect the locomotory rate of these mutants when
they were well-fed and on plates with no bacteria, suggesting that serotonin
preincubation does not lead to non-specific slowing of locomotory rate (Chapter 2,
Figure 2B, black bars). However, it remained possible that, when food-deprived, the
serotonin-pretreated bas-1; cat-4 mutants slow their locomotory rate even in the
absence of bacteria. Therefore, we assayed the locomotory rate of serotonin-
pretreated food-deprived bas-1; cat-4 mutants on plates without bacteria and found
that their locomotory rates were unaffected by the serotonin pretreatment (Figure 1).
Therefore, the slowing of locomotory rate of serotonin-pretreated food-deprived
bas-1; cat-4 mutants in response to bacteria (Figure 1 and Chapter 2, Figure 2B,
gray bars) is not a non-specific slowing of locomotory rate caused by the serotonin
preincubation but rather a specific restoration of the behavioral response.
The Enhanced Slowing Response of cat-2 mutants Is Potentiated by
Fluoxetine
The potentiation of the enhanced slowing response by fluoxetine is dependent on
endogenous serotonin (Chapter 2, Figure 5B and Chapter 4, Figure 5B). We sought
to confirm that loss of endogenous dopamine does not affect the ability of fluoxetine
to potentiate the enhanced slowing response using cat-2 mutants, which lack
dopamine but have normal levels of endogenous serotonin (see Chapter 2). The
enhanced slowing response of cat-2 mutants is still capable of being potentiated by
fluoxetine (Figure 2), confirming that fluoxetine does not require endogenous
dopamine for its potentiating effect.
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Food Deprivation Does Not Lead to a Change in the Kinetics of Serotonin
Sensitivity
The responsiveness of well-fed and food-deprived animals to exogenous serotonin
is identical over a range of serotonin concentrations (Chapter 2, Figure 5D). We
sought to determine if there was any difference in the onset of the response to
exogenous serotonin by well-fed and food-deprived animals. We assayed the
locomotory rate of animals at regular intervals during an exposure to 15 mM
serotonin and found that there was no difference between well-fed and food-
deprived animals in the kinetics of their responses to exogenous serotonin (Figure
3).
The Enhanced Slowing Response Does Not Depend on the Presence of
Fructose During Food-deprivation
In the locomotory rate assay devised to measure the enhanced slowing response
(Chapter 2), animals were incubated on a plate without bacteria for 30 minutes of
food deprivation. These food-deprivation plates contained a ring of high osmolarity
fructose on the outer edge so that the normal high osmolarity avoidance reflex of C.
elegans would prevent the animals from swimming off the agar surface and dying on
the plastic edge of the Petri plate. This food-deprivation protocol raised the formal
possibility that the enhanced slowing response was a result of exposure to high
osmolarity for 30 minutes or the combination of exposure for 30 minutes to both high
osmolarity and food-deprivation. To test this possibility, we transferred a large
number of wild-type animals to plates that had neither bacteria nor the high-
osmolarity ring. After 30 minutes, several animals had wandered off the agar surface
and died. The animals that remained alive on the agar surface were assayed and
found to be capable of exhibiting a normal enhanced slowing response (Figure 4;
compare with Chapter 2, Figure 1A). These observations confirm that the presence
of the high osmolarity fructose ring does not cause the enhanced slowing response.
This finding is further supported by the modified procedure that was used for the
genetic screen to isolate mutants that did exhibit the enhanced slowing response
(Chapter 2, Experimental Procedures), wherein the animals were deprived of food in
liquid for 30 minutes rather than on plates with high osmolarity fructose rings.
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Results Pertaining to Chapter 3
High Concentrations of Dopamine, Octopamine, and Tyramine Activate MOD-1
Xenopus oocytes expressing the MOD-1 ion channel responded specifically to
serotonin application (Chapter 3). The effect of various neurotransmitters on MOD-1
was tested to support this finding. In the course of such studies, we observed that
mod-1-injected eggs were capable of responding to high concentrations of
dopamine, octopamine, and tyramine (Figure 5). Octopamine and tyramine are
invertebrate-specific neurotransmitters. Such activation of receptors for one specific
biogenic amine by high concentrations of other biogenic amines has been observed
in other preparations (E. Kravitz, personal communication), and is likely to be a
result of the highly related structures of these amines. The ECOo for dopamine,
octopamine, and tyramine at MOD-1 receptors is at least 100-fold higher than that
for serotonin (Figure 5); this is a conservative estimate since a plateau of maximal
activation was not achieved with the concentrations tested for dopamine,
octopamine, and tyramine. It is therefore unlikely that dopamine, octopamine, or
tyramine function as ligands for the MOD-1 ion channel in vivo.
Ondansetron Does Not Block 5-HT-Gated MOD-1 Currents
Granisetron, an antagonist specific for the 5-HT3 a non-selective cation channel, had
no effect on MOD-1 (Chapter 3, Figure 4D). Similar results were obtained with
another such 5-HT3a-specific antagonist, ondansetron (Figure 6). These
observations suggested that it is unlikely to be a specific characteristic of granisetron
that makes it ineffective at blocking MOD-1, but that MOD-1 lacks a common feature
that is the target of these two drugs.
Mianserin and Methiothepin Block 5-HT-Gated MOD-1 Currents
Pretreatment of wild-type animals with mianserin and methiothepin, two serotonin
receptor antagonists, prevented the animals from exhibiting a normal enhanced
slowing response (Chapter 2, Figure 5A). These two drugs, even though they are
usually thought of as antagonists of metabotropic serotonin receptors, blocked 5-HT-
gated currents through MOD-1 (Chapter 3). The inhibition curves from which the
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approximate K values reported in Chapter 3 were derived are presented in Figure
7A.
That mianserin and methiothepin inhibited MOD-1 in Xenopus oocytes raised
the possibility that these drugs were acting on MOD-1 in vivo to block the enhanced
slowing response. If MOD-1 were the only in vivo target for these drugs to bring
about the effect on the enhanced slowing response, animals lacking MOD-1 should
be resistant to the effects of the drugs on the enhanced slowing response. There
was no additional defect in the enhanced slowing response of mod-1(ok103)
mutants when they were pretreated with methiothepin, but there was a small but
significant increase in the defect when pretreated with mianserin (Figure 7B). These
data suggested that methiothepin acts on an in vivo target(s) that is completely
dependent on the MOD-1 ion channel, while a minor fraction of mianserin's effects
are mediated via a target(s) that does not require MOD-1 for its function.
Nevertheless, given that both of these antagonists inhibited MOD-1 in Xenopus
oocytes (Figure 7A; and Chapter 3, Figure 4E), it is likely that mianserin and
methiothepin directly inhibit MOD-1 in vivo.
MOD-1 Channel Pore Is Similar to that of GABA- and Glycine-Gated Chloride
Channels
The rank order of anion permeability for the MOD-1 channel was described in
Chapter 3. This rank order was determined by measuring the reversal potential of
the 5-HT-gated current via the MOD-1 channel in Xenopus oocytes in the presence
of external bath solutions containing the various anions tested. Figure 8 presents
data from representative experiments that allowed us to measure the reversal
potential (E,,v) under these different salt conditions (Erv is the voltage at which the
current reverses direction from inward (traces below horizontal; see Nal trace) to
outward (traces above horizontal; see Nal trace). Figure 8 demonstrates that the
rank order of anion permeability is thiocyanate > bromide > iodide > chloride >
fluoride > aspartate > gluconate. This rank order of anion permeability is exactly the
same as that for the GABA- and glycine-gated chloride channels (Chapter 3). The
E,,v values cited in Chapter 3 were average values derived from at least five such
recordings for each anion.
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mod-1::gfp Transgene Generates Functional MOD-1 Protein
To determine the cells in which MOD-1 might function, a mod-1::gfp translational
reporter construct was constructed and introduced into mod-1(n3034) mutants, and
then a chromosomally integrated version of the transgene was generated (Chapter
3). These transgenic animals were no longer resistant to serotonin (Figure 9),
confirming that the protein product made by the array had sufficient MOD-1 function
to rescue the mutant phenotype. This rescue was more robust than that achieved by
the extrachromosomal arrays used for transformation rescue experiments while
cloning the gene (Chapter 3, Figure 1C), presumably because animals carrying a
chromosomally integrated transgene have more consistent transgene expression
and do not have transgene mosaicism.
Results Pertaining to Chapter 4
mod-5 Transgenes Render Animals Serotonin-Resistant
We cloned the gene mod-5 by rescuing the serotonin hypersensitivity of
mod-5(n823) mutants (Chapter 4). The extent to which each of these transgenic
lines, expressing the 8 kb fragment capable of encoding the first 507 amino acids of
MOD-5 (671 amino acids at full length), rescued the serotonin hypersensitivity of
mod-5(n823) mutants is depicted in Figure 10A. Three of the transgenic lines
possessed sufficient serotonin reuptake transporter activity that they did not just
restore the serotonin sensitivity to wild type but rendered the animals resistant to
serotonin (Figure 1 OB). This result could be a consequence of overexpression of the
transgene to levels beyond normal. Alternatively, it could be a consequence of
inappropriate regulation of the truncated transporter expressed by this transgene;
perhaps the C-terminal 164 amino acids contain key regulatory sites that modulate
transporter activity.
To test the cDNA we had isolated by RT-PCR and RACE, we generated a
mod-5 minigene (Chapter 4). This minigene is capable of rescuing the severe
serotonin hypersensitivity phenotype of mod-5(n3314) mutants (Figure 11). The
transgenic lines exhibited only partial rescue, probably caused by mosaic transgene
expression from the extrachromosomal array.
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mod-5 Complementation Tests
To confirm that the n3314 allele, which contained a large deletion in the mod-5
genomic locus is an allele of mod-5, we performed complementation tests with
mod-5(n822) and mod-5(n823). n822/n3314 and n823/n3314 transheterozygote
animals were hypersensitive to exogenous serotonin while n822/+, n823/+, and
n3314/+ heterozygous animals were not, confirming that n3314 did not complement
n822 or n823 (Figure 12). Moreover, the transheterozygote animals were more
hypersensitive to serotonin than were mod-5(n822) or mod-5(n823) homozygotes
(Figure 12), consistent with the conclusion (Chapter 4) that n3314 leads to a more
severe loss of mod-5 function than either n822 or n823.
MOD-5-Mediated [3H]5-HT-Uptake Is not Inhibited by Other Neurotransmitters
MOD-5 did not mediate the uptake of radiolabelled GABA, glutamate, glycine, NE,
histamine, or dopamine (Chapter 4, Figure 4D). We sought to determine if these
neurotransmitters could inhibit MOD-5-mediated [3H]5-HT uptake. We found that
none of the six neurotransmitters tested inhibited the 5-HT uptake (Figure 13),
suggesting that the MOD-5 serotonin reuptake transporter is unlikely to have binding
sites for any of these neurotransmitters that affect serotonin transport via MOD-5.
Potentiation of The Hyperenhanced Slowing Response of mod-5 Mutants
Cannot be Assayed
If fluoxetine brings about the potentiation of the enhanced slowing response
(Chapter 2, Figure 5B) by inhibiting MOD-5, then we reasoned that mutants lacking
MOD-5 should be resistant to such potentiation. We tested this possibility by
assaying mod-5 mutants after food-deprivation in the presence of fluoxetine. We
were not able to discern a difference in the response of mod-5 mutants in the
presence or absence of fluoxetine pretreatment because food-deprived mod-5
mutants were essentially immobile in response to bacteria (Figure 14). This
observation prompted us to utilize mod-5; mod-1 double mutants to test whether the
potentiation of the enhanced slowing response by fluoxetine requires MOD-5
(Chapter 4, Figure 5B).
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Figure 1. 5-HT-Pretreated Food-deprived bas-1; cat-4 Mutants Exhibit Normal
Locomotory Rate in the Absence of Bacteria
Following pre-incubation on bacteria-containing plates with no neurotransmitter
(Buffer) or with serotonin, bas-1; cat-4 mutants were transferred to food-
deprivation plates with buffer or serotonin for 30 minutes and then to assay
plates and locomotory rate was measured (two trials). In this and all subsequent
figures, unless otherwise stated, each trial involved testing at least five animals
in each of the conditions; a given animal was tested in only one of the conditions.
Error bars, SEM.
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Figure 2. Fluoxetine Potentiates the Enhanced Slowing Response of cat-2 Mutants
cat-2 mutants were not resistant to the potentiation of the enhanced slowing
response by fluoxetine. Ten wild-type animals and 10 cat-2 mutants were tested in
each condition in four trials. Error bars, SEM.
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Figure 3. Food-deprived Animals Are Not Hypersensitive to Serotonin
Time course of serotonin sensitivity. A single well-fed or food-
deprived animal was transferred to a plate (containing no bacteria)
with 15 mM serotonin, and locomotory rate was recorded after every
minute for five minutes (n=20 per condition). Error bars, SEM.
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Figure 4. The Enhanced Slowing Response Is Not Dependent on High
Osmolarity Ring on Food-Deprivation Plates
Animals were deprived of food for 30 minutes on plates that did not con-
tain a ring of high-osmolarity fructose. The animals were then transferred
to assay plates with or without a bacterial lawn, and five minutes later the
locomotory rate of each animal was recorded (n=5 for each condition).
Compare with Chapter 2, Figure 1A. Error bars, SEM.
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Figure 5. MOD-1 Channel is Responsive to High Concentrations of Dopamine, Octopamine,
and Tyramine
Each egg was first tested for its response to 50 nM serotonin, a concentration that does not
desensitize the egg's response to subsequent treatments (Chapter 3, and data not shown)
and then subjected to a single concentration of one of the other neurotransmitters. The
response of each egg to dopamine, octopamine, or tyramine was normalized to the response
of that egg to 50 nM serotonin. These normalized responses were then renormalized by
equating the 50 nM response in this experiment to the relative response to 50 nM serotonin
treatment on the serotonin dose-response curve (Chapter 3, Figure 4B). The serotonin dose-
response curve (Chapter 3, Figure 4B) is included in the figure to illustrate that the responses
of MOD-1 -injected eggs to these three biogenic amines are much weaker than the response
to serotonin. Error bars, SEM.
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Figure 6. The 5-HT3a-Specific Blocker Ondansetron Did Not Block MOD-1
Representative traces from oocytes injected with mod-1 cRNA (n=2) and
treated with 1 pLM serotonin in the presence or absence of 273 pM
granisetron.
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Figure 7. Mianserin and Methiothepin Block the MOD-1 Channel in Xenopus
Oocytes and in vivo
(A) Inhibition curves for mianserin and methiothepin. mod-1-injected oocytes (n=5)
first treated with 100 nM serotonin and then treated with 100 nM serotonin in the
presence or absence of varying concentrations of mianserin and methiothepin. The
maximal response in the presence of inhibitor is presented as a percentage of the
uninhibited response. K of -19 pM (mianserin) and -32 [M (methiothepin) were
calculated from the resultant curves. Error bars, SEM.
(B) Methiothepin pretreatment did not further disrupt the enhanced slowing response
of mod-1(ok103) mutants (3 trials). Mianserin pretreatment slightly exacerbated the
defect in the enhanced slowing response of mod-1(ok103) mutants (3 trials). Also
see Chapter 2, Figure 5A. Error bars, SEM.
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Figure 8. Anion Selectivity of the MOD-1 channel
mod-1-injected eggs were treated with 1 lM serotonin while the holding potential of
the egg was ramped in 10 mV steps (each step took 5 msec) from -70 mV to + 50
mV and then back down to -70 mV (graphs at the bottom of the figure). This protocol
was performed for each egg first in the presence of normal ND-96 external solution
and then in the presence of solutions where the chloride ions normally present in
ND-96 were substituted with an equivalent amount of one of the six other anions
tested. The concentration of the various cations were identical in all these solutions.
Representative traces from eggs in each of the salt conditions are shown. The NaCl
condition is depicted in each column for comparison to the other solutions in that
column. The vertical lines provide an approximate measure of the voltage in each
situation at which the current reverses direction (E,,,). The scale of the y axis
(current, in ptA) for each egg at each condition is different and hence has been
omitted for the sake of clarity. The magnitude of the current is not relevant to the
dependence of Er,, on the concentration of the anion present in the solution. A
horizontal line depicting zero current flow has been included in one of the Nal traces
to distinguish what is meant by inward vs. outward current.
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Figure 9. mod-1::gfp Transgene Rescues the Serotonin Resistance of mod-1(n3034) Mutants
mod-1(n3034); lin-15(n765ts) mutants were injected with 5 jig ml-1 of pRR16 (translational
fusion of GFP within the mod-1 coding sequence; Chapter 3, Figure 2A) and 80 pg ml-1 of
pL15EK (which contains the wild-type lin-15 gene). Stable transgenic lines, which produced a
percentage of non-Lin progeny, were subjected to gamma-irradiation and two isolates were
selected that produced only non-Lin progeny. One such isolate, n/s126, harbored the trans-
gene on chromosome il and this strain was no longer serotonin resistant, unlike mod-1(n3034)
mutants. We confirmed that n/s 126 strain still contained the n3034 mutation by independent
segregation of the GFP and the serotonin resistance in the F2 descended from n/s126; mod-
1(n3034) isolate mated with wild-type animals. The rescue was not complete, presumably
because the dominant effect of the n3034 mutation was not completely quenched by the wild-
type MOD-1 produced by the transgene. Error bars, SEM.
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Figure 10. Rescue of the Serotonin Hypersensitivity of mod-5(n823) Mutants
(A) 10 tg mlV of an eight kilobase PCR product capable of encoding the first 507
amino acids of MOD-5 was injected with 80 tg mV- pL15EK (which contains the wild-
type lin- 15 gene) into a mod-5(n823); in- 15(n765ts) strain and serotonin sensitivity
was scored in 20 transgenic lines that produced non-Lin progeny at 22.50C. Varying
degrees of rescue was observed in 16/20 lines. Twenty animals were tested for each
line. Zero; no animals were immobilized.
(B) Transgenic lines #1, #3, and #10 from (A) were resistant to serotonin. Twenty
animals were tested for each line. Exposure to 33 mM serotonin immobilizes mod-5
mutants faster than the wild type (data not shown).
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Figure 11. A mod-5 minigene rescues the serotonin hypersensitivity of mod-5(n3314) mutants
A mod-5 minigene construct (see Chapter 4 for details) was injected at 36 pg ml-1 with 80 pg
mi-1 pL15EK (which contains the wild-type lin-15 gene) into a mod-5(n3314); lin-15(n765ts)
strain and serotonin sensitivity was scored in transgenic lines that produced non-Lin progeny
at 22.50C. Data from one such transgenic line is presented. Error bars, SEM.
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Figure 12. mod-5 Complementation Tests
Animals of the following genotypes were tested for serotonin sensitivity by incubating 20
animals per trial (3 trials per genotype) in 5 mM serotonin for 5 min: mod-5(n822), mod-
5(n823), mod-5(n3314), mod-5(n822)/mod-5(n3314), mod-5(n823)/mod-5(n3314), mod-
5(n822)/+, mod-5(n823)/+, and mod-5(n3314)/+. The transheterozygotes exhibited a phe-
notype intermediate between the phenotypes of the n822 and n823 point mutants and the
n3314 deletion mutant. All heretozygotes were generated by mating males of one genotype
to hermaphrodites of the other genotype that were marked with the lon-2 mutation and
selecting non-Lon cross progeny. The Ion mutation does not affect serotonin sensitivity
(data not shown). Zero; no animals were immobilized. Error bars, SEM.
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Figure 13. Antagonism of MOD-5 CeSERT-Mediated 5-HT Uptake
The extent to which various neurotransmitters inhibited the ability
of MOD-5 CeSERT to transport [3H]5-HT. Assays were performed
for 10 min with 50 nM [3H]5-HT in the presence of 100 pM of each
of the other neurotransmitters. Error bars, SEM.
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Figure 14. The Effect of Fluoxetine on the Enhanced Slowing Response of mod-5(n3314)
Mutants Cannot be Measured
mod-5(n3314) mutants were deprived of food for 30 minutes in the presence of fluoxetine
and their locomotory rate assayed on plates with and without bacteria (3 trials). The
severe hyperenhanced slowing response of mod-5(n3314) mutants rendered it impossible
to detect any effect of fluoxetine treatment (also see Chapter 4). Error bars, SEM.
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Appendix 2
Preliminary Results and Future Directions
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In this chapter, I present the results of a preliminary pharmacological analysis of
a panel of mod mutants, the characterization and genetic mapping of
mod-6(n3076), and a screen for suppressors of mod-5(n3314). mod-6(n3076) is
of particular interest because it exhibits an interesting combination of
characteristics with respect to the enhanced slowing response and sensitivity to
exogenous serotonin. In addition, I suggest in this chapter directions that I
consider worthy of pursuit for the future.
Preliminary Results
Pharmacological Profile of mod Mutants
The first genetic screen for mutants with defects in the enhanced slowing
response yielded 17 mod mutants (Chapter 2, Figure 6). However, it has proven
prohibitively difficult to map and clone the mod genes on the basis of this defect
in the enhanced slowing response. Specifically, visible mutations that are used
for standard mapping purposes, for example unc and dpy mutations, affect
aspects of general locomotion enough to render useless the locomotory assay
for the enhanced slowing response. Even when recombinant chromosomes were
made homozygous and the presence of a mod mutation was tested by
complementation (Chapters 3 and 4), the laborious nature of the locomotory
assay for the enhanced slowing response slowed analysis enormously. In fact,
the focus of this dissertation, the cloning and characterization of the mod-1 and
mod-5 genes, would not have been possible without the development of the
liquid swimming assay (Chapters 3 and 4), which allowed us to rapidly score a
pleiotropy in the mod-1 and mod-5 mutants.
One alternative to mapping with respect to visible mutations is to map with
respect to single nucleotide polymorphisms or restriction length polymorphisms
that are present in different naturally occurring isolates of wild type C. elegans.
However, such strains are not always as healthy as the standard wild type strain
used in the laboratory. Therefore, before such a strain can be used for mapping
behavioral mutants, it must either exhibit normal responses in the behavioral
assay of interest or the strain must be outcrossed enough to render it healthy
while still continuing to carry the polymorphisms relevant for the mapping.
Given that assaying serotonin sensitivity proved useful for mapping and
cloning mod-1 and mod-5, we tested a subset of 11 mod mutants that had not
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been placed in a defined complementation group (Chapter 2, Figure 6) for their
responses to serotonin, octopamine, and phentolamine, a putative octopamine-
receptor antagonist (Howell and Evans, 1998). The results of these studies are
summarized in Table 1. The strong serotonin-resistance of n3053 (which
appeared to be a recessive phenotype; data not shown) and the strong
phentolamine-resistance of n3057 and n3074 should make further mapping of
these three mutants straightforward. As with any pleiotropy, it will be essential to
verify that the pleiotropy cosegregates with the primary defect of interest, an
impaired enhanced slowing response.
Such pharmacological analysis of all the existing mod mutants should be
conducted in a broader manner, including chemicals that affect serotonergic,
cholinergic, dopaminergic, histaminergic, and peptidergic neurotransmission. For
example, n3032 mutants exhibit partial resistance (data not shown) to the
paralysis induced by high concentrations of fluoxetine (Chapter 4, Figure 5C), a
pleiotropy that was not robust enough to serve as a tool for mapping purposes
(data not shown). Nevertheless, other chemicals with activities similar to
fluoxetine, such as paroxetine or sertraline (Chapter 4), could be tested to
determine if n3032 mutants exhibit a response that is robustly different from that
of the wild type. While performing such preliminary analysis, several key
parameters must be controlled and/or varied. Hence, to serve as a guide for such
future analysis, we have described in detail in the Experimental Procedures how
the analysis presented in Table 1 was performed.
mod-6(n3076) Is a Special mod Mutant
Using the pharmacological approach described in the section above, we
determined that mod-6(n3076) mutants, which were defective in the enhanced
slowing response (Chapter 2, Figure 6), were hypersensitive to exogenous
serotonin (Figure 1). These findings contradicted the model we proposed in
Chapter 2 (Figure 7): we expect mod mutants that have an impaired enhanced
slowing response to either be defective in responding to serotonin or be defective
in a non-serotonergic component that acts in parallel to the serotonin pathway
(Chapter 4, Figure 8). Furthermore, we expect mod mutants that exhibit
hypersensitivity to serotonin to exhibit a hyperenhanced slowing response, as do
mod-5 mutants. For this reason, we found mod-6(n3076) interesting and chose to
study it further.
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The serotonin hypersensitivity was used to map mod-6 to a 1.8 map unit
interval on chromosome I (see Experimental Procedures for details).
mod-6(n3076) has been subsequently mapped further by graduate student
Daniel Omura in our laboratory and shown to be an allele of the gene che-3 (data
not shown), which encodes a dynein heavy chain (Wicks et al., 2000). che-3
mutants are defective in the development of the chemosensory cilia (Wicks et al.,
2000) that may be used to sense bacteria. An impairment in the ability to
chemotactically perceive bacteria could explain the defect in the enhanced
slowing response in mod-6 mutants. In the next section, a hypothesis is
presented for why mod-6 mutants are hypersensitive to serotonin.
Octopamine and the mod Mutants
Octopamine has been proposed to act in opposition to serotonin in several
C. elegans behaviors (Horvitz et al., 1982). Given that serotonin signaling is
required for the enhanced slowing response, it is plausible that octopamine
signaling modulates the enhanced slowing response and that mod mutants are
defective in aspects of octopaminergic signaling. There are several preliminary
observations that indirectly suggest a role for octopamine signaling in the
enhanced slowing response.
A) C. elegans mutants containing deletions in the gene tbh-1, which encodes a
tyramine beta hydroxylase enzyme that converts tyramine to octopamine, do not
have detectable levels of octopamine (M. Alkema and H. R. Horvitz, personal
communication). tbh-1 mutants were hypersensitive to serotonin (M. Alkema, R.
R., and H. R. H., unpublished data) suggesting that a lack of octopamine leads to
a loss of an inhibitory influence on the ability to respond to serotonin. Given the
phenotype of mod-5 mutants, we expected tbh- 1 mutants to also have a
hyperenhanced slowing response. However, tbh-1 mutants move more slowly
not only when food-deprived and on plates with bacteria, but under all conditions
(M. Alkema, R. R., and H. R. H., unpublished data), making it difficult to interpret
the abnormally slow locomotory rate of food-deprived tbh-1 mutants on plates
with bacteria as a hyperenhanced slowing response.
B) che-3 mutants have reduced levels of octopamine (Horvitz et al., 1982). That
mod-6(n3076) mutants were hypersensitive to exogenous serotonin might be
explained by the deficiency in octopamine expected in mod-6(n3076) mutants
(octopamine levels in this mutant have not been directly analyzed). The
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confluence of an impaired enhanced slowing response and hypersensitivity to
exogenous serotonin in the mod-6 mutants might be serendipitous and
unrelated. Nevertheless, it is intriguing to consider why che-3 mutants lack
octopamine. Might the inability to chemotax to bacterial stimuli affect the
development of the nervous system in such a manner that octopamine
biosynthesis is downregulated? Mutants such as mod-6(n3076) would have to be
analyzed further to address this issue.
C) The preliminary pharmacological survey (Table 1) indicated that n3057 and
n3074 were resistant to phentolamine, an octopamine-receptor antagonist
(Howell and Evans, 1998). This suggests that at least indirectly mod mutants
may be defective in aspects of octopaminergic signaling.
The class of mutants defined by mod-6 (whose response to phentolamine
has not been analyzed), n3057, and n3074 may define a class of mutants that
are incapable of chemotaxis to bacteria, and this inability leads to two effects: a
defect in the enhanced slowing response and an unrelated yet intriguing defect in
octopaminergic signaling.
D) Mianserin has been shown to act as an octopamine antagonist in other
systems (Roeder, 1990). Perhaps some of its effects on the enhanced slowing
response (Chapter 2, Figure 5A) act via the disruption of octopaminergic
signaling.
Hypothesis
Might our analysis of the mod mutants have provided a serendipitous clue to the
role of octopamine in the nervous system of C. elegans? Perhaps, it is
octopamine that serves as a "mood regulator" in C. elegans. Specifically, certain
internal states may be linked to levels of octopamine in the animal; animals that
are food-deprived or are incapable of sensing food may have reduced levels of
octopamine. This change in octopamine levels may in turn set the behavioral
state or "mood" of the animal, such that there is a coordinated animal-wide
behavioral response to the presentation of various stimuli.
This hypothesis could be tested in several ways. Levels of octopamine
could be measured radio-enzymatically (Horvitz et al., 1982) in well-fed and food-
deprived animals. Other mutants that have defects in sensory structures that
might be used to sense food could be tested for levels of octopamine. tbh-1
mutants could be analyzed for the expression levels of various neurotransmitters,
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tested for behavioral responses related to food, such as egg laying (Horvitz et al.,
1982), pharyngeal pumping (Horvitz et al., 1982), dauer formation (Golden and
Riddle, 1984), and enhancement of olfactory adaptation (Colbert and Bargmann,
1997). Octopamine-treated wild-type animals could be assayed for global
changes in behavioral responsivity in the above-mentioned assays. The effect of
tbh-1 overexpression from extrachromosomal arrays in the various behavioral
assays could also be explored. Octopamine receptor antagonists, such as
phentolamine, promethazine, and epinastine (Roeder, 1990; Roeder et al.,
1998), and receptor agonists such as NC-5Z (Nathanson and Kaugars, 1989)
could be used to perturb octopaminergic signaling. Given that octopamine and
serotonin have proposed antagonistic roles in C. elegans (Horvitz et al., 1982),
mutants with defects in serotonin signaling could be tested for octopamine levels;
especially tph-1 mutants, which completely lack serotonin (Sze et al., 2000), and
mod-5 mutants, which have defective serotonin reuptake (Chapter 4).
A Genetic Screen for Suppressors of mod-5(n3314)
A key deterrent to the rapid analysis of mod mutants is the difficult nature of the
locomotory assay for the enhanced slowing response. If a collection of mutants
could be isolated on the basis of defects in serotonin signaling, which we know is
required for the enhanced slowing response, then the analysis would be greatly
facilitated. Therefore, we decided to screen for suppressors of the mod-5(n3314)
mutation. There are two attributes of mod-5(n3314) mutants that lend themselves
to easy screening - the severe hyperenhanced slowing response and the
extreme hypersensitivity to exogenous serotonin. It is worth enumerating the
merits and demerits of using one or the other of these characteristics as the
basis for a genetic screen.
A screen that seeks suppressors of the hyperenhanced slowing response
of mod-5(n3314) mutants remains firmly rooted in the behavioral response of
interest - the enhanced slowing response. Therefore, the suppressors isolated
are likely to be mod mutants in that they will affect the signaling pathway for the
enhanced slowing response that involves mod-5. However, such suppressors
might suffer from the same problem that has hampered the analysis of the
original collection of mod mutants, i. e., their suppression of the hyperenhanced
slowing response will be a difficult assay for mapping and cloning purposes.
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Further analysis of such suppressors may require the identification of pleiotropies
such as differential response to serotonin or some other chemical.
A screen that is designed to isolate suppressors of the hypersensitivity to
exogenous serotonin exhibited by mod-5(n3314) mutants is extremely powerful
in its efficiency and throughput. A large number of animals can be screened very
rapidly and the screen can be performed to saturation. However, there is no a
priori reason that the suppressors will be involved in the enhanced slowing
response. They may non-specifically impair the ability of the animal to respond to
serotonin, for example by making the cuticle of the animal more impermeable to
serotonin, and not affect the response of food-deprived animals to bacteria.
However, any suppressor mutation that robustly suppresses the hypersensitivity
to exogenous serotonin exhibited by mod-5(n3314) mutants will be tractable, by
the same strategy used to map and clone mod-1 and mod-5. For this reason, we
decided to perform the screen assaying the suppression of the hypersensitivity to
serotonin of mod-5(n3314) mutants.
We performed an F2 non-clonal screen using ethyl methanesulphonate as
the mutagen (Brenner, 1974). The general strategy is diagrammed in Figure 2.
We screened 18,350 haploid genomes and isolated 98 suppressed isolates, of
which 61 must be independent isolates (see Figure 2 legend for details of screen
design). The serotonin sensitivity of these isolates varied enormously (Table 2;
only the data for the independent isolates are presented). The 61 independent
isolates were tested for suppression of the hyperenhanced slowing response
conferred by mod-5(n3314) and in 18 isolates food-deprived animals had faster
locomotory rates on plates with bacteria than did mod-5(n3314) mutants (Figure
3A). In this preliminary analysis we did not test whether these suppressed strains
exhibited a faster baseline rate of locomotion. This remains an important test to
perform as mutants with faster baseline rates of locomotion need not be true
suppressors of the hyperenhanced slowing response of mod-5(n3314).
Interestingly, the strength of suppression of the hyperenhanced slowing response
did not correlate with the strength of suppression of the hypersensitivity to
exogenous serotonin (Figure 3B). This observation suggested that aspects of the
serotonin signaling pathway that are affected by exogenous serotonin application
differ from those utilized to bring about the enhanced slowing response.
Two of these suppressors, n3461 and n3488, were mapped to
chromosome 2 on the basis of weak two-factor linkage to rol-6. No existing mod
mutations map to this chromosome. Both of these mutations exhibit dominant
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characteristics at low serotonin concentrations while at high serotonin
concentrations, they appear recessive (Figure 4). The reason for such dose-
dependent differences requires further investigation.
The Neural Circuit for the Enhanced Slowing Response
One of the implicit goals of this dissertation was to understand how the enhanced
slowing response is brought about at the level of a neural circuit within the
animal. Sawin (1996) began such an analysis by attempting to define the subset
of serotonergic neurons in the animal that are required for the enhanced slowing
response. Extensive laser-ablation studies revealed a partial requirement for only
the NSMs (Sawin, 1996; and Chapter 2). Our cloning of the mod-1 and mod-5
genes prompted us to identify the neurons in which these proteins were made as
a first step towards defining the neural circuit that might be required for the
behavior.
MOD-1
We generated two rabbit polyclonal antisera and three rat polyclonal antisera
each against GST-fusion proteins of the predicted large N-terminal extracellular
domain of MOD-1 (amino acids 18-232). We also generated two rabbit polyclonal
antisera and two rat polyclonal antisera against GST-fusion proteins of the
predicted intracellular domain (amino acids 329-456) between transmembrane
regions M3 and M4 of MOD-1 (Chapter 3, Figure 2B). While the crude antisera
were capable of recognizing the corresponding bacterial-expressed MOD-1
polypeptides (data not shown), none of them revealed specific immunoreactivity
in either Western blots of total protein extracts from wild-type animals or whole
mount preparations of fixed wild-type animals. Affinity purification of these
antisera against 6xHistidine tagged versions of the two MOD-1 antigens did not
result in any improvement in detection of specific immunoreactivity. It is possible
that the regions chosen for generating antibodies were of poor antigenicity.
We generated two different reporters of the mod-1 gene by fusion with gfp
(Chalfie et al., 1994): a transcriptional fusion in which -1 kb of non-coding
sequence upstream of the mod-1 translational start site served as the promoter
for the gfp gene and an in-frame translational insertion of the gfp into the mod-1
genomic locus (Chapter 3, Figure 2A) which contains the 5' and 3' untranslated
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regions required for rescue (Chapter 3, Figure 1C). We generated an integrated
version of this mod-1::gfp::mod-1 translational reporter, n/s126, and found that it
was capable of rescuing the serotonin resistance phenotype of mod-1 mutants
(Chapter 5, Figure 9). This reporter was used to identify neurons that might
express MOD-1. Twelve neurons within the head and retrovesicular ganglion, 17
neurons in the ventral cord, and 6 neurons in the tail of the animal exhibited
reporter expression. From the position of the neuronal cell bodies with respect to
their neighbors and the morphologies of the axons, we were able to make
preliminary identification of several neurons (Table 3). Three of the neurons in
the head were determined with good certainty to be AVE, AIB, and RIB by cell
body position. The AY and AIZ neurons were also identified as likely to be
expressing the reporter. However, the position of AIZ is not always invariant from
animal to animal, and we could not rule out that the neuron we identified as AIY
was not AIM. In the young Li larvae, we observed reporter expression in the
DB3, 4, 5, 6, and 7 neurons in the ventral cord. In the adult, in addition to the DB
neurons, several more ventral cord neurons displayed reporter expression. We
think that these additional neurons are likely to be the VBs. We tentatively
identified two other neurons in the head as RID and RIP or RMEL. Reporter
expression in the RIP/RMEL neuron was observed only in the adult. All of these
identifications must be verified using other reporters expressed in these cells,
using antibodies that recognize epitopes expressed in the candidate neurons,
and by a more careful analysis of cell position possibly combined with laser
microsurgery, before a clear picture of the neural circuit can be derived.
The transcriptional GFP reporter was expressed in far fewer neurons than
the translational mod-1::gfp::mod-1 reporter and also showed expressed in cells
not seen in the translational GFP reporter. Therefore, the expression pattern of
the transcriptional reporter was not examined in more detail as it was likely that
this reporter lacked key regulatory sequences required for expression in the
appropriate cells.
When the n/s126-carrying strain was stained with the various anti-MOD-1
antibodies described above, we observed that the two crude rat antisera raised
against the predicted MOD-1 intracellular domain stained, albeit very weakly, the
same set of cells that fluoresce in the n/s126-carrying strain (data not shown). It
is possible that further affinity purification of at least these two antisera will yield a
more sensitive tool for detecting endogenous MOD-1 protein.
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MOD-5
We generated GST- and 6xHIS-tagged fusion constructs with the N-terminal
portion (amino acids 67-273) of MOD-5. However, we did not detect any
production of fusion protein when these constructs were introduced into bacteria
(data not shown). It is possible that the three predicted transmembrane segments
contained within this region (Chapter 4, Figure 3B) affected expression in
bacteria. Therefore, we analyzed the MOD-5 protein sequence for a suitable
short stretch that would serve as a antigenic peptide for raising MOD-5 specific
antisera. The short peptide formed by amino acids 243-256 was chosen as this
region was not part of any predicted transmembrane region, had few similarities
to the entire set of predicted proteins in C. elegans (The C. elegans Sequencing
Consortium, 1998) and was likely to be antigenic as per the PolyQuik computer
algorithm (Zymed). We affinity-purified these antisera and tested them on both
western blots of total protein extracts from wild-type animals and on whole-mount
fixed preparations; we observed no detectable signal in either case.
The generation of gfp reporter constructs of mod-5 has proven difficult as
sequences from the mod-5 genomic region do not appear to be tolerated by
bacteria. Perhaps, this also explains why the mod-5 genomic region is only
contained within a yeast artificial chromosome and is not represented in any
bacterially derived clones (The C. elegans Sequencing Consortium, 1998).
Given the in vivo serotonin reuptake results we obtained (Chapter 4, Table
1), we think that it is very likely that MOD-5-express.ing cells will be the
serotonergic neurons in the animal. Nevertheless, this possibility must be
corroborated with direct evidence of protein or reporter expression. Two
promising venues must be explored: (a) Baculovirus expression systems for
making antigens for antibody generation and (b) making a gfp reporter construct
by inserting the gfp gene within the functional mod-5 minigene construct that we
were able to generate (Chapter 4 and Chapter 5, Figure 11).
Future Directions
In this section, I briefly outline the broad spectrum of experiments that I consider
most relevant to understanding the enhanced slowing response. This section is
by no means an exhaustive list of all possible experiments and is only meant to
serve as the starting point for further exploration.
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Analysis of Existing mod Mutants
The further analysis of the 11 mutations that are yet to be placed in
complementation groups is limited only by the absence of an exploration of the
pleiotropies that these mutations might exhibit. Our preliminary pharmacological
analysis (Table 1) has shown that at least three of these 11 mutations are
immediately tractable. A thorough exploration of the pharmacological profile of
these mutants should provide the requisite robust and easy assay for mapping
and cloning purposes.
The pleiotropies in these mutants need not be limited to a difference in the
liquid swimming assay described in this thesis and could well extend to other
easily quantifiable behaviors, such as egg laying or pharyngeal pumping.
Therefore, a survey of the responses of these mutants to various chemicals
could also assay behaviors other than swimming in liquid.
Suppressors of mod-5
From the pilot screen performed thus far, there are numerous mutations that are
amenable for further analysis (Table 2). However, I propose that it will be more
efficient to perform the screen to saturation with more stringent criteria to isolate
a collection of mutations such as n3461 and n3488, which exhibit strong
suppression for both the hypersensitivity to exogenous serotonin and the
hyperenhanced slowing response.
The large goal of this project is to analyze the enhanced slowing response
at the level of genes and molecules in an attempt to delineate the processes that
control the switch in the state of the animal from "well-fed" to "food-deprived."
Such processes could well lie upstream of the serotonergic synapses in which
MOD-1 and MOD-5 function (Chapter 4, Figure 8). If so, then the suppressor
screen, based on the hypersensitivity to exogenous serotonin of mod-5(n3314)
mutants, is unlikely to isolate mutations in upstream components, since it is
mainly geared towards the targets downstream of mod-5 that are involved in
responding to serotonin. Our preliminary observations suggested that the
presence of bacteria in the microtiter wells renders animals more sensitive to
exogenous serotonin (data not shown). It is possible that when bacteria are
present, endogenous serotonin is released and hence results in a higher
effective concentration at postsynaptic targets. Therefore, if this screen for
208
II
suppressors of mod-5(n3314) were performed in the presence of bacteria, it is
possible that mutations will be isolated in the signaling pathway that triggers the
release of endogenous serotonin. Such mutations might address the question of
what is involved in establishing and changing the behavioral state of the animal.
Further analysis of mod-1
Structure-Function
MOD-1 has the unique property of being a chloride channel that is gated by
serotonin. Structure-function analysis of the MOD-1 protein might reveal features
that are important to these aspects of channel function. As discussed in more
detail in the Introduction, merely three amino acids residues in the M2 region of a
anion or cation channel determine the ion selectivity of the channel (Galzi et al.,
1992; Keramidas et al., 2000). Can changing these three residues in MOD-1
convert MOD-1 into a cation channel? Answering this question is interesting, not
because it provides yet another example for an established principle, but
because it would allow us to understand how MOD-1 functions in vivo. As
discussed in the Introduction, depending on the concentration of ions on the two
sides of the neuronal membrane, activation of a chloride channel could lead to
either depolarization or hyperpolarization of the neuron expressing that chloride
channel. We do not know if activation of MOD-1 in vivo leads to neuronal
activation or inhibition. However, if we were to generate a variant of MOD-1 that
is a serotonin-gated non-selective cation channel, and express such a variant in
mod-i(ok103) null mutants, we could explore whether such a transgene could
rescue the Mod-1 mutant phenotype. If such rescue were observed, it would
suggest that the wild-type MOD-1 chloride channel is likely to function to
depolarize neurons. On the other hand, if the transgene-bearing animals were to
exhibit a phenotype opposite to that of mod-1 mutants, for example they
exhibited hypersensitivity to exogenous serotonin or a hyperenhanced slowing
response, we would conclude that wild-type MOD-1 acts as an inhibitory chloride
channel in vivo.
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Direct in vivo Analysis
Recent advances have been made in performing in vivo electrophysiological
recordings from C. elegans (Richmond et al., 1999). Such techniques could be
utilized to explore MOD-1 function in vivo. For example, if the response of a
MOD-1-expressing neuron to application of serotonin is measured, this would
allow us to determine if activation of MOD-1 excites or inhibits the neuron it is
expressed in. However, this experiment is subject to the drawback that the
experimenter has to perfuse an external bath solution on the exposed neurons
and therefore the MOD-1 activity recorded under these conditions may not reflect
the in vivo situation.
Another exciting alternative is the possibility of using FRET-based in vivo
measurement of chloride ion flux (Kuner and Augustine, 2000). Such
measurements would allow us to determine whether upon activation of MOD-1,
chloride ions enter the cell (leading to hyperpolarization) or they exit the cell
(leading to depolarization).
Suppressors of mod-1
A genetic screen for suppressors of mod-1 should define elements that function
downstream of or in parallel to mod-1. A screen seeking suppressors of the
resistance to exogenous serotonin of mod-1 mutants is likely to be yield
mutations that impair the ability of animals to swim, which would include a large
number of non-specific mutations that lead to dysfunction of the locomotory
neuromusculature. On the other hand, a screen for suppressors of the defective
enhanced slowing response of mod-1 mutants should be feasible. The assay
must be designed such that the animals have to move at a normal speed to
reach the bacterial source within a time interval before they exhibit their response
to bacteria. This requirement should eliminate the background of mutations that
would plague the first screen.
The Role of Neuropeptides in Sensing Food
Neuropeptides are thought to act as co-neurotransmitters or neuromodulators in
many systems and have been proposed to work in concert with serotonin in the
nervous system of both invertebrates and vertebrates (Fuller, 1996). There are
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approximately 30 neuropeptide genes in C. elegans (Bargmann, 1998) of which
at least 15 belong to the FRMFamide (Phe -Met-Arg-Phe-amide)-related
neuropeptide family (Nelson et al., 1998). These 15 FRMFamide-like genes are
capable of encoding 53 distinct FRMFamide (Phe-Met-Arg-Phe-amide)-related
neuropeptide (Nelson et al., 1998). Mutations in one such gene, flp-1, causes
numerous behavioral defects, including an increased amplitude during the
characteristically sinusoidal locomotion of C. elegans and a resistance to the
inhibitory effects of serotonin on locomotion (Nelson et al., 1998). flp-1 also
appears to act in concert with serotonin to control the states of egg laying in the
animal (Waggoner et al., 2000). Specifically, flp-1 mutants were not as
responsive as the wild type in assays of serotonin-mediated egg laying
suggesting that the neuropeptides made by the flp-1 gene are required for
serotonin to have its full effect on the egg-laying process (Waggoner et al.,
2000).
Given the roles of the flp-1 gene in serotonin-mediated behaviors, I
believe it will be worthwhile assaying flp-1 mutants and other mutations in
neuropeptide genes for defects in the enhanced slowing response. Analysis of
double-mutants between mutations in neuropeptide genes and cloned mod
genes may also be informative since some of the contributions of neuropeptides
might only be revealed in a sensitized background.
Fluoxetine Targets
We showed in Chapter 4 that fluoxetine can act on MOD-5- and serotonin-
independent targets to mediate nose contraction and paralysis. Fluoxetine also
stimulates egg laying in a MOD-5-independent and partially serotonin-
independent pathway. We suggested that targets of fluoxetine other than human
SERT might well be important for understanding the side-effects of fluoxetine in
humans. We can use the power of C. elegans genetics to screen for non-MOD-5
targets in the hope that human homologs of such targets are involved in
mediating the effects of fluoxetine in humans.
I suggest that future experiments be based on fluoxetine-induced egg-
laying behavior, for several reasons. First, other groups (Choy and Thomas,
1999) are actively studying the nose contraction response to fluoxetine. Second,
the paralysis phenotype is variable and unlikely to be robust enough to be useful
in genetic screens (Choy and Thomas, 1999; my unpublished observations).
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Third, the egg laying phenotype lends itself to robust quantitation, which should
prove helpful during further analysis.
Before performing a genetic screen seeking mutants resistant to fluoxetine
in the egg-laying behavior, a general survey should be performed of C. elegans
mutants defective in neurotransmitter signaling pathways for their response to
fluoxetine treatment. We tested tph-1 mutants, that are defective in serotonin
biosynthesis (Sze et al., 2000), and found them to be partially resistant to
fluoxetine-mediated egg laying (Chapter 4). Preliminary analysis suggests that
tbh-1 mutants that are defective in octopamine biosynthesis (M. Alkema and H.
R. H., unpublished observations) and adc-1 mutants that are probably defective
in histamine biosynthesis (M. Hunter-Ensor and H. R. H., unpublished
observations) are no different from the wild type in their responses to fluoxetine
in assays of egg laying, nose contraction, and paralysis (data not shown). cat-2
mutants appeared to be resistant to fluoxetine-induced egg laying (data not
shown). However, cat-2 mutants have fewer eggs in the gonad than the wild type
(data not shown). Therefore, these assays with cat-2 must be repeated: the
number of eggs laid in response to fluoxetine and the number of eggs retained in
the animals after the fluoxetine treatment should be quantified to obtain a
measure of the percentage of available eggs that are laid in response to
fluoxetine treatment. Mutants that lack neuropeptides, such as f/p-1, should be
tested
Fluoxetine has been shown to directly inhibit nicotinic acetylcholine
receptors in heterologous expression systems (Maggi et al., 1998; Fryer and
Lukas, 1999; Garcia-Colunga and Miledi, 1999). Since acetylcholine stimulates
egg laying (Weinshenker et al., 1995; Waggoner et al., 2000), inhibition of
acetylcholine function in C. elegans is unlikely to stimulate egg laying. There is
no a priori reason to negate the possibility that fluoxetine could still affect
cholinergic function in C. elegans. Therefore, I think that mutants defective in
cholinergic neurotransmission should be tested for their response to fluoxetine
treatment, since fluoxetine may well act differently in vivo. Such mutants should
include cha-1, which encodes the choline acetyltransferase (Alfonso et al., 1994);
lev-1, unc-29, and unc-38, which encode nicotinic acetylcholine receptor
(nAChR) subunits (Fleming et al., 1997); and unc-17, unc-18, unc-41, unc-13,
unc-63, unc- 11, and unc-64, all of which have defects in acetylcholine release
(Hosono and Kamiya, 1991). unc-25 mutants deficient in GABA (Jin et al., 1999)
should also be tested.
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The design of any genetic screen for mutants resistant to stimulation of
egg laying by fluoxetine will be shaped by the results of the general survey
outlined above. Nevertheless, such a screen should be done in a mod-5 genetic
background, so that only targets other than mod-5 are isolated.
A Comparison of the Effect of Food and Serotonin on Olfaction and the
Enhanced Slowing Response
In Chapter 1, 1 discussed the olfaction studies by Colbert and Bargmann (1997)
wherein they observed that if animals had been starved for 60 minutes or longer
prior to the olfactory adaptation regimen (usually 60 minutes in the presence of a
field of uniform odorant concentration), the adaptation was enhanced. They also
noted that the presence of serotonin during the starvation prevented the
starvation-mediated enhancement of adaptation. By contrast, we did not observe
a block of the enhanced slowing response when wild-type animals were deprived
of food in the presence of serotonin. (Chapter 2, Figure 2B). In this section, I
discuss the possible reasons for this apparent difference, propose a model to
explain both sets of observations, and outline further tests that could be
performed.
Throughout this dissertation, we have refrained from referring to the
removal of animals for 30 minutes from food as starvation primarily because we
did not want to make assumptions about the motivational drive of the animal.
Furthermore, this also allows us to maintain a distinction between the treatment
used to elicit the enhanced slowing response and the longer periods of removal
from food used and referred to as starvation by others (Colbert and Bargmann,
1997; Mori, 1999). The differences in the protocols used in this dissertation and
by Colbert and Bargmann (1997) are as follows:
(1) The duration away from food
The enhanced slowing response is assayed after just 30 minutes of food-
deprivation (Chapter 2), whereas at least 60 minutes of starvation are required to
enhance olfactory adaptation; a two- to three-hour starvation period is the
standard treatment used by Colbert and Bargmann (1997). Moreover, it is
important to note that while the animals are adapting to the odorant (usually for
60-90 minutes) they are in the absence of food (Colbert and Bargmann, 1995;
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Colbert and Bargmann, 1997). Therefore, all animals that experience the
adaptation protocol (with or without the odorant) were starved for at least 60
minutes. And animals that were starved before the adaptation were away from
food for at least 3 hours before the chemotaxis assay. Thus, Colbert and
Bargmann (1997) are assaying the effect of the additional duration of time away
from food (two- to three-hour starvation period) prior to the duration of
adaptation.
(2) The differential effect of serotonin treatment
The experiments in Chapter 2 use a pretreatment to serotonin in the presence of
food for two hours prior to the 30 minutes of food deprivation. The animals are
also exposed to serotonin during the 30 minutes of food deprivation. In Colbert
and Bargmann (1997), the animals are exposed to serotonin in the presence
(well-fed) or absence (starved) of food for two hours before they undergo the
adaptation regimen which, as noted above, involves another 60 minutes of
further food-deprivation, but now in the absence of serotonin in all cases.
These differences in the assay may account for the discrepancy we noted
above between our results and those of Colbert and Bargmann (1997).
Hormonal and Neuronal Roles for Serotonin
The following is a highly speculative model to explain the effect of the differences
in the protocols in the two studies:
Animals when deprived of food for 30 minutes have an altered internal
state that allows them to respond to newly-found sources of food by slowing their
locomotory rate (the enhanced slowing response). This altered state does not
change their olfactory sensibilities. When the animals are starved for 2 hours or
greater, they are now in a different internal state that enhances their proclivity to
ignore olfactory stimuli that have been present during the period of starvation.
Suspending our disinclination to divine the motivational state of the worm under
these situations, these two different internal states may be better understood
from the perspective of the animal: When food has been scarce for only 30
minutes, there is no need yet to activate dramatically different sensory modalities
to find a new food source, but it would still be prudent to slow down when a food
source is perchance encountered. However, when food has been scarce for
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longer periods of time, there is now the need to ignore the sensory stimuli that
are present in the nearby locale where there has been no food and make the
effort to sense olfactory stimuli further afield that might lead to new sources of
food. Serotonin plays a role in both these internal states but in mechanistically
distinct ways. During the first 30 minutes of food deprivation, no serotonin is
released as no bacterial stimulus is present. And when a food source is then
encountered, there is an increased release of serotonin that leads to the
enhanced slowing response. This brief absence of serotonin signaling does not
affect olfactory circuits. But starvation, i. e., 120 or more minutes away from food,
results in a prolonged absence of serotonin release which allows the olfactory
circuit to either lose certain negative feedback mechanisms or gain some new
positive input involved in establishing normal olfactory adaptation. The end result
is enhanced adaptation.
Furthermore, I propose that the mechanisms of serotonin action on the
locomotory and olfactory circuit are distinct - I suggest that it is a hormonal
effect of serotonin that leads to the enhancement of olfactory adaptation and that
this can occurs at the 2-5 mM exogenous serotonin used (Colbert and
Bargmann, 1997) during the two or more hours of starvation. By contrast, I
suggest that serotonin acting in the enhanced slowing response is neuronal. The
2 mM exogenous serotonin pretreatment does not lead to the stimulation of
locomotory circuit, possibly because either a higher effective concentration of
serotonin is required at the relevant synapses to achieve locomotory inhibition or
the active serotonin reuptake mechanism in serotonergic neurons (Chapter 4)
ensures that not enough serotonin lingers in the relevant synaptic cleft to have an
effect. However, when food is detected again, the sudden burst of serotonin
release from serotonergic neurons is sufficient to bring about the enhanced
slowing response.
Outlined below are experiments that might begin to test the hypothesis
presented above: tph-1, mod-1, and mod-5 mutants should be tested for their
starvation-mediated enhancement of olfactory adaptation. mod-1 and mod-5
mutants exhibit normal chemotaxis to several chemicals (E. Miska and H. R. H.,
unpublished observations). For the sake of the model proposed here, these
mutants need to be normal in the standard adaptation assay and in the
starvation-mediated enhancement of olfactory adaptation. This may not be the
case if absence of these genes during development affected the olfactory circuit
in a manner not discernable in standard assays of chemotaxis or adaptation of
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chemotaxis. The key question then would be whether the presence of serotonin
during starvation can now inhibit the starvation-mediated enhancement of
olfactory adaptation of any of these mutants.
If serotonin is acting as a hormone in the olfactory adaptation paradigm,
tph-1, mod-5, and mod-1 mutants should exhibit normal inhibition since these
gene products should not interfere with the hormonal effects of exogenously
added serotonin on the olfactory circuit. However, it is conceivable that mod-1
mutants may be defective if the MOD-1 ion channel happens to be required in
the olfactory circuit to respond to the effect of hormonal serotonin.
If serotonin is acting as a neurotransmitter in the olfactory adaptation
paradigm, serotonergic neurons should be involved in the signaling process, and
at least mod-5 mutants would be defective: they would be expected to show
inhibition of starvation-mediated enhancement of olfactory adaptation at much
lower concentrations of serotonin. mod-1 mutants may also be defective if the
MOD-1 ion channel is required for this neuronal effect of serotonin on the
olfactory circuit.
In sum, I propose that serotonin acts differently on different neural circuits;
as a neurotransmitter while modulating locomotion, but as a hormone while
modulating olfaction. Furthermore, I suggest that in response to the duration of
time that the animal has been away from food, the animal can exist in different
internal states and that these different states utilize serotonin in distinct ways.
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Experimental Procedures
mod-6 Mapping
mod-6(n3076) was mapped to LG I based upon two-factor linkage to dpy-5 1.
The following three-factor data were obtained: unc-11 (28/28) dpy-5 (5/28*)
mod-6, mod-6 (2/22*) dpy-24 (22/22) unc- 101, dpy-5 (43/62) mod-6 (19/62) unc-
29, dpy-5 (37/37) unc-13 (2/37*) mod-6, dpy-14 (6/14) mod-6 (8/14) unc-29. The
asterisks represent the instances where we inferred from all of the mapping
experiments that the isolates must have had A-non B chromosomes with two
crossover events. All mapping experiments were performed by mating
hermaphrodites homozygous for the recombinant chromosome with
mod-5(n3076) males and scoring the F1 cross progeny for 5-HT hypersensitivity.
Pharmacological Analysis
The data presented in Table 1 were generated following the scheme outlined
here. Approximate synchrony of the animals was be achieved by picking L4
larval-stage animals the day before the assay. Assays of swimming behavior
were performed in 96-well microtiter plates with 100 or 200 p1 of M9 solution
containing the drug. Dissolving chemicals in water appeared to dramatically
enhance the bioavailability; this could be used in the case of compounds that do
not dissolve easily or no response is seen at the highest concentrations that
dissolve in M9. However, water is not a isotonic solution for C. elegans and
hence extended exposure could result in non-specific effects. S-Basal solution is
not recommended as a solvent for these assays as the cholesterol in S Basal
interferes with solubility of many compounds. Fresh solutions were made for use
the same day. Reusing frozen stocks solutions of neuroactive chemicals should
be avoided, especially in the absence of information about stability. For each
chemical, the dependence of the response of wild-type animals on both time (5-
120 minute range) and concentration (at least 2 orders of magnitude) was
determined. At least 10 animals were tested in each microtiter well at each
concentration and their response over time was recorded at regular intervals.
Controls with no drugs were performed for mutant animals to ensure that there
were no non-specific defects in the swimming ability of the mutants. Once the
relevant concentration and time range for wild-type animals had been
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Iestablished, mutant and wild-type animals were tested in parallel using the same
batch of solution. Tests were designed to reveal both resistance (using high
concentrations and long times) and hypersensitivity (using low concentrations
and short times) to the chemical. Often, a difference was be detected only within
a specific time window within a certain concentration range. Once the assay was
established, we determined whether the response to a chemical was recessive or
dominant. If the mutant heterozygotes cannot be easily separated from either
wild-type animals or homozygous mutants, using that particular assay for
mapping purposes will be difficult.
Protein Production
PCR fragments were generated with the following primers using template
plasmid pRR18 (full length mod-1 cDNA): GCTAGCAGGCATGGCGGATCCACA
CAGGCTAAAGGAAAACG and GTAGCCAGCTAGCGGGGATCCAACTTGAAG
CTGATCCCAG (GST fusion of MOD-1 N-terminus), GCTAGCAGGCATGGCGG
ATCCTGTCAGAACAGCGTAAG and GTAGCCAGCTAGCGGGGATCCCACTG
CTTCCGGATGG (GST fusion of MOD-1 intracellular domain), GCTAGCAGGCA
TGGCCTCGAGACACAGGCTAAAGGAAAACG and GTAGCCAGCTAGCGGCT
CGAGAACTTGAAGCTGATC CCAG (6xHIS fusion of MOD-1 N-terminus),
GCTAGCAGGCATGGCCTCGAGA CACAGGCTAAAGGAAAACG and
GTAGCCAGCTAGCGGCTCGAGAACTTGAAGCTGATCCCAG (6xHIS fusion of
MOD-1 N-terminus). The PCR products for the GST fusions were digested with
Bam HI and ligated into plasmid pGEX-2T (Pharmacia) digested with Bam HI.
The PCR products for the 6xHIS fusions were digested with Xho I and ligated
into plasmid pET19b (Novagen) digested with Xho I. In all cases, directionality of
insert was checked by diagnostic restriction digests and the insert was
sequenced to ensure that no errors were introduced during the PCR. The protein
was produced in E. coli and purified by polyacrylamide gel electrophoresis
according to standard methods (Harlow and Lane, 1988). Polyclonal antibodies
were prepared by immunizing rabbits and rats with the purified fusion proteins.
Crude antisera were used at dilutions ranging from 1:100 to 1:2000 on both
western blots and whole mounts. Antisera were purified by binding to a
nitrocellulose filter strip containing the 6xHIS fusions of the corresponding
antigens and eluting the specifically bound antibodies with 100 mM glycine (pH
2.5). Affinity purified antisera were used at dilutions of ranging from 1:200 to
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1:5000 on both western blots and whole mounts. For western blots, the
immunoreactivity was visualized by using horse-radish peroxidase-conjugated
secondary antibodies (Bio-Rad) and chemiluminescent detection reagents
(Amersham). Whole-mount immunofluorescence staining was performed as
described previously (Finney and Ruvkun, 1990; McIntire et al., 1992; Nonet et
al., 1993; Nonet et al., 1997).
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Tables
Table 1. Preliminary Pharmacological Analysis of a Subset of mod Mutants
Genotype Serotonin Serotonin Serotonina Octopamine Phentolamine
(33 mM) (20 mM) (14 mM) (35 mg/ml) (4 mg/ml)
n3052 N 10% R N N inc.
n3057 N 15% R 25% R N 85% R
n3053 5% R 50% R 80% R N inc.
n3074 N 30% R 30% R N 65% R
n3075 N 45% R 45%R N inc.
n3056 5% R 40% R 40%R N inc.
N; Normal, R; Resistant, inc.; inconclusive. In all cases, the data presented are
the responses after 20 minutes of exposure. There were instances where the
difference between mutant and wild-type responses was greater at shorter time
intervals (data not shown).
aSince wild-type animals were not completely immobilized after 20 minutes at this
serotonin concentration, we subtracted the percentage of wild-type animals not
immobilized from the percentage of resistant mutant animals.
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Serotonin Sensil
Allele % immobilized
n3510 0
n3461 5
n3488 10
n3475 15
n3495 20
n3473 25
n3483 25
n3484 25
n3498 25
n3469 30
n3470 30
n3477 40
n3490 40
n3514 40
n3525 40
n3504 45
n3463 50
n3474 50
n3505 50
n3507 50
n3518 50
n3520 50
n3479 55
n3489 55
n3493 55
n3496 55
n3517 55
n3472 65
n3491 65
n3500 65
n3501 65
Table 2.
20 animals were placed in 200 ml of 5 mM serotonin and swimming
activity was recorded 5 minutes later.
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ivity of Suppressors of mod-5(n3314)
Allele % immobilized
n3464 70
n3499 70
n3503 70
n3482 75
n3502 75
n3508 75
n3462 80
n3468 80
n3476 80
n3481 80
n3486 80
n3494 80
n3497 80
n3506 80
n3519 80
n3465 85
n3467 85
n3471 85
n3478 85
n3487 85
n3492 85
n3509 85
n3511 85
n3513 85
n3516 85
n3466 90
n3480 90
n3485 90
n3512 90
n3515 90
I
1Table 3. Preliminary Identification of Neurons Expressing mod-1::gfp Reporter.
Certain
AVE
AIB
RIB
Need confirmation
AIY - use ttx-3 reporter (Hobert et al., 1997) to confirm; need to rule out AIM
AIZ - use lin-11 reporter (Hobert et al., 1998) to confirm
DB neurons in the ventral cord - use acr-5 reporter (Winnier et al., 1999) to
confirm
A note of caution: Relying on other reporters for colocalization data can be
misleading if the cell identifications using the other reporters were not performed
rigorously.
Likely
RID
RIP or RMEL (adult-specific)
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Figure 1. mod-6(n3076) Mutants Are Hypersensitive to Exogenous Serotonin
Animals were placed in 200 I1 of 10 mM serotonin and the number of animals immobilized
recorded after 9 minutes (3 trials with 20 animals each). mod-6(n3076)/+ heterozygotes were
obtained by crossing mod-6(n3076) males to lon-2 hermaphrodites. Ion-2 does not affect sero-
tonin sensitivity (data not shown). Error bars, SEM.
100
N 80
0
CD
E 60
E
Z- 40
0
o -
Eo~
Figure 2. Genetic Screen for Isolating Suppressors of mod-5(n3314)
Gravid mod-5(n3314) hermaphrodites were treated with alkaline bleach (Wood et
al., 1988) to release eggs contained within the animals. These animals were
synchronized by starvation-arrest as Li larvae. They were then seeded onto
plates with food and allowed to grow. Standard ethyl methanesulphonate
mutagenesis (Brenner, 1974) was performed on late L4 larvae. These
mutagenized Pos were plated at low density onto large plates so that the F1 s
would become adults before they exhausted the food on the plates. These F1 s
were then subjected to the alkaline bleach treatment to harvest the F2 eggs and
these F2s were once again synchronized by starvation-arrest as Li s. The F2
eggs from each plate containing Pos were kept separate. The F2s were then
plated at -300 animals/plate (one plate per F2 population) as this was the
maximum number that could be optimally screened in one well of serotonin.
Given the large number of F1s that generated the large collection of F2s from
which the 300 animals were plated, each of the 300 animals has a high
probability of harboring an independent mutation and hence each F2 animal
tested was considered to represent 0.5 haploid genomes. The -300 F2s were
rinsed off the plate with 1 ml of M9 and added to 1 ml of 35 mM serotonin
dissolved in M9, resulting in a final concentration of 17.5 mM serotonin. After 5
minutes, animals that were still swimming were removed and plated 1 animal per
plate.
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Figure 2
Mutagenize mod-5(n3314)
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